Reviewer #1 (Public review):

This work provides important new evidence of the cognitive and neural mechanisms that give rise to feelings of shame and guilt, as well as their transformation into compensatory behavior. The authors use a well-designed interpersonal task to manipulate responsibility and harm, eliciting varying levels of shame and guilt in participants. The study combines behavioral, computational, and neuroimaging approaches to offer a comprehensive account of how these emotions are experienced and acted upon. Notably, the findings reveal distinct patterns in how harm and responsibility contribute to guilt and shame and how these factors are integrated into compensatory decision-making.

Strengths:

• Investigating both guilt and shame in a single experimental framework allows for a direct comparison of their behavioral and neural effects while minimizing confounds

• The study provides a novel contribution to the literature by exploring the neural bases underlying the conversion of shame into behavior

• The task is creative and ecologically valid, simulating a realistic social situation while retaining experimental control

• Computational modeling and fMRI analysis yield converging evidence for a quotient-based integration of harm and responsibility in guiding compensatory behavior

Limitations:

The authors address the study's limitations and offer well-reasoned explanations for their methodological choices.

The conclusions of the paper are well supported by the data. It would be valuable for future studies to validate these findings using alternative tasks or paradigms, to ensure the robustness and generalizability of the observed behavioral and neural mechanisms. Overall, this is a well-executed and insightful study that makes a meaningful contribution to understanding the cognitive and neural mechanisms underlying guilt and shame.

Reviewer #2 (Public review):

Summary:

The authors combined behavioral experiments, computational modeling, and functional magnetic resonance imaging (fMRI) to investigate the psychological and neural mechanisms underlying guilt, shame, and the altruistic behaviors driven by these emotions. The results revealed that guilt is more strongly associated with harm, whereas shame is more closely linked to responsibility. Compared to shame, guilt elicited a higher level of altruistic behavior. Computational modeling demonstrated how individuals integrate information about harm and responsibility. The fMRI findings identified a set of brain regions involved in representing harm and responsibility, transforming responsibility into feelings of shame, converting guilt and shame into altruistic actions, and mediating the effect of trait guilt on compensatory behavior.

Strengths:

This study offers a significant contribution to the literature on social emotions by moving beyond prior research that typically focused on isolated aspects of guilt and shame. The study presents a comprehensive examination of these emotions, encompassing their cognitive antecedents, affective experiences, behavioral consequences, trait-level characteristics, and neural correlates. The authors have introduce a novel experimental task that enables such a systematic investigation and holds strong potential for future research applications. The computational modeling procedures were implemented in accordance with current field standards. The findings are rich and offer meaningful theoretical insights. The manuscript is well written, and the results are clearly and logically presented.

Weaknesses:

In this study, participants' feelings of guilt and shame were assessed retrospectively, after they had completed all altruistic decision-making tasks. This reliance on memory-based self-reports may introduce recall bias, potentially compromising the accuracy of the emotion measurements.

In many behavioral economic models, self-interest plays a central role in shaping individual decision-making, including moral decisions. However, the model comparison results in this study suggest that models without a self-interest component (such as Model 1.3) outperform those that incorporate it (such as Model 1.1 and Model 1.2). The authors have not provided a satisfactory explanation for this counterintuitive finding.

The phrases "individuals integrate harm and responsibility in the form of a quotient" and "harm and responsibility are integrated in the form of a quotient" appear in the Abstract and Discussion sections. However, based on the results of the computational modeling, it is more accurate to state that "harm and the number of wrongdoers are integrated in the form of a quotient." The current phrasing misleadingly suggests that participants represent information as harm divided by responsibility, which does not align with the modeling results. This potentially confusing expression should be revised for clarity and accuracy.

In the Discussion, the authors state: "Since no brain region associated social cognition showed significant responses to harm or responsibility, it appears that human brain encodes a unified measure integrating harm and responsibility (i.e., the quotient) rather than processing them as separate entities when both are relevant to subsequent emotional experience and decision-making." However, this interpretation overstates the implications of the null fMRI findings. The absence of significant activation in response to harm or responsibility does not necessarily imply that the brain does not represent these dimensions separately. Null results can arise from various factors, including limitations in the sensitivity of fMRI. It is possible that more fine-grained techniques, such as intracranial electrophysiological recordings, could reveal distinct neural representations of harm and responsibility. The interpretation of these null findings should be made with greater caution.

For the revised manuscript, the authors have provided additional evidence and clarified expressions. all the comments were responded. I have no further comments.

Reviewer #3 (Public review):

Summary:

Zhu et al. set out to elucidate how the moral emotions of guilt and shame emerge from specific cognitive antecedents - harm and responsibility - and how these emotions subsequently drive compensatory behavior. Consistent with their prediction derived from functionalist theories of emotion, their behavioral findings indicate that guilt is more influenced by harm, whereas shame is more influenced by responsibility. In line with previous research, their results also demonstrate that guilt has a stronger facilitating effect on compensatory behavior than shame. Furthermore, computational modeling and neuroimaging results suggest that individuals integrate harm and responsibility information into a composite representation of the individual's share of the harm caused. Brain areas such as the striatum, insula, temporoparietal junction, lateral prefrontal cortex, and cingulate cortex were implicated in distinct stages of the processing of guilt and/or shame. In general, this work makes an important contribution to the field of moral emotions. Its impact could be further enhanced by clarifying methodological details, offering a more nuanced interpretation of the findings, and discussing their potential practical implications in greater depth.

Strengths:

First, this work conceptualizes guilt and shame as processes unfolding across distinct stages (cognitive appraisal, emotional experience, and behavioral response) and investigates the psychological and neural characteristics associated with their transitions from one stage to the next.

Second, the well-designed experiment effectively manipulates harm and responsibility - two critical antecedents of guilt and shame.

Third, the findings deepen our understanding of the mechanisms underlying guilt and shame beyond what has been established in previous research.

Comments on revisions:

The authors have addressed the issues I raised in the previous review. I have no more comments on the manuscript.

Reviewer #1 (Public review):

Summary:

In this review, the author covered several aspects of the inflammation response, mainly focusing on the mechanisms controlling leukocyte extravasation and inflammation resolution.

Strengths:

This review is based on an impressive number of sources, trying to comprehensively present a very broad and complex topic. The revised version strengthens the connection with the ECM and all sections are now better integrated.

Reviewer #2 (Public review):

Summary:

The manuscript is a timely and comprehensive review of how the extracellular matrix (ECM), particularly the vascular basement membrane, regulates leukocyte extravasation, migration, and downstream immune function. It integrates molecular, mechanical, and spatial aspects of ECM biology in the context of inflammation, drawing from recent advances. The framing of ECM as an active instructor of immune cell fate is a conceptual strength.

Strengths:

• Comprehensive synthesis of ECM functions across leukocyte extravasation and post-transmigration activity.
• Incorporation of recent high-impact findings alongside classical literature.
• Conceptually novel framing of ECM as an active regulator of immune function.
• Effective integration of molecular, mechanical, and spatial perspectives.

Weaknesses:

• Some sections remain dense with signalling detail.
• Figure readability could be improved through simplified labeling.

Appraisal and Impact:

The authors have achieved their aim of presenting an integrated view of ECM-immune interactions. The review provides conceptual and visual clarity on a complex topic.

Reviewer #3 (Public review):

Summary & Strengths:

This review by Yu-Tung Li sheds new light on the processes involved in leukocyte extravasation, with a focus on the inter between leukocytes and the extracellular matrix. In doing so, it presents a fresh perspective on the topic of leukocyte extravasation, which has been extensively covered in numerous excellent reviews. Notably, the role of the extracellular matrix in leukocyte extravasation has received relatively little attention until recently. This review synthesizes the substantial knowledge accumulated over the past two decades in a novel and compelling manner.

The author discusses the relevant barriers leukocytes face during extravasation, addresses interactions with and transmigrate through endothelial junctions, mechanisms supporting extravasation, and how minimal plasma leakage is achieved during this process. The question whether extravasation affects leukocyte differentiation and properties is original and thought-provoking and has received limited consideration thus far. The consequences leukocytes extracellular matrix interaction, non-linear responses to substrate stiffness and effects on macrophage polarization, efferocytosis and the outcome of inflammation are relevant topics raised. Finally, a unifying descriptive framework MIKA is introduced, which provides a tool for classifying macrophages based on their expression patterns and could inform the development of targeted therapies aimed at modulating macrophage identity and improving outcomes in inflammatory scenarios.

In summary, this review provides a stimulating perspective on leukocyte extravasation in the context of extracellular matrix biology.

Weaknesses:

One potential drawback of this review is that the attempt to integrate a vast amount of information has resulted in complex figures, which may lead to important details being overlooked by readers.

Reviewer #1 (Public review):

Summary:

The work used open peer reviews and followed them through a succession of reviews and author revisions. It assessed whether a reviewer had requested the author include additional citations and references to the reviewers' work. It then assessed whether the author had followed these suggestions and what the probability of acceptance was based on the authors decision. Reviewers who were cited were more likely to recommend the article for publication when compared with reviewers that were not cited. Reviewers who requested and received a citation were much likely to accept than reviewers that requested and did not receive a citation.

Strengths and weaknesses:

The work's strengths are the in-depth and thorough statistical analysis it contains and the very large dataset it uses. The methods are robust and reported in detail.

I am still concerned that there is a major confounding factor: if you ignore the reviewers requests for citations are you more likely to have ignored all their other suggestions too? This has now been mentioned briefly and slightly circuitously in the limitations section. I would still like this (I think) major limitation to be given more consideration and discussion, although I am happy that it cannot be addressed directly in the analysis.

Reviewer #2 (Public review):

Summary:

This article examines reviewer coercion in the form of requesting citations to the reviewer's own work as a possible trade for acceptance and shows that, under certain conditions, this happens.

Strengths:

The methods are well done and the results support the conclusions that some reviewers "request" self-citations and may be making acceptance decisions based on whether an author fulfills that request.

Weakness:

I thank the author for addressing my comments about the original version.

Reviewer #3 (Public review):

Summary:

In this article, Barnett examines a pressing question regarding citing behavior of authors during the peer review process. In particular, the author studies the interaction between reviewers and authors, focusing on the odds of acceptance, and how this may be affected by whether or not the authors cited the reviewers' prior work, whether the reviewer requested such citations be added, and whether the authors complied/how that affected the reviewer decision-making.

Strengths:

The author uses a clever analytical design, examining four journals that use the same open peer review system, in which the identities of the authors and reviewers are both available and linkable to structured data. Categorical information about the approval is also available as structured data. This design allows a large scale investigation of this question.

Weaknesses:

My original concerns have been largely addressed. Much more detail is provided about the number of documents under consideration for each analysis, which clarifies a great deal.

Much of the observed reviewer behavior disappears or has much lower effect sizes depending on whether "Accept with Reservations" is considered an Accept or a Reject. This is acknowledged in the results text. Language has been toned down in the revised version.

The conditional analysis on the 441 reviews (lines 224-228) does support the revised interpretation as presented.

No additional concerns are noted.

Reviewer #4 (Public review):

Summary:

This work investigates whether a citation to a referee made by a paper is associated with a more positive evaluation by that referee for that paper. It provides evidence supporting this hypothesis. The work also investigates the role of self-citations by referees where the referee would ask authors to cite the referee's paper.

Strengths:

This is an important problem: referees for scientific papers must provide their impartial opinions rooted in core scientific principles. Any undue influence due to the role of citations breaks this requirement. This work studies the possible presence and extent of this.

The methods are solid and well done. The work uses a matched pair design which controls for article-level confounding and further investigates robustness to other potential confounds.

Weaknesses:

The authors have addressed most concerns in the initial review. The only remaining concern is the asymmetric reporting and highlighting of version 1 (null result) versus version 2 (rejecting null). For example the abstract says "We find that reviewers who were cited in the article under review were more likely to recommend approval, but only after the first version (odds ratio = 1.61; adjusted 99.4% CI: 1.16 to 2.23)" instead of a symmetric sentence "We find ... in version 1 and ... in version 2"

Reviewer #1 (Public review):

Overall, the manuscript reveals the role for actin polymerization to drive fusion of myoblasts during adult muscle regeneration. This pathway regulates fusion in many contexts, but whether it was conserved in adult muscle regeneration remained unknown. Robust genetic tools and histological analyses were used to convincingly support the claims.

Reviewer #2 (Public review):

To fuse, differentiated muscle cells must rearrange their cytoskeleton and assemble actin-enriched cytoskeletal structures. These actin foci are proposed to generate mechanical forces necessary to drive close membrane apposition and the fusion pore formation. While the study of these actin-rich structures has been conducted mainly in drosophila and in vertebrate embryonic development, the present manuscript present clear evidence this mechanism is necessary for fusion of adult muscle stem cells in vivo, in mice. The data presented here clearly demonstrate that ARP2/3 and SCAR/WAVE complexes are required for differentiating satellite cells fusion into multinucleated myotubes, during skeletal muscle regeneration.

Reviewer #3 (Public review):

This manuscript addresses an important biological question regarding the mechanisms of muscle cell fusion during regeneration. The primary strength of this work lies in the clean and convincing experiments, with the major conclusions being well-supported by the data provided.

The authors have satisfactorily addressed my inquiries.

Reviewer #1 (Public review):

The revised manuscript addresses several reviewer concerns, and the study continues to provide useful insights into how ZIP10 regulates zinc homeostasis and zinc sparks during fertilization in mice. The authors have improved the clarity of the figures, shifted emphasis in the abstract more clearly to ZIP10, and added brief discussion of ZIP6/ZIP10 interactions and ZIP10's role in zinc spark-calcium oscillation decoupling. However, some critical issues remain only partially addressed.

(1) Oocyte health confound: The use of Gdf9-Cre deletes ZIP10 during oocyte growth, meaning observed defects could result from earlier disruptions in zinc signaling rather than solely from the absence of zinc sparks at fertilization. The authors acknowledge this and propose transcriptome profiling as a future direction. However, since mRNA levels often do not accurately reflect protein levels and activity in oocytes, transcriptomics may not be particularly informative in this context. Proteomic approaches that directly assess the molecular effects of ZIP10 loss seem more promising. Although current sensitivity limitations make proteomics from small oocyte samples challenging, ongoing improvements in this area may soon allow for more detailed mechanistic insights.

(2) ZIP6 context and focus: The authors clarified the abstract to emphasize ZIP10, enhancing narrative clarity. This revision is appropriate and appreciated.

(3) Follicular development effects: The biological consequences of ZIP6 and ZIP10 knockout during folliculogenesis are still unknown. The authors now say these effects will be studied in the future, but this still leaves a major mechanistic gap unaddressed in the current version.

(4) Zinc spark imaging and probe limitations: The addition of calcium imaging enhances the clarity of Figure 3. However, zinc fluorescence remains inadequate, and the authors depend solely on FluoZin-3AM, a dye known for artifacts and limited ability to detect subcellular labile zinc. The suggestion that C57BL/6J mice may differ from CD1 in vesicle appearance is plausible but does not fully address concerns about probe specificity and resolution. As the authors acknowledge, future studies with more selective probes would increase confidence in both the spatial and quantitative analysis of zinc dynamics.

(5) Mechanistic insight remains limited: The revised discussion now recognizes the lack of detailed mechanistic understanding but does not significantly expand on potential signaling pathways or downstream targets of ZIP10. The descriptive data are useful, but the inability to pinpoint how ZIP10 mediates zinc spark regulation remains a key limitation. Again, proteomic profiling would probably be more informative than transcriptomic analysis for identifying ZIP10-dependent pathways once technical barriers to low-input proteomics are overcome.

Overall, the authors have reasonably revised and clarified key points raised by reviewers, and the manuscript now reads more clearly. However, the main limitation, lack of mechanistic insight and the inability to distinguish between developmental and fertilization-stage roles of ZIP10, remains unresolved. These should be explicitly acknowledged when framing the conclusions.

Comments on revisions: I have no further comments to add to this review.

Reviewer #1 (Public review):

Summary:

The manuscript "Lifestyles shape genome size and gene content in fungal pathogens" by Fijarczyk et al. presents a comprehensive analyses of a large dataset of fungal genomes to investigate what genomic features correlate with pathogenicity and insect associations. The authors focus on a single class of fungi, due to the diversity of life styles and availability of genomes. They analyze a set of 12 genomic features for correlations with either pathogenicity or insect association and find that, contrary to previous assertions, repeat content does not associate with pathogenicity. They discover that the number of protein coding genes, including total size of non-repetitive DNA does correlate with pathogenicity. However, unique features are associated to insect associations. This work represents an important contribution to the attempts to understand what features of genomic architecture impact the evolution of pathogenicity in fungi.

Strengths:

The statistical methods appear to be properly employed and analyses thoroughly conducted. The size of the dataset is impressive and likely makes the conclusions robust. The manuscript is well written and the information, while dense, is generally presented in a clear manner.

Reviewer #2 (Public review):

Summary:

In this paper, the authors report on the genomic correlates of the transition to the pathogenic lifestyle in Sordariomycetes. The pathogenic lifestyle was found to be better explained by the number of genes, and in particular effectors and tRNAs, but this was modulated by the type of interacting host (insect or not insect) and the ability to be vectored by insects.

Strengths:

The main strengths of this study lie in (i) the size of the dataset, and the potentially high number of lifestyle transitions in Sordariomycetes, (ii) the quality of the analyses and the quality of the presentation of the results, (iii) the importance of the authors' findings.

Weaknesses:

The weakness is a common issue in most comparative genomics studies in fungi, but it remains important and valid to highlight it. Defining lifestyles is complex because many fungi go through different lifestyles during their life cycles (for instance, symbiotic phases interspersed with saprotrophic phases). In many fungi, the lifestyle referenced in the literature is merely the sampling substrate (such as wood or dung), which does not necessarily mean that this substrate is a key part of the life cycle. The authors discuss this issue, but they do not eliminate the underlying uncertainties.

[Editors' note: this version was assessed by the editors, without involving the reviewers again.]

Joint Public Review:

Summary:

Sha K et al aimed at identifying mechanism of response and resistance to castration in the Pten knock out GEM model. They found elevated levels of TNF overexpressed in castrated tumors associated to an expansion of basal-like stem cells during recurrence, which they show occurring in prostate cancer cells in culture upon enzalutamide treatment. Further, the authors carry on timed dependent analysis of the role of TNF in regression and recurrence to show that TNF regulates both processes. Similarly, CCL2, which the authors had proposed as a chemokine secreted upon TNF induction following enzalutamide treatment, is also shown elevated during recurrence and associate it to the remodeling of an immunosuppressive microenvironment through depletion of T cells and recruitment of TAMs.

Strengths:

The paper exploits a well stablished GEM model to interrogate mechanisms of response to standard of care treatment. This of utmost importance since prostate cancer recurrence after ADT or ARSi marks the onset of an incurable disease stage for which limited treatments exist. The work is relevant in the confirmation that recurrent prostate cancer is mostly an immunologically "cold" tumor with an immunosuppressive immune microenvironment.

Comments on revised version:

The Reviewing Editor has reviewed the response letter and revised manuscript and has the following recommendations (all text revisions) prior to the Version of Record.

More information for Panel 4A:

For the most part, the authors have addressed the statistical concerns raised in the initial review through inclusion of p values in the relevant figure legends. One important exception is Fig 4A which includes some of the most impactful data in the paper. The response letter and the new Fig4A legend refers to statistical in Supp Table 3. I could not find this in the package. Because this is such an important panel, I would urge the authors to include the statistics in the main figure. The display should include a fourth panel with castration alone, as requested by at least one reviewer.

I would also urge the authors to place a schema of the experimental design at the top of the figure to clarify the timing of anti-TNF therapy and the fact that it is administered continuously rather than as a single dose (I was confused by this upon first reading). Last, it is hard to reconcile the curves in the day +3 panel with the conclusion that there is no effect (the red curve in particular).

Include a model cartoon of the TNF switch:

A key concept in the report is the concept of a "TNF switch". I recommend the authors include a model cartoon that lays out this out visually in an easily understandable format. The cartoon in Supp Fig 8 touches on this but is more biochemically focused and does not easily convey the "switch" concept.

Add a "study limitations" paragraph at the end of the discussion:

The authors noted that several other concerns expressed by the reviewers were considered beyond the scope of this report. These include the inclusion of additional tumor response endpoints beyond US-guided assessment of tumor volume (e.g., histology, proliferation markers, etc.) and the purely correlative association of macrophage and T cell infiltration with recurrence, in the absence of immune cell depletion experiments. To this point, the subheading "Immune suppression is a key consequence of increased tumor cell stemness" in the Discussion is too strongly worded.

Similarly, there is no experimental proof that CCL2 from stroma (vs from tumor cell) is required for late relapse. Prior to formal publication, I suggest the authors include a "limitations of the study" paragraph at the end of the discussions that delineates several of these points.

Other points:

For concerns that several reviewers raised about basal versus luminal cells and stemness, the authors have modified the text to soften the conclusions and not assign specific lineage identities.

The answer to the question regarding timing of castration (based on tumor size, not age) needs more detail. This is particularly relevant for the Hi-MYC model that is exquisitely castration sensitive and not known to relapse, except perhaps at very late time points (9-12 months). Surely the authors can include some information on the age range of the mice.

Reviewer #1 (Public review):

Summary:

This paper investigates the physical basis of epithelial invagination in the morphogenesis of the ascidian siphon tube. The authors observe changes in actin and myosin distribution during siphon tube morphogenesis using fixed specimens and immunohistochemistry. They discover that there is a biphasic change in the actomyosin localization that correlates with changes in cell shapes. Initially, there is the well-known relocation of actomyosin from the lateral sides to the apical surface of cells that will invaginate, accompanied by a concomitant lengthening of the central cells within the invagination, but not a lot of invagination. Coincident with a second, more rapid, phase of invagination, the authors see a relocalization of actomyosin back to the lateral sides of the cells. This 2nd "bidirectional" relocation of actin appears to be important because optogenetic inhibition of myosin in the lateral domain after the initial invaginations phase resulted in a block of further invagination. Although not noted in the paper, that the second phase of siphon invagination is dependent on actomyosin is interesting and important because it has been shown that during Drosophila mesoderm invagination that a second "folding" phase of invagination is independent of actomyosin contraction (Guo et al. elife 2022), so there appear to be important differences between the Drosophila mesoderm system and the ascidian siphon tube systems.

Using the experimental data, the authors create a vertex model of the invagination, and simulations reveal a coupled mechanism of apicobasal tension imbalance and lateral contraction that creates the invagination. The resultant model appears to recapitulate many aspects of the observed cell behaviors, although there are some caveats to consider (described below).

Strengths:

The studies and presented results are well done and provide important insights into the physical forces of epithelial invagination, which is important because invaginations are how a large fraction of organs in multicellular organisms are formed.

Weaknesses:

(1) This reviewer has concerns about two aspects of the computational model. First, the model in Figure 5D shows a simulation of a flat epithelial sheet creating an invagination. However, the actual invagination is occurring in a small embryo that has significant curvature, such that nine or so cells occupy a 90-degree arc of the 360-degree circle that defines the embryo's cross-section (e.g., see Figure 1A). This curvature could have important effects on cell behavior.

(2) The second concern about the model is that Figure 5 D shows the vertex model developing significant "puckering" (bulging) surrounding the invagination. Such "puckering" is not seen in the in vivo invagination (Figure 1A, 2A). This issue is not discussed in the text, so it is unclear how big an issue this is for the developed model, but the model does not recapitulate all aspects of the siphon invagination system.

(3) In Figure 2A, Top View, and the schematic in Figure 2C, the developing invagination is surrounded by a ring of aligned cell edges characteristic of a "purse string" type actomyosin cable that would create pressure on the invaginating cells, which has been documented in multiple systems. Notably, the schematic in Figure 2C shows myosin II localizing to aligned "purse string" edges, suggesting the purse string is actively compressing the more central cells. If the purse string consistently appears during siphon invagination, a complete understanding of siphon invagination will require understanding the contributions of the purse string to the invagination process.

(4) The introduction and discussion put the work in the context of work on physical forces in invagination, but there is not much discussion of how the modeling fits into the literature.

Reviewer #2 (Public review):

Summary:

The authors propose that bidirectional translocation of actomyosin drives tissue invagination in Ciona siphon tube formation. They suggest a two-stage model where actomyosin first accumulates apically to drive a slow initial invagination, followed by translocation to lateral domains to accelerate the invagination process through cell shortening. They have shown that actomyosin activity is important for invagination - modulation of myosin activity through expression of myosin mutants altered the timing and speed of invagination; furthermore, optogenetic inhibition of myosin during the transition of the slow and fast stages disrupted invagination. The authors further developed a vertex model to validate the relationship between contractile force distribution and epithelial invagination.

Strengths:

(1) The authors employed various techniques to address the research question, including optogenetics, the use of MRLC mutants, and vertex modelling.

(2) The authors provide quantitative analyses for a substantial portion of their imaging data, including cell and tissue geometry parameters as well as actin and myosin distributions. The sample sizes used in these analyses appear appropriate.

(3) The authors combined experimental measurements with computer modeling to test the proposed mechanical models, which represents a strength of the study. It provides a framework to explore the mechanical principles underlying the observed morphogenesis.

Weaknesses:

(1) The concept of coordinated and sequential action of apical and lateral actomyosin in support of epithelial folding has been documented through a combination of experimental and modeling approaches in other contexts, such as ascidian endoderm invagination (PMID: 20691592) and gastrulation in Drosophila (PMIDs: 21127270, 22511944, 31273212). While the manuscript addresses an important question, related findings have been reported in these previous studies. This overlap reduces the degree of novelty, and it remains to be clarified how their work advances beyond these prior contributions.

(2) One of the central statements made by the authors is that the translocation of actomyosin between the apical and lateral domains mediates invagination. The use of the term "translocation" infers that the same actomyosin structures physically move from one location to another location, which is not demonstrated by the data. Given the time scale of the process (several hours), it is also possible that the observed spatiotemporal patterns of actomyosin intensity result from sequential activation/assembly and inactivation/disassembly at specific locations on the cell cortex, rather than from the physical translocation of actomyosin structures over time.

(3) Some aspects of the data on actomyosin localization require further clarification. (1) The authors state that actomyosin translocation is bidirectional, first moving from the lateral domain to the apical domain; however, the reduction of the lateral actomyosin at this step was not rigorously tested. (2) During the slow invagination stage, it is unclear whether myosin consistently localizes to the apical cell-cell borders or instead relocalizes to the medioapical domain, as suggested by the schematic illustration presented in Figure 2C. (3) It is unclear how many cells along the axis orthogonal to the furrow accumulate apical and lateral myosin.

(4) The overexpression of MRLC mutants appears to be rather patchy in some cases (e.g., in Figure 3A, 17.0 hpf, only cells located at the right side of the furrow appeared to express MRLC T18ES19E). It is unclear how such patchy expression would impact the phenotype.

(5) In the optogenetic experiment, it appears that after one hour of light stimulation, the apical side of the tissue underwent relaxation (comparing 17 hpf and 16 hpf in Figure 4B). It is therefore unclear whether the observed defect in invagination is due to apical relaxation or lack of lateral contractility, or both. Therefore, the phenotype is not sufficient to support the authors' statement that "redistribution of myosin contractility from the apical to lateral regions is essential for the development of invagination".

(6) The vertex model is designed to explore how apical and lateral tensions contribute to distinct morphological outcomes. While the authors raise several interesting predictions, these are not further tested, making it unclear to what extent the model provides new insights that can be validated experimentally. In addition, modeling the epithelium as a flat sheet and not accounting for cell curvature is a simplification that may limit the model's accuracy. Finally, the model does not fully recapitulate the deeply invaginated furrow configuration as observed in a real embryo (comparing 18 hpf in Figure 5D and 18 hpf in Figure 1A) and does not fully capture certain mutant phenotypes (comparing 18 hpf in Figure 5F and 18 hpf in Figure 3B right panel).

Reviewer #3 (Public review):

Summary:

In this manuscript by Qiao et al., the authors seek to uncover force and contractility dynamics that drive tissue morphogenesis, using the Ciona atrial siphon primordium as a model. Specifically, the authors perform a detailed examination of epithelial folding dynamics. Generally, the authors' claims were supported by their data, and the conceptual advances may have broader implications for other epithelial morphogenesis processes in other systems.

Strengths:

The strengths of this manuscript include the variety of experimental and theoretical methods, including generally rigorous imaging and quantitative analyses of actomyosin dynamics during this epithelial folding process, and the derivation of a mathematical model based on their empirical data, which they perturb in order to gain novel insights into the process of epithelial morphogenesis.

Weaknesses:

There are concerns related to wording and interpretations of results, as well as some missing descriptions and details regarding experimental methods.

Reviewer #1 (Public review):

Summary:

In their paper, Shimizu and Baron describe the signaling potential of cancer gain-of-function Notch alleles using the Drosophila Notch transfected in S2 cells. These cells do not express Notch or the ligand Dl or Dx, which are all transfected. With this simple cellular system, the authors have previously shown that it is possible to measure Notch signaling levels by using a reporter for the 3 main types of signaling outputs, basal signaling, ligand-induced signaling and ligand-independent signaling regulated by deltex. The authors proceed to test 22 cancer mutations for the above-mentioned 3 outputs. The mutation is considered a cluster in the negative regulatory region (NRR) that is composed of 3 LNR repeats wrapping around the HD domain. This arrangement shields the S2 cleavage site that starts the activation reaction.

The main findings are:

(1) Figure 1: the cell system can recapture ectopic activation of 3 existing Drosophila alleles validated in vivo.

(2) Figure 2: Some of the HD mutants do show ectopic activation that is not induced by Dl or Dx, arguing that these mutations fully expose the S2 site. Some of the HD mutants do not show ectopic activation in this system, a fact that is suggested to be related to retention in the secretory pathway.

(3) Figure 3: Some of the LNR mutants do show ectopic activation that is induced by Dl or Dx, arguing that these might partially expose the S2 site.

(4) Figure 4-6: 3 sites of the LNR3 on the surface that are involved in receptor heterodimerization, if mutated to A, are found to cause ectopic activation that is induced by Dl or Dx. This is not due to changes in their dimerization ability, and these mutants are found to be expressed at a higher level than WT, possibly due to decreased levels of protein degradation.

Strengths and Weaknesses:

The paper is very clearly written, and the experiments are robust, complete, and controlled. It is somewhat limited in scope, considering that Figure 1 and 5 could be supplementary data (setup of the system and negative data). However, the comparative approach and the controlled and well-known system allow the extraction of meaningful information in a field that has struggled to find specific anticancer approaches. In this sense, the authors contribute limited but highly valuable information.

Reviewer #2 (Public review):

Summary:

This ambitious study introduced 22 mutations corresponding to amino acid substitution mutations known to induce cancer in human Notch1, located within the Negative Regulatory Region, into the Drosophila Notch gene. It comprehensively examined their effects on activity, intracellular transport, protein levels, and stability. The results revealed that the impact of amino acid substitutions within the Negative Regulatory Region can be grouped based on their location, differing between the Heterodimerization Domain and the Lin12/Notch Repeat. These findings provide important insights into elucidating the mechanisms by which amino acid substitution mutations in human Notch1 cause leukemia and cancer.

Strengths:

In this study, the authors successfully measured the activity of amino acid-substituted Notch with high precision by effectively leveraging the advantages of their previously established experimental system. Furthermore, they clearly demonstrated ligand-dependent and Deltex-dependent properties.

Weaknesses:

Amino acid substitution mutations exhibit interesting effects depending on their position, so interest naturally turns to the mechanisms generating these differences. Unfortunately, however, elucidating these mechanisms will require considerable time in the future. Therefore, it is reasonable to conclude that questions regarding the mechanism fall outside the scope of this paper.

Reviewer #3 (Public review):

Summary:

Overall, the work is fine; however, I find it very preliminary. To the best of my understanding, to make any claims for altered Notch signaling from this study that is physiologically relevant remains to be discerned.

Strengths:

This manuscript systematically analyzes cancer-associated mutations in the Negative Regulatory Region (NRR) of Drosophila Notch to reveal diverse regulatory mechanisms with implications for cancer modelling and therapy development. The study introduces cancer-associated mutations equivalent to human NOTCH1 mutations, covering a broad spectrum across the LNR and HD domains. The authors use rigorous phenotypic assays to classify their functional outcomes. By leveraging the S2 cell-based assay platform, the work identifies mechanistic differences between mutations that disrupt the LNR-HD interface, core HD, and LNR surface domains, enhancing understanding of Notch regulation. The discovery that certain HD and LNR-HD interface mutations (e.g., R1626Q and E1705P) in Drosophila mirror the constitutive activation and synergy with PEST deletion seen in mammalian T-ALL is nice and provides a platform for future cancer modelling. Surface-exposed LNR-C mutations were shown to increase Notch protein stability and decrease turnover, suggesting a previously unappreciated regulatory layer distinct from canonical cleavage-exposure mechanisms. By linking mutant-specific mechanistic diversity to differential signaling properties, the work directly informs targeted approaches for modulating Notch activity in cancer cells.

Weaknesses:

While this is indeed an exciting set of observations, the work is entirely cell-line-based, and is the primary reason why this approach dampens the enthusiasm for the study. The analysis is confined to Drosophila S2 cells, which may not fully recapitulate tissue or organism-level regulatory complexity observed in vivo. Some Drosophila HD domain mutants accumulate in the secretory pathway and do not phenocopy human T-ALL mutations. Possibly due to limitations on physiological inputs that S2 cells cannot account for, or species-specific differences such as the absence of S1 cleavage.

Thus, the findings may not translate directly to understanding Notch 1 function in mammalian cancer models. While the manuscript highlights mechanistic variety, the functional significance of these mutations for hematopoietic malignancies or developmental contexts in live animals remains untested. Overall, the work does not yet provide evidence for altered Notch signaling that is physiologically relevant.

Reviewer #1 (Public review):

Summary:

In the paper, the authors investigate how the availability of genomic information and the timing of vaccine strain selection influence the accuracy of influenza A/H3N2 forecasting. The manuscript presents three key findings:

(1) Using real and simulated data, the authors demonstrate that shortening the forecasting horizon and reducing submission delays for sharing genomic data improve the accuracy of virus forecasting.

(2) Reducing submission delays also enhances estimates of current clade frequencies.

(3) Shorter forecasting horizons, for example allowed by the proposed use of "faster" vaccine platforms such as mRNA, result in the most significant improvements in forecasting accuracy.

Strengths:

The authors present a robust analysis, using statistical methods based on previously published genetic based techniques to forecast influenza evolution. Optimizing prediction methods is crucial from both scientific and public health perspectives. The use of simulated as well as real genetic data (collected between April 1, 2005, and October 1, 2019) to assess the effects of shorter forecasting horizons and reduced submission delays is valuable and provides a comprehensive dataset. Moreover, the accompanying code is openly available on GitHub and is well-documented.

Limitations of the authors genomic-data-only approach are discussed in depth and within the context of existing literature. In particular, the impact of subsampling, necessary for computational reasons in this study, or restriction to Northen/Southern Hemisphere data is explored and discussed.

Weaknesses:

Although the authors acknowledge these limitations in their discussion, the impact of the analysis is somewhat constrained by its exclusive reliance on methods using genomic information, without incorporating or testing the impact of phenotypic data. The analysis with respect to more integrative models remains open and the authors do not empirically validate how the inclusion of phenotypic information might alter or impact the findings. Instead, we must rely on the authors' expectation that their findings are expected to hold across different forecasting models, including those integrating both phenotypic and genetic data. This expectation, while reasonable, remains untested within the scope of the current study.

Comments on latest version:

Thanks to the authors for the revised version of the manuscript, which addresses and clarifies all of my previously raised points.

In particular, the exploration of how subsampling of genomic information, hemisphere-specific forecasting, and the check for time dependence potentially influence the findings is now included and adds to the discussion. The manuscript also benefits from a look at these limitations when relying only on genomic data.

The authors have carefully placed these limitations within the context of existing literature, especially on the raised concern to not include phenotypic data. As a minor comment, the conclusion that the findings potentially stay across different forecasting models, including those integrating both phenotypic and genetic data, rely on the author's expectation. While this expectation might be plausible, it remains to be validated empirically in future work.

Reviewer #1 (Public review):

Summary:

van der Linden et al. report on the development of a new green-fluorescent sensor for calcium, following a novel rational design strategy based on the modification of the cyan-emissive sensor mTq2-CaFLITS. Through a mutational strategy similar to the one used to convert EGFP into EYFP, coupled with optimization of strategic amino acids located in proximity of the chromophore, they identify a novel sensor, G-CaFLITS. Through a careful characterization of the photophysical properties in vitro and the expression level in cell cultures, the authors demonstrate that G-CaFLITS combines a large lifetime response with a good brightness in both the bound and unbound states. This relative independence of the brightness on calcium binding, compared with existing sensors that often feature at least one very dim form, is an interesting feature of this new type of sensors, which allows for a more robust usage in fluorescence lifetime imaging. Furthermore, the authors evaluate the performance of G-CaFLITS in different subcellular compartments and under two-photon excitation in Drosophila. While the data appears robust and the characterization thorough, the interpretation of the results in some cases appears less solid, and alternative explanations cannot be excluded.

Strengths:

The approach is innovative and extends the excellent photophysical properties of the mTq2-based to more red-shifted variants. While the spectral shift might appear relatively minor, as the authors correctly point out, it has interesting practical implications, such as the possibility to perform FLIM imaging of calcium using widely available laser wavelengths, or to reduce background autofluorescence, which can be a significant problem in FLIM.

The screening was simple and rationally guided, demonstrating that, at least for this class of sensors, a careful choice of screening positions is an excellent strategy to obtain variants with large FLIM responses without the need of high-throughput screening.

The description of the methodologies is very complete and accurate, greatly facilitating the reproduction of the results by others, or the adoption of similar methods. This is particularly true for the description of the experimental conditions for optimal screening of sensor variants in lysed bacterial cultures.

The photophysical characterization is very thorough and complete, and the vast amount of data reported in the supporting information is a valuable reference for other researchers willing to attempt a similar sensor development strategy. Particularly well done is the characterization of the brightness in cells, and the comparison on multiple parameters with existing sensors.

Overall, G-CaFLITS displays excellent properties for a FLIM sensor: very large lifetime change, bright emission in both forms and independence from pH in the physiological range.

Comment on revised version:

The authors have significantly improved the manuscript, and overall I fully agree in maintaining the assessment as it is now.

Reviewer #2 (Public review):

Summary:

Van der Linden et al. describe the addition of the T203Y mutation to their previously described fluorescence lifetime calcium sensor Tq-Ca-FLITS to shift the fluorescence to green emission. This mutation was previously described to similarly red-shift the emission of green and cyan FPs. Tq-Ca-FLITS_T203Y behaves as a green calcium sensor with opposite polarity compared with the original (lifetime goes down upon calcium binding instead of up). They then screen a library of variants at two linker positions and identify a variant with slightly improved lifetime contrast (Tq-Ca-FLITS_T203Y_V27A_N271D, named G-Ca-FLITS). The authors then characterize the performance of G-Ca-FLITS relative to Tq-Ca-FLITS in purified protein samples, in cultured cells, and in the brains of fruit flies.

Strengths:

This work is interesting as it extends their prior work generating a calcium indicator scaffold for fluorescent protein-based lifetime sensors with large contrast at a single wavelength, which is already being adopted by the community for production of other FLIM biosensors. This work effectively extends that from cyan to green fluorescence. While the cyan and green sensors are not spectrally distinct enough (~20-30nm shift) to easily multiplex together, it at least shifts the spectra to wavelengths that are more commonly available on commercial microscopes.

The observations of organellar calcium concentrations were interesting and could potentially lead to new biological insight if followed up.

Reviewer #3 (Public review):

Summary:

The authors present a variant of a previously described fluorescence lifetime sensor for calcium. Much of the manuscript describes the process of developing appropriate assays for screening sensor variants, and thorough characterization of those variants (inherent fluorescence characteristics, response to calcium and pH, comparisons to other calcium sensors). The final two figures show how the sensor performs in cultured cells and in vivo drosophila brains.

Strengths:

The work is presented clearly and the conclusion (this is a new calcium sensor that could be useful in some circumstances) is supported by the data.

Weaknesses:

There are probably few circumstances where this sensor would facilitate experiments (calcium measurements) that other sensors would prove insufficient.

Comment on revised version:

I think the manuscript has been significantly improved and I concur with the eLife Assessment statement.

[Editors' note: There are no further requests by the reviewers. All of them expressed their approval of the new version of the manuscript.]

Reviewer #1 (Public review):

Summary:

Mancl et al. present a comprehensive integrative study combining cryo-EM, SAXS, enzymatic assays, and molecular dynamics (MD) simulations to characterize conformational dynamics of human insulin-degrading enzyme (IDE). In the revised manuscript, the study now also includes time-resolved cryo-EM and coarse-grained MD simulations, which strengthen the mechanistic model by revealing insulin-induced allostery and β-sheet interactions between IDE and insulin. Together, these results expand the original mechanistic insight and further validate R668 as a key residue governing the open-close transition and substrate-dependent activity modulation of IDE.

Strengths:

The authors have substantially expanded the experimental scope by adding time-resolved cryo-EM data and coarse-grained MD simulations, directly addressing requests for mechanistic depth and temporal insight. The integration of multiple resolution scales (cryo-EM heterogeneity analysis, all-atom and coarse-grained MD simulations, and biochemical validation) now provides a coherent description of the conformational transitions and allosteric regulation of IDE. The addition of Aβ degradation assays strengthens the claim that R668 modulates IDE function in a substrate-specific manner. Finally, the manuscript reads more clearly: figure organization, section headers, and inclusion of a new introductory figure make it accessible to a broader audience. Overall, the revision reinforces the conceptual advance that the dynamic interdomain motions of IDE underlie both its unfoldase and protease activities and identifies structural motifs that could be targeted pharmacologically.

Weaknesses:

While the authors acknowledge that future studies on additional IDE substrates (e.g., amylin and glucagon) are warranted, such experiments remain outside the present scope. Their absence modestly limits the generalization of the R668 mechanism across all IDE substrates. Despite improved discussion of kinetic timescales and enzyme-substrate interactions, experimental correlation between MD timescales and catalysis remains primarily inferential. The moderate local resolution of some cryo-EM states (notably O/pO) continues to limit atomic interpretation of the most flexible regions, though the authors address this carefully.

Reviewer #2 (Public review):

Summary:

The manuscript describes various conformational states and structural dynamics of the Insulin degrading enzyme (IDE), a zinc metalloprotease by nature. Both open and closed state structures of IDE have been previously solved using crystallography and cryo-EM which reveal a dimeric organization of IDE where each monomer is organized into N and C domains. C-domains form the interacting interface in the dimeric protein while the two N-domains are positioned on the outer sides of the core formed by C-domains. It remains elusive how the open state is converted into the closed state but it is generally accepted that it involves large-scale movement of N-domains relative to the C-domains. Authors here have used various complementary experimental techniques such as cryo-EM, SAXS, size-exclusion chromatography and enzymatic assays to characterize the structure and dynamics of IDE protein in the presence of substrate protein insulin whose density is captured in all the structures solved. The experimental structural data from cryo-EM suffered from high degree of intrinsic motion amongst the different domains and consequently, the resultant structures were moderately resolved at 3-4.1 Å resolution. Total five structures were generated in the originally submitted manuscript using cryo-EM. Another cryo-EM reconstruction (sixth) at 5.1Å resolution was mentioned after first revision which was obtained using time-resolved cryo-EM experiments. Authors have extensively used Molecular dynamics simulation to fish out important inter-subunit contacts which involves R668, E381, D309, etc residues. In summary, authors have explored the conformational dynamics of IDE protein using experimental approaches which are complimented and analyzed in atomic details by using MD simulation studies. The studies are meticulously conducted and lay ground for future exploration of protease structure-function relationship.

Comments after first peer-review:

The authors have addressed all my concerns, and have added new data and explanations in terms of time-resolved cryo-EM (Fig. 7) and upside simulations (Fig. 8) which in my opinion have strengthened the merit of the manuscript.

Reviewer #1 (Public review):

Summary:

The study conducted by the Shouldiner's group advances the understanding of mitochondrial biology through the utilization of their bi-genomic (BiG) split-GFP assay, they had previously developed and reported. This research endeavors to consolidate the catalog of matrix and inner membrane mitochondrial proteins. In their approach, a genetic framework was employed wherein a GFP fragment (GFP1-10) is encoded within the mitochondrial genome. Subsequently, a collection of strains was created, with each strain expressing a distinct protein tagged with the GFP11 fragment. The reconstitution of GFP fluorescence occurs upon the import of the protein under examination into the mitochondria.

Strengths:

Notably, this assay was executed under six distinct conditions, facilitating the visualization of approximately 400 mitochondrial proteins. Remarkably, 50 proteins were conclusively assigned to mitochondria for the first time through this methodology. The strains developed and the extensive dataset generated in this study serve as a valuable resource for the comprehensive study of mitochondrial biology. Specifically, it provides a list of 50 "eclipsed" proteins whose role in mitochondrial remains to be characterized.

The work could include some functional studies of the dually localized Gpp1 protein, as an example.

Reviewer #2 (Public review):

The authors addressed the question how mitochondrial proteins that are dually localized or only to a minor fraction localized to mitochondria can be visualized. For this they used an established and previously published method called BiG split-GFP, in which GFP strands 1-10 are encoded in the mitochondrial DNA and fused the GFP11 strand C-terminally to the yeast ORFs using the C-SWAT library. The generated library was imaged under different growth and stress conditions and yielded positive mitochondrial localization for approximately 400 proteins. The strength of this method is the detection of proteins that are dually localized with only a minor fraction within mitochondria, which was so far has hampered due to strong fluorescent signals from other cellular localizations. The weakness of this method is that due to the localization of the GFP1-10 in the mitochondrial matrix, only matrix proteins and IM protein with their C-termini facing the matrix can be detected. In addition, The C-terminal GFP11 might impact on assembly of proteins into multimeric complexes or interfere with biogenesis trapping the tagged protein in an unproductive transport intermediate. Taken these limitations into consideration, the authors provide a new library that can help in identification of eclipsed protein distribution within mitochondria, thus further increasing our knowledge on the complete mitochondrial proteome. The approach of global tagging of the yeast genome is the logical consequence after the successful establishment of the BiG split-GFP for mitochondria. The authors also propose that their approach can be applied to investigate the topology of inner membrane proteins, however, for this the inherent issue remains that even the small GFP11 tag can impact on protein biogenesis and topology. Thus, the approach will not overcome the need to assess protein topology via biochemical approaches detecting endogenous untagged proteins.

Comments on revisions:

The first sentence of the abstract should be changed as the statement that "The majority of the mitochondrial proteins (...) often lack clear targeting signals" is in particular for the here analysed IM and matrix protein not correct: Several N-proteomics analysis have defined N-terminal cleavable targeting signals in great detail.

Also the statement in the title that the assay illuminates protein targeting routes should be reconsidered as experimental evidence for this statement is still scarce.

Reviewer #3 (Public review):

Summary:

Here, Bykov et al move the bi-genomic split-GFP system they previously established to the genome-wide level in order to obtain a more comprehensive list of mitochondrial matrix and inner membrane proteins. In this very elegant split-GFP system, the longer GFP fragment, GFP1-10, is encoded in the mitochondrial genome and the shorter one, GFP11, is C-terminally attached to every protein encoded in the genome of yeast Saccharomyces cerevisiae. GFP fluorescence can therefore only be reconstituted if the C-terminus of the protein is present in the mitochondrial matrix, either as part of a soluble protein, a peripheral membrane protein or an integral inner membrane protein. The system, combined with high-throughput fluorescence microscopy of yeast cells grown under six different conditions, enabled the authors to visualize ca. 400 mitochondrial proteins, 50 of which were not visualised before and 8 of which were not shown to be mitochondrial before. The system appears to be particularly well suited for analysis of dually localized proteins and could potentially be used to study sorting pathways of mitochondrial inner membrane proteins.

Strengths:

Many fluorescence-based genome-wide screen were previously performed in yeast and were central to revealing the subcellular location of a large fraction of yeast proteome. Nonetheless, these screens also showed that tagging with full-length fluorescent proteins (FP) can affect both the function and targeting of proteins. The strength of the system used in the current manuscript is that the shorter tag is beneficial for detection of a number of proteins whose targeting and/or function is affected by tagging with full length FPs.

Furthermore, the system used here can nicely detect mitochondrial pools of dually localized proteins. It is especially useful when these pools are minor and their signals are therefore easily masked by the strong signals coming from the major, nonmitochondrial pools of the proteins.

Weaknesses:

My only concern is that the biological significance of the screen performed appears limited. The dataset obtained is largely in agreement with several previous proteomic screens but it is, unfortunately, not more comprehensive than them, rather the opposite. For proteins that were identified inside mitochondria for the first time here or were identified in an unexpected location within the organelle, it remains unclear whether these localizations represent some minor, missorted pools of proteins or are indeed functionally important fractions and/or productive translocation intermediates. The authors also allude to several potential applications of the system but do little to explore any of these directions.

Comments on revisions:

The revised version of the manuscript submitted by Bykov et al addresses the comments and concerns raised by the Reviewers. It is a pity that the verification of the newly obtained data and its further biological exploration is apparently more challenging than perhaps anticipated.

Reviewer #1 (Public review):

Summary:

This work shows that a specific adenosine deaminase protein in Dictyostelium generates the ammonia that is required for tip formation during Dictyostelium development. Cells with an insertion in the adgf gene aggregate but do not form tips. A remarkable result, shown by several different ways, is that the adgf mutant can be rescued by exposing the mutant to ammonia gas. The authors also describe other phenotypes of the adgf mutant such as increased mound size, altered cAMP signaling, and abnormal cell type differentiation. It appears that the adgf mutant has defects the expression of a large number of genes, resulting in not only the tip defect but also the mound size, cAMP signaling, and differentiation phenotypes.

Strengths:

The data and statistics are excellent.

Comments on previous version:

Looks better, but I think you answered my questions (listed as weaknesses in the public review) in the reply to the reviewer but not in the paper. I'd suggest carefully thinking about my questions and addressing them in the Discussion (The authors have now done this).

Reviewer #2 (Public review):

Summary:

The paper describes new insights into the role of adenosine deaminase-related growth factor (adgf), an enzyme that catalyses the breakdown of adenosine into ammonia and inosine, in tip formation during Dictyostelium development. The adgf null mutant has a pre-tip mound arrest phenotype, which can be rescued by external addition of ammonia. Analysis suggests that the phenotype involves changes in cAMP signaling possibly involving a histidine kinase dhkD, but details remain to be resolved.

Strengths:

The generation of an adgf mutant showed a strong mound arrest phenotype and successful rescue by external ammonia. Characterisation of significant changes in cAMP signaling components, suggesting low cAMP signaling in the mutant and identification of the histidine kinase dhkD as a possible component of the transduction pathway. Identification of a change in cell-type differentiation towards prestalk fate

Comments on previous version:

The revised version of the paper has improved significantly in terms of structure and clarity. The additional data on rescue of total cAMP production by ammonia (Fig. 7C) in the adgf- mutant and the 5-fold increased prespore expression of adgf RNA compared to prestalk cells (Fig 9) are useful data additions.

The link between changes in cAMP signaling (lower aca expression) and wave geometry (concentric waves rather than spiral waves) remains speculative.

I noted that Fig 6 contains different images than the previous version (Fig 7).

The statement "Interestingly, Klebsiella pneumoniae physically separated from the Dictyostelium adgf mutants in a partitioned dish, also rescues the mound arrest phenotype suggesting a cross-kingdom interaction that drives development" in the summary is rather overdone. All experiments were performed with axenic strains (no bacteria).

as is the sentence "Remarkably, in higher vertebrates, adgf expression is elevated during gastrulation and thus adenosine deamination may be a conserved process driving organizer development in different organisms"

The data supporting this in the supplementary information is hardly legible and poorly presented. What is shown is ADA expression in different tissues, not at different stages. I would suggest taking these figures out and concentrating the summary on the key mechanistic findings of the paper. (The authors have now done this.)

Reviewer #1 (Public review):

Summary:

In this manuscript Lu & Cui et al. observe that adult male zebrafish are more resistant to infection and disease following exposure to Spring Viremia of Carp Virus (SVCV) than female fish. The authors then attempt to identify some of the molecular underpinnings of this apparent sexual dimorphism and focus their investigations on a gene called cytochrome P450, family 17, subfamily A, polypeptide 2 (cyp17a2) because it was among genes that they found to be more highly expressed in kidney tissue from males than in females. Their investigations lead them to propose a direct connection between cyp17a2 and modulation of interferon signaling as the key underlying driver of difference between male and female susceptibility to SVCV.

Strengths:

Strengths of this study include the interesting observation of a substantial difference between adult male and female zebrafish in their susceptibility to SVCV, and also the breadth of experiments that were performed linking cyp17a2 to infection phenotypes and molecularly to the stability of host and virus proteins in cell lines. The authors place the infection phenotype in an interesting and complex context of many other sexual dimorphisms in infection phenotypes in vertebrates. This study succeeds in highlighting an unexpected factor involved in antiviral immunity that will be an important subject for future investigations of infection, metabolism, and other contexts.

Weaknesses:

Weaknesses of this study include a proposed mechanism underlying the sexual dimorphism phenotype based on experimentation in only males, and widespread reliance on over-expression when investigating protein-protein interaction and localization. Additionally, a minor weakness is that the text describing the identification of cyp17a2 as a candidate contains errors that are confusing. For example:

- Lines 139-140 describe the data for Figure 2 as deriving from "healthy hermaphroditic adult zebrafish". This appears to be a language error and should be corrected to something that specifies that the comparison made is between healthy adult male and female kidneys.

- In Figure 2A and associated text cyp17a2 is highlighted but the volcano plot does not indicate why this was an obvious choice. For example, many other genes are also highly induced in male vs female kidneys. Figure 2B and line 143 describe a subset of "eight sex-related genes" but it is not clear how these relate to Figure 2A. The narrative could be improved to clarify how cyp17a2 was selected from Figure 2A and it seems that the authors made an attempt to do this with Figure 2B but it is not clear how these are related. This is important because the available data do not rule out the possibility that other factors also mediate the sexual dimorphism they observed either in combination, in a redundant fashion, or in a more complex genetic fashion. The narrative of the text and title suggests that they consider this to be a monogenic trait but more evidence is needed.

Reviewer #2 (Public review):

This study conducted by Lu et al. explores the molecular underpinnings of sexual dimorphism in antiviral immunity in zebrafish, with a particular emphasis on the male-biased gene cyp17a2. The authors demonstrate that male zebrafish exhibit stronger antiviral responses than females, and they identify a teleost-specific gene cyp17a2 as a key regulator of this dimorphism. Utilizing a combination of in vivo and in vitro methodologies, they demonstrate that Cyp17a2 potentiates IFN responses by stabilizing STING via K33-linked polyubiquitination and directly degrades the viral P protein via USP8-mediated deubiquitination. The work challenges conventional views of sex-based immunity and proposes a novel, hormone- and sex chromosome-independent mechanism.

Strengths:

(1) The following constitutes a novel concept, sexual dimorphism in immunity can be driven by an autosomal gene rather than sex chromosomes or hormones represents a significant advance in the field, offering a more comprehensive understanding of immune evolution.

(2) The present study provides a comprehensive molecular pathway, from gene expression to protein-protein interactions and post-translational modifications, thereby establishing a link between Cyp17a2 and both host immune enhancement (via STING) and direct antiviral activity (via viral protein degradation).

(3) In order to substantiate their claims, the authors utilize a wide range of techniques, including transcriptomics, Co-IP, ubiquitination assays, confocal microscopy, and knockout models.

(4) The utilization of a singular model is imperative. Zebrafish, which are characterized by their absence of sex chromosomes, offer a clear genetic background for the dissection of autosomal contributions to sexual dimorphism.

Weaknesses:

(1) Limited discussion on whether this mechanism extends beyond Cyprinidae and its implications for teleost adaptation.

Comments on revisions:

The authors successfully achieved their primary aim, which was to identify and characterize a male-biased gene governing antiviral sexual dimorphism in fish. The data provide robust support for the conclusion that Cyp17a2 enhances antiviral immunity through dual mechanisms, STING stabilization and viral protein degradation, independent of classical sex-determining pathways. The findings are consistent across a range of experimental setups and are statistically robust. The revisions have significantly enhanced the clarity, depth, and overall quality of the manuscript. The authors have addressed each concern meticulously, resulting in a much-improved and robust article. No further suggestions are offered.

Reviewer #1 (Public review):

Summary:

This manuscript reports the discovery and characterization of the first bifunctional degrader of tankyrase. Notably, the tankyrase degrader exhibits stronger β-catenin inhibition and tumor growth suppression compared to conventional tankyrase inhibitors. Mechanistically, while tankyrase inhibitors stabilize tankyrase and promote Axin puncta formation - thereby impairing β-catenin degradation - the degrader avoids this effect, resulting in deeper suppression of β-catenin signaling. These findings suggest that targeted degradation of tankyrase offers a novel therapeutic strategy for β-catenin-driven cancers. Overall, this is a compelling study with significant translational potential.

Strengths:

(1) The manuscript presents a rigorous and well-executed study on a timely and impactful topic.

(2) The biochemical and cellular characterization of the tankyrase degrader is thorough, and the comparative analysis with tankyrase inhibitors is insightful.

(3) The finding that tankyrase stabilization by inhibitors may interfere with Axin function is novel and significant. It aligns with earlier observations (e.g., Huang 2009) that transient tankyrase overexpression can stabilize β-catenin independently of PAR domain activity.

(4) The use of TNKS1/2 knockout cells expressing catalytically inactive tankyrase to demonstrate β-catenin inhibitory activity of the tankyrase degrader is elegant.

(5) The finding that the tankyrase degrader has superior anti-proliferative effects in colorectal cancer models has important therapeutic implications.

Weaknesses:

(1) A key caveat is that the identified tankyrase degrader also targets GSPT1 for degradation. This raises the possibility that GSPT1 degradation may contribute to the observed β-catenin and tumor growth inhibition.

(2) The authors address this concern reasonably by showing that DLD1 cells resistant to GSPT1 degradation remain sensitive to the tankyrase degraded.

(3) To further strengthen this point, the authors might consider generating TNKS1/2 double knockout cells (e.g., in DLD1 or SW480 backgrounds) and demonstrating that the degrader loses its growth-inhibitory effect in these models. However, given the technical challenges of creating double knockouts in cancer cell lines, such experiments could be considered optional.

Reviewer #2 (Public review):

Summary:

The ADP-ribosyltransferase tankyrase controls many biological processes, many of which are relevant to human disease. This includes Wnt/beta-catenin signalling, which is dysregulated in many cancers, most notably colorectal cancer. Tankyrase is a positive regulator of Wnt/beta-catenin signalling in that it counters the activity of the beta-catenin destruction complex (DC). Catalytic inhibition of tankyrase not only blocks PAR-dependent ubiquitylation and degradation of AXIN1/2, the central scaffolding protein in the DC, but also tankyrase itself. As a result, blocking tankyrase gives rise to tankyrase accumulation, which may accentuate its non-catalytic functions, which have been proposed to drive Wnt/beta-catenin signalling. Most tankyrase catalytic inhibitors have shown limited efficacy and substantial toxicity in vivo. By developing tankyrase-directed PROTACs, the authors aim to block both catalytic and non-catalytic functions of tankyrase, aspiring to achieve a more complete inhibition of Wnt/beta-catenin signalling. The successfully developed PROTAC, based on the existing catalytic inhibitor IWR1, IWR1-POMA, induces the degradation of both TNKS and TNKS2, blocks beta-catenin-dependent transcription without stabilising the DC in puncta/degradasomes, and inhibits cancer cell growth in vitro. Mechanistically, this points to a scaffolding role of tankyrase in the DC, at least under conditions of tankyrase catalytic inhibition, in line with previous proposals.

Strengths:

The study clearly illustrates the incentive for developing a tankyrase degrader, namely, to abolish both catalytic and non-catalytic functions of tankyrase. By and large, the study achieves these ambitions, and the findings support the main conclusions, although the statement that a more complete inhibition of the pathway is achieved requires corroboration. The proteomics studies are powerful. IWR1-POMA constitutes a very useful tool to re-evaluate targeting of tankyrase in oncogenic Wnt/beta-catenin signalling. The paired compounds will benefit investigations of tankyrase scaffolding functions across many different biological systems controlled by tankyrase. The findings are exciting.

Weaknesses:

Although the results are promising and mostly compelling, the claim that the PROTACs provide "a deeper suppression of the WNT/β-catenin pathway activity" requires further corroboration, particularly at endogenous tankyrase levels.

There are also some other points that, if considered, would further improve the manuscript, as detailed below.

(1) Abstract and line 62: Many catalytic tankyrase inhibitors tend to display toxicity, which is likely on-target (e.g., 10.1177/0192623315621192; 10.1158/0008-5472). This constitutes the main limiting factor for these compounds. An incomplete inhibition of Wnt/beta-catenin signalling may contribute to the challenges, but this does not appear to be the dominant problem. A more prominent introduction to this important challenge is probably expected by the field.

(2) The authors do a good job in setting the scene for the need for tankyrase degraders. Their observations relating to the formation of puncta (degradasomes) being tankyrase-dependent are compatible with a previous study by Martino-Echarri et al. 2016 (10.1371/journal.pone.0150484): simultaneous silencing of TNKS and TNKS2 by RNAi abolishes degradasome formation. The paper is cited as reference 17, but only in passing, and deserves more prominence. (It includes an entire paragraph titled "Expression of tankyrases 1 and 2 is required for TNKSi-induced formation of axin puncta").

(3) Moreover, the scaffolding concept has been discussed comprehensively in other studies: 10.1111/bph.14038 and more recently 10.1042/BCJ20230230. There are also a few studies that focus on targeting the ankyrin repeat clusters of tankyrase to disengage substrates (10.1038/s41598-020-69229-y; 10.1038/s41598-019-55240-5) that illustrate the concept of blocking the scaffolding function. In that sense, the hypotheses are mature, and it is interesting to see some of them supported in this study. The authors could improve how they set their work into the context of these other efforts and proposals.

(4) In several places in the manuscript, the DC is referred to as "biomolecular condensate", at times even as a "classic example", implying that it operates through phase separation. This has not been demonstrated. In fact, super-resolution microscopy indicates that the puncta are not droplet-like (10.7554/eLife.08022), which would argue against the condensate hypothesis.

(5) It is beautiful to be able to use IWR1 and IWR1-POMA at identical concentrations for direct comparisons. However, this requires the two compounds to bind to tankyrase similarly well and reach the target to a comparable extent. How sure are authors that target engagement is comparable? Has this been evaluated?

(6) Figure 1F: It is not immediately apparent how IWR1-POMA shows more complete containment of Wnt/beta-catenin signalling. Most Wnt/beta-catenin targets lie close to the perfect diagonal, so I do not see how the statement "that IWR1-POMA controlled WNT/β-catenin signaling more effectively than IWR1" (in the legend of Figure 1F) is supported. Minimally, an expanded explanation would benefit the reader. Providing the colour-coding legend directly in the figure would help improve clarity. Also, the panel is very small and may benefit from a different presentation in the figure.

(7) Figure 2: The conclusion of a "deeper suppression" of signalling relies on overexpression of tankyrase in an otherwise tankyrase-null background. Have the authors attempted to measure reporter activity or endogenous gene expression without tankyrase overexpression, in Wnt3a-stimulated cells (in the context of a normal Wnt/beta-catenin pathway) or CRC cells at the basal level? Non-catalytic activity in a similar assay has previously been observed upon tankyrase overexpression (10.1016/j.molcel.2016.06.019). Whether or not there is a substantial scaffolding effect at endogenous tankyrase levels after tankyrase inhibition remains unconfirmed, and the PROTAC is a valuable tool to address this important question. The findings presented in Figure S7C and D go some way towards answering this question - these data could be presented more prominently, and similar assays could be performed in other cell systems.

(8) Line 237/238: "TNKS accumulation negatively impacts the catalytic activity of the DC (Figure 5D)" - the data do not show this. Beta-catenin levels are a surrogate readout for DC function (phosphorylation and ubiquitylation). Minimally, this requires rewording, with reference to beta-catenin levels.

(9) Line 303-304: Beta-catenin is thought to exchange at beta-catenin degradasomes; this is clear from previous FRAP assays and the observation that phospho-beta-catenin accumulates in degradasomes upon proteasome inhibition (10.1158/1541-7786.MCR-15-0125). However, degradasome size hasn't, to my knowledge, been related to activity. Can this be clarified, please?

(10) There are previous hypotheses/proposals that the sensitivity of CRC cells to tankyrase inhibition correlates with APC truncation or PIK3CA status (10.1158/1535-7163.MCT-16-0578; 10.1038/s41416-023-02484-8). Have the authors considered expanding their cell line panel (Figure S7) to sample a wider range of cell lines, including some that are wild-type with regard to APC or Wnt/beta-catenin signalling in general? This would be a valuable addition to the work. Quantitated colony formation data could be moved to the main body of the manuscript.

(11) The manuscript only mentions toxicity (i.e., therapeutic window) in the last sentence of the Discussion section. As this is THE main challenge with tankyrase inhibitors (as mentioned above), can the authors expand their discussion of this aspect? Is there an expectation that PROTACs may be less toxic?

(12) Figures 3, 4, 5A: For fluorescence microscopy experiments, can these be quantified, and can repeat data be included?

(13) Figure 4, S6: An additional channel illustrating the distribution of cells (e.g., nuclei, cytoskeleton, or membrane) would be helpful for orientation and context for the AXIN1 signal.

(14) How were cytosolic fractions of cells prepared to assess cytosolic beta-catenin levels? This detail is missing from the methods.

Reviewer #3 (Public review):

In this manuscript, Wang et al employ a chemical biology approach to investigate the differences between the enzymatic and scaffolding roles of tankyrase during Wnt β-catenin signalling. It was previously established that, in addition to its enzymatic activity, tankyrase 1/2 also plays a scaffolding function within the destruction complex, a property conferred by SAM-domain-dependent polymerization (PMID: 27494558). It is also known that TNKS1/2 is an autoregulated protein and that its enzymatic inhibition leads to accumulation of total TNKS proteins and stabilization of Axin punctae (through the scaffolding function of TNKS1/2), leading to rigidification of the DC and decreased β-catenin turnover. The authors surmised that this could, in part, explain the limited efficacy of TNKS1/2 catalytic inhibition for the treatment of colorectal cancers. To test this hypothesis, they evaluated a series of PROTAC molecules promoting the degradation of TNKS1/2 to block both the catalytic and scaffolding activities. They show that IWR1-POMA (their most active molecule) promotes more efficient suppression of beta-catenin-mediated transcription and is more active in inhibiting colorectal cancer cell and CRC patient-derived organoids growth. Mechanistically, the authors used FRAP to demonstrate that catalytic inhibitors of TNKS led to a reduced dynamic assembly of the DC (rigidification), whereas IWR1-POMA did not affect the dynamics.

Overall, this is an interesting study describing the design and development of a PROTAC for TNKS1/2 that could have increased efficacy where catalytic inhibitors have displayed limited activity. Knowing the importance of the scaffolding role of TNKS1/2 within the destruction complex, targeting both the catalytic and scaffolding roles certainly makes sense. The manuscript contains convincing evidence of the different mechanisms of the PROTAC vs catalytic inhibitors. Some additional efforts to quantify several of the experiments and to indicate the reproducibility and statistical analysis would strengthen the manuscript. Ultimately, it would have been great to evaluate the in vivo efficacy of IWR1-POMA in an in vivo CRC assay (APCmin mice or using PDX models); however, I realize that this is likely beyond the scope of this manuscript.

I have some recommendations listed below for consideration by the authors to strengthen their study:

(1) The title is slightly misleading, as it is already known that the scaffolding function of TNKS is important within the DC. The authors should consider incorporating the PROTAC targeting aspect in the title (e.g., PROTAC-mediated targeting of tankyrase leads to increased inhibition of betacat signaling and CRC growth inhibition).

(2) The authors should comment in the manuscript on the bell-shaped curve obtained with treatment of cells with the PROTACs (Figure S2C). This likely indicates tittering of the targets within a bifunctional molecule with increasing concentration (and likely reveals the auto-inhibition conferred by the catalytic inhibition alone).

(3) The authors comment that using G007-LK as warehead was unsuccessful, but they do not show data. Do the authors know why this was the case?

(4) Throughout the manuscript, the authors need to do a better job at quantifying their results (i.e., the western blots and the IF). For example, the degradation of TNKS1/2 in Figure 1D is not overly convincing. Similarly, the IF data in Figure 3 needs to be quantified in some ways. Along the same lines, the effect of IWR1-POMA treatments on the proliferation of cells and organoids should be quantified using viability assays... There is also no indication of how many times these experiments were performed and whether the blots shown are representative experiments. The quantification should include all experiments.

Reviewer #1 (Public review):

Summary:

The authors aim to demonstrate that GWAS summary statistics, previously considered safe for open sharing, can, under certain conditions, be used to recover individual-level genotypes when combined with large numbers of high-dimensional phenotypes. By reformulating the GWAS linear model as a system of linear programming constraints, they identify a critical phenotype-to-sample size ratio (R/N) above which genotype reconstruction becomes theoretically feasible.

Strengths:

There is conceptual originality and mathematical clarity. The authors establish a fundamental quantitative relationship between data dimensionality and privacy leakage and validate their theory through well-designed simulations and application to the GTEx dataset. The derivation is rigorous, the implementation reproducible, and the work provides a formal framework for assessing privacy risks in genomic research.

Weaknesses:

The study simplifies assumptions that phenotypes are independent, which is not the truth, and are measured without noise. Real-world data are highly correlated across different levels, not only genotype but also multi-omics, which may overstate recovery potential. The empirical evidence, while illustrative, is limited to small-scale data and idealized conditions; thus, the full practical impact remains to be demonstrated. GTEx analysis used only whole blood eQTL data from 369 individuals, which cannot capture the complexity, sample heterogeneity, or cross-tissue dependencies typical of biobank-scale studies.

Reviewer #2 (Public review):

Summary:

This study focuses on the genomic privacy risks associated with Genome-Wide Association Study (GWAS) summary statistics, employing a three-tiered demonstration framework of "theoretical derivation - simulation experiments - real-data validation". The research finds that when GWAS summary statistics are combined with high-dimensional phenotypic data, genotype recovery and individual re-identification can be achieved using linear programming methods. It further identifies key influencing factors such as the effective phenotype-to-sample size ratio (R/N) and minor allele frequency (MAF). These findings provide practical reference for improving data governance policies in genomic research, holding certain real-world significance.

Strengths:

This study integrates theoretical analysis, simulation validation, and the application of real-world datasets to construct a comprehensive research framework, which is conducive to understanding and mitigating the risk of private information leakage in genomic research.

Weaknesses:

(1) Limited scope of variant types covered:

The analysis is conducted solely on Single Nucleotide Polymorphisms (SNPs), omitting other crucial genomic variant types such as Copy Number Variations (CNVs), Insertions/Deletions (InDels), and chromosomal translocations/inversions. From a genomic structure perspective, variants like CNVs and InDels are also core components of individual genetic characteristics, and in some disease-related studies, association signals for these variants can be even more significant than those for SNPs. From the perspective of privacy risk logic, the genotypes of these variants (e.g., copy number for CNVs, base insertion/deletion status for InDels) can also be quantified and could theoretically be inferred backwards using the combination of "summary statistics + high-dimensional phenotypes". Their privacy leakage risks might differ from those of SNPs (for instance, rare CNVs might be more easily re-identified due to higher genetic specificity).

(2) Bias in data applicability scope:

Both the simulation experiments and real-data validation in the study primarily rely on European population samples (e.g., 489 European samples from the 1000 Genomes Project; the genetic background of whole blood tissue samples from the GTEx project is not explicitly mentioned regarding non-European proportions). It only briefly notes a higher risk for African populations in the individual re-identification risk assessment, without conducting systematic analyses for other populations, such as East Asian, South Asian, or admixed American populations. Significant differences in genetic structure (e.g., MAF distribution, linkage disequilibrium patterns) exist across different populations. This may result in the R/N threshold and the relationship between MAF and recovery accuracy identified in the study not being fully applicable to other populations

Hence, addressing the aforementioned issues through supplementary work would enhance the study's scientific rigor and application value, potentially providing more comprehensive theoretical and technical support for "privacy protection" in genomic data sharing.

Reviewer #1 (Public review):

Summary:

The authors aim to interrogate the sets of intramolecular interactions that cause kinesin-1 hetero-tetramer autoinhibition and the mechanism by which cargo interactions via the light chain tetratricopeptide repeat domains can initiate motor activation. The molecular mechanisms of kinesin regulation remain an important question with respect to intracellular transport. It has implications for the accuracy and efficiency of motor transport by different motor families, for example, the direction of cargos towards one or other microtubules.

Strengths:

The authors focus on the response of inactivated kinesin-1 to peptides found in cargos and the cascade of conformational changes that occur. They also test the effects of the known activator of kinesin-1 - MAP7 - in the context of their model. The study benefits from multiple complementary methods - structural prediction using AlphaFold3, 2D and 3D analysis of (mainly negative stain) TEM images of several engineered kinesin constructs, biophysical characterisation of the complexes, peptide design, hydrogen/deuterium-exchange mass spectrometry, and simple cell-based imaging. Each set of experiments is thoughtfully designed, and the intrinsic limitations of each method are offset by other approaches such that the assembled data convincingly support the authors' conclusions. This study benefits from prior work by the authors on this system and the tools and constructs they previously accrued, as well as from other recent contributions to the field.

Weaknesses:

It is not always straightforward to follow the design logic of a particular set of experiments, with the result that the internal consistency of the data appears unconvincing in places. For example, i) the Figure 1 AlphaFold3 models do not include motor domains whereas the nearly all of the rest of the data involve constructs with the motor domains; ii) the kinesin constructs are chemically cross-linked prior to TEM sample preparation - this is clear in the Methods but should be included in the Results text, together with some discussion of how this might influence consistency with other methods where crosslinking was not used. Can those cross-links themselves be used to probe the intramolecular interactions in the molecular populations by mass spec? In general, the information content of some of the figure panels can also be improved with more annotations (e.g. angular relationship between views in Figure 1B, approximate interpretations of the various blobs in Fig 3F, and more thought given to what the reader should extract from the representative micrographs in several figures - inclusion of the raw data is welcome but extraction and magnification of exemplar particles (as is done more effectively in Fig S5) could convey more useful information elsewhere.

Reviewer #2 (Public review):

Summary:

In this paper, Shukla, Cross, Kish, and colleagues investigate how binding of a cargo-adaptor mimic (KinTag) to the TPR domains of the kinesin-1 light chain, or disruption of the TPR docking site (TDS) on the kinesin-1 heavy chain, triggers release of the TPR domains from the holoenzyme. This dislocation provides a plausible mechanism for transition out of the autoinhibited lambda-particle toward the open and active conformation of kinesin-1. Using a combination of negative-stain electron microscopy, AlphaFold modeling, biochemical assays, hydrogen-deuterium exchange mass spectrometry (HDX-MS), and other methods, the authors show how TPR undocking propagates conformational changes through the coiled-coil stalk to the motor domains, increasing their mobility and enhancing interactions with the microtubule-bound cofactor MAP7. Together, they propose a model in which the TDS on CC1 of the heavy chain forms a "shoulder" in the compact, autoinhibited state. Cargo-adaptor binding, mimicked here by KinTag, dislodges this shoulder, liberating the motor domains and promoting MAP7 association, driving kinesin-1 activation.

Strengths:

Throughout the study, the authors use a clever construct design - e.g., delta-Elbow, ElbowLock, CC-Di, and the high-affinity KinTag - to test specific mechanisms by directly perturbing structural contacts or affecting interactions. The proposed mechanism of releasing autoinhibition via adaptor-induced TPR undocking is also interrogated with a number of complementary techniques that converge on a convincing model for activation that can be further tested in future studies. The paper is well-written and easy to follow, though some more attention to figure labels and legends would improve the manuscript (detailed in recommendations for the authors).

Weaknesses:

These reflect limits of what the current data can establish rather than flaws in execution. It remains to be tested if the open state of kinesin-1 initiated by TPR undocking is indeed an active state of kinesin-1 capable of processive movement and/or cargo transport. It also remains to be determined what the mechanism of motor domain undocking from the autoinhibited conformation is, and perhaps this could have been explored more here. The authors have shown by HDX-MS that the motor domains become more mobile on KinTag binding, but perhaps molecular dynamics would also be useful for modelling how that might occur.

Reviewer #3 (Public review):

Summary:

The manuscript by Shukla and colleagues presents a comprehensive study that addresses a central question in kinesin-1 regulation - how cargo binding to the kinesin light chain (KLC) tetratricopeptide repeat (TPR) domains triggers activation of full-length kinesin-1 (KHC). The authors combine AlphaFold3 modeling, biophysical analysis (fluorescence polarization, hydrogen-deuterium exchange), and electron microscopy to derive a mechanistic model in which the KLC-TPR domains dock onto coiled-coil 1 (CC1) of the KHC to form the "TPR shoulder," stabilizing the autoinhibited (λ-particle) conformation. Binding of a W/Y-acidic cargo motif (KinTag) or deletion of the CC1 docking site (TDS) dislocates this shoulder, liberating the motor domains and enhancing accessibility to cofactors such as MAP7. The results link cargo recognition to allosteric structural transitions and present a unified model of kinesin-1 activation.

Strengths:

(1) The study addresses a fundamental and long-standing question in kinesin-1 regulation using a multidisciplinary approach that combines structural modeling, quantitative biophysics, and electron microscopy.

(2) The mechanistic model linking cargo-induced dislocation of the TPR shoulder to activation of the motor complex is well supported by both structural and biochemical evidence.

(3) The authors employ elegant protein-engineering strategies (e.g., ElbowLock and ΔTDS constructs) that enable direct testing of model predictions, providing clear mechanistic insight rather than purely correlative data.

(4) The data are internally consistent and align well with previous studies on kinesin-1 regulation and MAP7-mediated activation, strengthening the overall conclusion.

Weaknesses:

(1) While the EM and HDX-MS analyses are informative, the conformational heterogeneity of the complex limits structural resolution, making some aspects of the model (e.g., stoichiometry or symmetry of TPR docking) indirect rather than directly visualized.

(2) The dynamics of KLC-TPR docking and undocking remain incompletely defined; it is unclear whether both TPR domains engage CC1 simultaneously or in an alternating fashion.

(3) The interplay between cargo adaptors and MAP7 is discussed but not experimentally explored, leaving open questions about the sequence and exclusivity of their interactions with CC1.

Reviewer #1 (Public review):

Summary:

In this study, Besson et al. investigate how environmental nutrient signals regulate chromosome biology through the TORC1 signaling pathway in Schizosaccharomyces pombe. Specifically, the authors explore the impact of TORC1 on cohesin function - a protein complex essential for chromosome segregation and transcriptional regulation. Through a combination of genetic screens, biochemical analysis, phospho-proteomics, and transcriptional profiling, they uncover a functional and physical interaction between TORC1 and cohesin. The data suggest that reduced TORC1 activity enhances cohesin binding to chromosomes and improves chromosome segregation, with implications for stress-responsive gene expression, especially in subtelomeric regions.

Strengths:

This work presents a compelling link between nutrient sensing and chromosome regulation. The major strength of the study lies in its comprehensive and multi-disciplinary approach. The authors integrate genetic suppression screens, live-cell imaging, chromatin immunoprecipitation, co-immunoprecipitation, and mass spectrometry to uncover the functional connection between TORC1 signaling and cohesin. The use of phospho-mutant alleles of cohesin subunits and their loader provides mechanistic insight into the regulatory role of phosphorylation. The addition of transcriptomic analysis further strengthens the biological relevance of the findings and places them in a broader physiological context. Altogether, the dataset convincingly supports the authors' main conclusions and opens up new avenues of investigation.

Weaknesses:

While the study is strong overall, a few limitations are worth noting. The consistency of cohesin phosphorylation changes under different TORC1-inhibiting conditions (e.g., genetic mutants vs. rapamycin treatment) is unclear and could benefit from further clarification. The phosphorylation sites identified on cohesin subunits do not match known AGC kinase consensus motifs, raising the possibility that the modifications are indirect. The study relies heavily on one TORC1 mutant allele (mip1-R401G), and additional alleles could strengthen the generality of the findings. Furthermore, while the results suggest that nutrient availability influences cohesin function, this is not directly tested by comparing growth or cohesin dynamics under defined nutrient conditions.

Reviewer #2 (Public review):

Summary:

In this study, the authors follow up on a previous suppressor screen of a temperature-sensitive allele of mis4 (mis4-G1487D), the cohesin loading factor in S. pombe, and identify additional suppressor alleles tied to the S. pombe TORC1 complex. Their analysis suggests that these suppressor mutations attenuate TORC1 activity, while enhanced TORC1 activity is deleterious in this context. Suppression of TORC1 activity also ameliorates chromosome segregation and spindle defects observed in the mis4-G1487D strain, although some more subtle effects are not reconstituted. The authors provide evidence that this genetic suppression is also tied to the reconstitution of cohesin loading. Moreover, disrupting TORC1 also enhances Mis4/cohesin association with chromatin (likely reflecting enhanced loading) in WT cells, while rapamycin treatment can enhance the robustness of chromosome transmission. These effects likely arise directly through TORC1 or its downstream effector kinases, as TORC1 co-purifies with Mis4 and Rad21; these factors are also phosphorylated in a TORC1-dependent fashion. Disrupting Sck2, a kinase downstream of TORC1, also suppresses the mis4-G1487D allele while simultaneous disruption of Sck1 and Sck2 enhances cohesin association with chromatin, albeit with differing effects on phosphorylation of Mis4 and Psm1/Scm1. Phosphomutants of Mis4 and Psm1 that mimic observed phosphorylation states identified by mass spectrometry that are TORC1-dependent also suppressed phenotypes observed in the mis4-G1487D background. Last, the authors provide evidence that the mis4-G1487D background and TORC1 mutant backgrounds display an overlap in the dysregulation of genes that respond to environmental conditions, particularly in genes tied to meiosis or other "stress".

Overall, the authors provide compelling evidence from genetics, biochemistry, and cell biology to support a previously unknown mechanism by which nutrient sensing regulates cohesin loading with implications for the stress response. The technical approaches are generally sound, well-controlled, and comprehensive.

Specific Points:

(1) While the authors favor the model that the enhanced cohesin loading upon diminished TORC1 activity helps cells to survive harsh environmental conditions, as starvation of S. pombe also drives commitment to meiosis, it seems as plausible that enhanced cohesin loading is related to preparing the chromosomes to mate.

(2) Related to Point 1, the lab of Sophie Martin previously published that phosphorylation of Mis4 characterizes a cluster of phosphotargets during starvation/meiotic induction (PMID: 39705284). This work should be cited, and the authors should interrogate how their observations do or do not relate to these prior observations (are these the same phosphosites?).

(3) It would be useful for the authors to combine their experimental data sets to interrogate whether there is a relationship between the regions where gene expression is altered in the mis4-G1487D strain and changes in the loading of cohesin in their ChIP experiments.

(4) Given that the genes that are affected are predominantly sub-telomeric while most genes are not affected in the mis4-G1487D strain, one possibility that the authors may wish to consider is that the regions that become dysregulated are tied to heterochromatic regions where Swi6/HP1 has been implicated in cohesin loading.

(5) It would be helpful to show individual data points from replicates in the bar graphs - it is not always clear what comprises the data sets, and superplots would be of great help.

Reviewer #1 (Public review):

Summary:

The authors investigate how UVC-induced DNA damage alters the interaction between the mitochondrial transcription factor TFAM and mtDNA. Using live-cell imaging, qPCR, atomic force microscopy (AFM), fluorescence anisotropy, and high-throughput DNA-chip assays, they show that UVC irradiation reduces TFAM sequence specificity and increases mtDNA compaction without protecting mtDNA from lesion formation. From these findings, the authors suggest that TFAM acts as a "sensor" of damage rather than a protective or repair-promoting factor.

Strengths:

(1) The focus on UVC damage offers a clean system to study mtDNA damage sensing independently of more commonly studied repair pathways, such as oxidative DNA damage. The impact of UVC damage is not well understood in the mitochondria, and this study fills that gap in knowledge.

(2) In particular, the custom mitochondrial genome DNA chip provides high-resolution mapping of TFAM binding and reveals a global loss of sequence specificity following UVC exposure.

(3) The combination of in vitro TFAM DNA biophysical approaches, combined with cellular responses (gene expression, mtDNA turnover), provides a coherent multi-scale view.

(4) The authors demonstrate that TFAM-induced compaction does not protect mtDNA from UVC lesions, an important contribution given assumptions about TFAM providing protection.

Weaknesses:

(1) The authors show a decrease in mtDNA levels and increased lysosomal colocalization but do not define the pathway responsible for degradation. Distinguishing between replication dilution, mitophagy, or targeted degradation would strengthen the interpretation

(2) The sudden induction of mtDNA replication genes and transcription at 24 h suggests that intermediate timepoints (e.g., 12 hours) could clarify the kinetics of the response and avoid the impression that the sampling coincidentally captured the peak.

(3) The authors report no loss of mitochondrial membrane potential, but this single measure is limited. Complementary assays such as Seahorse analysis, ATP quantification, or reactive oxygen species measurement could more fully assess functional integrity.

(4) The manuscript briefly notes enrichment of TFAM at certain regions of the mitochondrial genome but provides little interpretation of why these regions are favored. Discussion of whether high-occupancy sites correspond to regulatory or structural elements would add valuable context.

(5) It remains unclear whether the altered DNA topology promotes TFAM compaction or vice versa. Addressing this directionality, perhaps by including UVC-only controls for plasmid conformation, would help disentangle these effects if UVC is causing compaction alone.

(6) The authors provide a discrepancy between the anisotropy and binding array results. The reason for this is not clear, and one wonders if an orthogonal approach for the binding experiments would elucidate this difference (minor point).

Assessment of conclusions:

The manuscript successfully meets its primary goal of testing whether TFAM protects mtDNA from UVC damage and the impact this has on the mtDNA. While their data points to an intriguing model that TFAM acts as a sensor of damaged mtDNA, the validation of this model requires further investigation to make the model more convincing. This is likely warranted for a follow-up study. Also, the biological impact of this compaction, such as altering transcription levels, is not clear in this study.

Impact and utility of the methods:

This work advances our understanding of how mitochondria manage UVC genome damage and proposes a structural mechanism for damage "sensing" independent of canonical repair. The methodology, including the custom TFAM DNA chip, will be broadly useful to the scientific community.

Context:

The study supports a model in which mitochondrial genome integrity is maintained not only by repair factors, but also by selective sequestration or removal of damaged genomes. The demonstration that TFAM compaction correlates with damage rather than protection reframes an interesting role in mtDNA quality control.

Reviewer #2 (Public review):

Summary:

King et al. present several sets of experiments aimed to address the potential impact of UV irradiation on human mitochondrial DNA as well as the possible role of mitochondrial TFAM protein in handling UV-irradiated mitochondrial genomes. The carefully worded conclusion derived from the results of experiments performed with human HeLa cells, in vitro small plasmid DNA, with PCR-generated human mitochondrial DNA, and with UV-irradiated small oligonucleotides is presented in the title of the manuscript: "UV irradiation alters TFAM binding to mitochondrial DNA". The authors also interpret results of somewhat unconnected experimental approaches to speculate that "TFAM is a potential DNA damage sensing protein in that it promotes UVC-dependent conformational changes in the [mitochondrial] nucleoids, making them more compact." They further propose that such a proposed compaction triggers the removal of UV-damaged mitochondrial genomes as well as facilitates replication of undamaged mitochondrial genomes.

Strengths:

(1) The authors presented convincing evidence that a very high dose (1500 J/m2) of UVC applied to oligonucleotides covering the entire mitochondrial DNA genome alleviates sequence specificity of TFAM binding (Figure 3). This high dose was sufficient to cause UV lesions in a large fraction of individual oligonucleotides. The method was developed in the lab of one of the corresponding authors (reference 74) and is technically well-refined. This result can be published as is or in combination with other data.

(2) The manuscript also presents AFM evidence (Figure 4) that TFAM, which was long known to facilitate compaction of the mitochondrial genome (Alam et al., 2003; PMID 12626705 and follow-up citations), causes in vitro compaction of a small pUC19 plasmid and that approximately 3 UVC lesions per plasmid molecule result in a slight, albeit detectable, increase in TFAM compaction of the plasmid. Both results can be discussed in line with a possible extrapolation to in vivo phenomena, but such a discussion should include a clear statement that no in vivo support was provided within the set of experiments presented in the manuscript.

Weaknesses:

Besides the experiments presented in Figures 3 and 4, other results do not either support or contradict the speculation that TFAM can play a protective role, eliminating mitochondrial genomes with bulky lesions by way of excessive compaction and removing damaged genomes from the in vivo pool.

To specify these weaknesses:

(1) Figure 1 - presents evidence that UVC causes a reduction in the number of mitochondrial spots in cells. The role of TFAM is not assessed.

(2) Figure 2 - presents evidence that UVC causes lesions in mitochondrial genomes in vivo, detectable by qPCR. No direct assessment of TFAM roles in damage repair or mitochondrial DNA turnover is assessed despite the statements in the title of Figure 2 or in associated text. Approximately 2-fold change in gene expression of TFAM and of the three other genes does not provide any reasonable support to suggestion about increased mitochondrial DNA turnover over multiple explanations on related to mitochondrial DNA maintenance.

(3) Figure 5. Shows that TFAM does not protect either mitochondrial nucleoids formed in vitro or mitochondrial DNA in vivo from UVC lesions as well as has no effect on in vivo repair of UV lesions.

(4) Figure 6: Based on the above analysis, the model of the role of TFAM in sensing mtDNA damage and elimination of damaged genomes in vivo appears unsupported.

(5) Additional concern about Figure 3 and relevant discussion: It is not clear if more uniform TFAM binding to UV irradiated oligonucleotides with varying sequence as compared to non-irradiated oligonucleotides can be explained by just overall reduced binding eliminating sequence specific peaks.

Reviewer #3 (Public review):

Summary:

The study is grounded in the observations that mitochondrial DNA (mtDNA) exhibits a degree of resistance to mutagenesis under genotoxic stress. The manuscript focuses on the effects of UVC-induced DNA damage on TFAM-DNA binding in vitro and in cells. The authors demonstrate increased TFAM-DNA compaction following UVC irradiation in vitro based on high-throughput protein-DNA binding and atomic force microscopy (AFM) experiments. They did not observe a similar trend in fluorescence polarization assays. In cells, the authors found that UVC exposure upregulated TFAM, POLG, and POLRMT mRNA levels without affecting the mitochondrial membrane potential. Overexpressing TFAM in cells or varying TFAM concentration in reconstituted nucleoids did not alter the accumulation or disappearance of mtDNA damage. Based on their data, the authors proposed a plausible model that, following UVC-induced DNA damage, TFAM facilitates nucleoid compaction, which may serve to signal damage in the mitochondrial genome.

Strengths:

The presented data are solid, technically rigorous, and consistent with established literature findings. The experiments are well-executed, providing reliable evidence on the change of TFAM-DNA interactions following UVC irradiation. The proposed model may inspire future follow-up studies to further study the role of TFAM in sensing UVC-induced damage.

Weaknesses:

The manuscript could be further improved by refining specific interpretations and ensuring terminology aligns precisely with the data presented.

(1) In line 322, the claim of increased "nucleoid compaction" in cells should be removed, as there is a lack of direct cellular evidence. Given that non-DNA-bound TFAM is subject to protease digestion, it is uncertain to what extent the overexpressed TFAM actually integrates into and compacts mitochondrial nucleoids in the absence of supporting immunofluorescence data.

(2) In lines 405 and 406, the authors should avoid equating TFAM overexpression with compaction in the cellular context unless the compaction is directly visualized or measured.

(3) In lines 304 and 305 (and several other places throughout the manuscript), the authors use the term "removal rates". A "removal rate" requires a direct comparison of accumulated lesion levels over a time course under different conditions. Given the complexity of UV-induced DNA damage-which involves both damage formation and potential removal via multiple pathways-a more accurate term that reflects the net result of these opposing processes is "accumulated DNA damage levels." This terminology better reflects the final state measured and avoids implying a single, active 'removal' pathway without sufficient kinetic data.

(4) In line 357, the authors refer to the decrease in the total DNA damage level as "The removal of damaged mtDNA". The decrease may be simply due to the turnover and resynthesis of non-damaged mtDNA molecules. The term "removal" may mislead the casual reader into interpreting the effect as an active repair/removal process.

Reviewer #1 (Public review):

Summary:

This paper investigates the thermal and mechanical unfolding pathways of the doubly knotted protein TrmD-Tm1570 using molecular simulations, optical tweezers experiments, and other methods. In particular, the detailed analysis of the four major unfolding pathways using a well-established simulation method is an interesting and valuable result.

Strengths:

A key finding that lends credibility to the simulation results is that the molecular simulations at least qualitatively reproduce the characteristic force-extension distance profiles obtained from optical tweezers experiments during mechanical unfolding. Furthermore, a major strength is that the authors have consistently studied the folding and unfolding processes of knotted proteins, and this paper represents a careful advancement building upon that foundation.

Weaknesses:

While optical tweezers experiments offer valuable insights, the knowledge gained from them is limited, as the experiments are restricted to this single technique.

The paper mentions that the high aggregation propensity of the TrmD-Tm1570 protein appears to hinder other types of experiments. This is likely the reason why a key aspect, such as whether a ribosome or molecular chaperones are essential for the folding of TrmD-Tm1570, has not been experimentally clarified, even though it should be possible in principle.

Reviewer #2 (Public review):

Summary:

In this manuscript, the authors combined coarse-grained structure-based model simulation, optical tweezer experiments, and AI-based analysis to assess the knotting behavior of the TrmD-Tm1570 protein. Interestingly, they found that while the structure-based model can fold the single knot from TrmD and Tm1570, the double-knot protein TrmD-Tm1570 cannot form a knot itself, suggesting the need for chaperone proteins to facilitate this knotting process. This study has strong potential to understand the molecular mechanism of knotted proteins, supported by many experimental and simulation evidence. However, there are a few places that appear to lack sufficient details, and more clarification in the presentation is needed.

Strengths:

A combination of both experimental and computational studies.

Weaknesses:

There is a lack of detail to support some statements.

(1) The use of the AI-based method, SOM, can be emphasized further, especially in its analysis of the simulated unfolding trajectories and discovery of the four unfolding/folding pathways. This will strengthen the statistical robustness of the discovery.

(2) The manuscript would benefit from a clearer description of the correlation between the simulation and experimental results. The current correlation, presented in the paragraph starting from Line 250, focuses on measured distances. The authors could consider providing additional evidence on the order of events observed experimentally and computationally. More statistical analyses on the experimental curves presented in Figure 4 supplement would be helpful.

(3) How did the authors calibrate the timescale between simulation and experiment? Specifically, what is the value \tau used in Line 270, and how was it calculated? Relevant information would strengthen the connection between simulation and experiment.

(4) In Line 342, the authors comment that whether using native contacts or not, they cannot fold double-knotted TrmD-Tm1570. Could the authors provide more details on how non-native interactions were analyzed?

(5) It appears that the manuscript lacks simulation or experimental evidence to support the statement at Line 343: While each domain can self-tie into its native knot, this process inhibits the knotting of the other domain. Specifically, more clarification on this inhibition is needed.

Reviewer #1 (Public review):

Summary:

The researchers sought to determine whether Ptbp1, an RNA-binding protein formerly thought to be a master regulator of neuronal differentiation, is required for retinal neurogenesis and cell fate specification. They used a conditional knockout mouse line to remove Ptbp1 in retinal progenitors and analyzed the results using bulk RNA-seq, single-cell RNA-seq, immunohistochemistry, and EdU labeling. Their findings show that Ptbp1 deletion has no effect on retinal development, since no defects were found in retinal lamination, progenitor proliferation, or cell type composition. Although bulk RNA-seq indicated changes in RNA splicing and increased expression of late-stage progenitor and photoreceptor genes in the mutants, and single-cell RNA-seq detected relatively minor transcriptional shifts in Müller glia, the overall phenotypic impact was low. As a result, the authors conclude that Ptbp1 is not required for retinal neurogenesis and development, thus contradicting prior statements about its important role as a master regulator of neurogenesis. They argue for a reassessment of this stated role. While the findings are strong in the setting of the retina, the larger implications for other areas of the CNS require more investigation. Furthermore, questions about potential reimbursement from Ptbp2 warrant further research.

Strengths:

This study calls into doubt the commonly held belief that Ptbp1 is a critical regulator of neurogenesis in the CNS, particularly in retinal development. The adoption of a conditional knockout mouse model provides a reliable way for eliminating Ptbp1 in retinal progenitors while avoiding the off-target effects often reported in RNAi experiments. The combination of bulk RNA-seq, scRNA-seq, and immunohistochemistry enables a thorough examination of molecular and cellular alterations at both embryonic and postnatal stages, which strengthens the study's findings. Furthermore, using publicly available RNA-Seq datasets for comparison improves the investigation of splicing and expression across tissues and cell types. The work is well-organized, with informative figure legends and supplemental data that clearly show no substantial phenotypic changes in retinal lamination, proliferation, or cell destiny, despite identified transcriptional and splicing modifications.

Weaknesses:

The retina-specific method raises questions regarding whether Ptbp1 is required in other CNS locations where its neurogenic roles were first proposed. Although the study performs well in transcriptome and histological analyses, it lacks functional assessments (such as electrophysiological or behavioral testing) to determine if small changes in splicing or gene expression affect retinal function.

Reviewer #2 (Public review):

Summary:

Ptbp1 has been proposed as a key regulator of neuronal fate through its role in repressing neurogenesis. In this study, the authors conditionally inactivated Ptbp1 in mouse retinal progenitor cells using the Chx10-Cre line. While RNA-seq analysis at E16 revealed some changes in gene expression, there were no significant alterations in retinal cell type composition, and only modest transcriptional changes in the mature retina, as assessed by immunofluorescence and scRNAseq. Based on these findings, the authors conclude that Ptbp1 is not essential for cell fate determination during retinal development.

Strengths:

Despite some effects of Ptbp1 inactivation (initiated around E11.5 with the onset of Chx10-Cre activity) on gene expression and splicing, the data convincingly demonstrate that retinal cell type composition remains largely unaffected. This study is highly significant since it challenges the prevailing view of Ptbp1 as a central repressor of neurogenesis and highlights the need to further investigate, or re-evaluate, its role in other model systems and regions of the CNS.

Weaknesses:

A limitation of the study is the use of the Chx10-Cre driver, which initiates recombination around E11. This timing does not permit assessment of Ptbp1 function during the earliest phases of retinal development, if expressed at that time.

Comments on revisions:

The authors have thoroughly and satisfactorily addressed all my previous comments.

Reviewer #1 (Public review):

Summary:

While previous studies by this group and others have demonstrated the anti-inflammatory properties of osteoactivin, its specific role in cartilage homeostasis and disease pathogenesis remains unknown.

Strengths:

Strengths of the study include its clinical relevance, given the lack of curative treatments for osteoarthritis, as well as the clarity of the narrative and the quality of most results."

Weaknesses:

A limitation of the study is the reliance on standard techniques; however, this is a minor concern that does not diminish the overall impact or significance of the work.

Comments on revisions:

The authors have satisfactorily addressed my concerns.

Reviewer #2 (Public review):

Summary:

This manuscript presents compelling evidence for a novel anti-inflammatory function of glycoprotein non-metastatic melanoma protein B (GPNMB) in chondrocyte biology and osteoarthritis (OA) pathology. Through a combination of in vitro, ex vivo, and in vivo models, including the destabilization of the medial meniscus (DMM) surgery in mice, the authors demonstrate that GPNMB expression is upregulated in OA-affected cartilage and that recombinant GPNMB treatment reduces the expression of key catabolic markers (MMPs, Adamts-4, and IL-6) without impairing anabolic gene expression. Notably, DBA/2J mice lacking functional GPNMB exhibit exacerbated cartilage degradation post-injury. Mechanistically, GPNMB appears to mitigate inflammation via the MAPK/ERK pathway. Overall, the work is thorough, methodologically sound, and significantly advances our understanding of GPNMB as a protective modulator in osteoarthritic joint disease. The findings could open pathways for therapeutic development.

Strengths:

(1) Clear hypothesis addressing a well-defined knowledge gap.

(2) Robust and multi-modal experimental design: includes human, mouse, cell-line, explant, and surgical OA models.

(3) Elegant use of DBA/2J GPNMB-deficient mice to mimic endogenous loss-of-function.

(4) Mechanistic insight provided through MAPK signaling analysis.

(5) Statistical analysis appears rigorous and the figures are informative.

Weaknesses:

(1) Clarify the strain background of the DBA/2J GPNMB+ mice: While DBA/2J GPNMB+ is described as a control, it would help to explicitly state whether these are transgenically rescued mice or another background strain. Are they littermates, congenic, or a separate colony?

(2) Provide exact sample sizes and variance in all figure legends: Some figures (e.g., Figure 2 panels) do not consistently mention how many replicates were used (biological vs. technical) for each experimental group. Standardizing this across all panels would improve reproducibility.

(3) Expand on potential sex differences: The DMM model is applied only in male mice, which is noted in the methods. It would be helpful if the authors added 1-2 lines in the discussion acknowledging potential sex-based differences in OA progression and GPNMB function.

(4) Visual clarity in schematic (Figure 7): The proposed mechanism is helpful but the text within the schematic is somewhat dense and could be made more readable with spacing or enlarged font. Also, label the MAPK/ERK pathway explicitly in panel B.

Comments on revisions:

The authors have addressed all the concerns raised in the initial review.

Reviewer #1 (Public review):

Summary:

The study by Teplenin and coworkers assesses the combined effects of localized depolarization and excitatory electrical stimulation in myocardial monolayers. They study the electrophysiological behaviour of cultured neonatal rat ventricular cardiomyocytes expressing the light-gated cation channel Cheriff, allowing them to induce local depolarization of varying area and amplitude, the latter titrated by the applied light intensity. In addition, they used computational modeling to screen for critical parameters determining state transitions, and for dissecting the underlying mechanisms. Two stable states, thus bistability, could be induced upon local depolarization and electrical stimulation, one state characterized by a constant membrane voltage and a second spontaneously firing, thus oscillatory state. The resulting 'state' of the monolayer was dependent on the duration and frequency of electrical stimuli, as well as the size of the illuminated area and the applied light intensity determining the degree of depolarization as well as the steepness of the local voltage gradient. In addition to the induction of oscillatory behaviour, they also tested frequency-dependent termination of induced oscillations.

Strengths:

The data from optogenetic experiments and computational modelling provide quantitative insights into the parameter space determining the induction of spontaneous excitation in the monolayer. The most important findings can also be reproduced using a strongly reduced computational model, suggesting that the observed phenomena might be more generally applicable.

Weaknesses:

While the study is thoroughly performed and provides interesting mechanistic insights into scenarios of ventricular arrhythmogenesis in the presence of localized depolarized tissue areas, the translational perspective of the study remains relatively vague. In addition, the chosen theoretical approach and the way the data is presented might make it difficult for the wider community of cardiac researchers to understand the significance of the study.

Comments on Revision:

The provided revisions address some of the raised concerns, but they do not change my general assessment of the paper, including its strengths and weaknesses.

Reviewer #2 (Public review):

In the presented manuscript, Teplenin and colleagues use both electrical pacing and optogenetic stimulation to create a reproducible, controllable source of ectopy in cardiomyocyte monolayers. To accomplish this, they use a careful calibration of electrical pacing characteristics (i.e., frequency, number of pulses) and illumination characteristics (i.e., light intensity, surface area) to show that there exists a "sweet spot" where oscillatory excitations can emerge proximal to the optogenetically depolarized region following electrical pacing cessation, akin to pacemaker cells. Furthermore, the authors demonstrate that a high-frequency electrical wave-train can be used to terminate these oscillatory excitations. The authors observed this oscillatory phenomenon both in vitro (using neonatal rat ventricular cardiomyocyte monolayers) and in silico (using a computational action potential model of the same cell type). These are surprising findings and provide a novel approach for studying triggered activity in cardiac tissue.

The study is extremely thorough and one of the more memorable and grounded applications of cardiac optogenetics in the past decade. One of the benefits of the authors' "two-prong" approach of experimental preps and computational models is that they could probe the number of potential variable combinations much deeper than through in vitro experiments alone. The strong similarities between the real-life and computational findings suggest that these oscillatory excitations are consistent, reproducible, and controllable.

Triggered activity, which can lead to ventricular arrhythmias and cardiac sudden death, has been largely contributed to sub-cellular phenomena, such as early or delayed afterdepolarizations, and thus to date has largely been studied in isolated single cardiomyocytes. However, these findings have been difficult to translate to tissue- and organ-scale experiments, as well-coupled cardiac tissue has notably different electrical properties. This underscores the significance of the study's methodological advances: use of a constant depolarizing current in a subset of (illuminated) cells to reliably result in triggered activity could facilitate the more consistent evaluation of triggered activity at various scales. An experimental prep that is both repeatable and controllable (i.e., both initiated and terminated through the same means) is a boon for further inquiry.

The authors also substantially explored phase space and single cell analyses to document how this "hidden" bi-stable phenomenon can be uncovered during emergent collective tissue behavior. Calibration and testing of different aspects (e.g.: light intensity, illuminated surface area, electrical pulse frequency, electrical pulse count) and other deeper analyses, as illustrated in Figures S3-S8 and Video S1, are significant and commendable.

Given the study is computational, it is surprising that the authors did not replicate their findings using well-validated adult ventricular cardiomyocyte action potential models, such ten Tusscher 2006 or O'Hara 2011. This may have felt out-of-scope, given the nice alignment of rat cardiomyocyte data between in vitro and in silico experiments. However, it would have been helpful peace-of-mind validation, given the significant ionic current differences between neonatal rat and adult ventricular tissue. It is not fully clear whether the pulse trains could have resulted in the same bi-stable oscillatory behavior, given the longer APD of humans relative to rats. The observed phenomenon certainly would be frequency-dependent and would have required tedious calibration for a new cell type, albeit partially mitigated by the relative ease of in silico experiments.

There are likely also mechanistic differences between this optogenetically-tied oscillatory behavior and triggered activity observed in other studies. This is because the constant light-elicited depolarizing current is disrupting the typical resting cardiomyocyte state, thereby altering the balance between depolarizing ionic currents (such as Na+ and Ca2+) and repolarizing ionic currents (such as K+ and Ca2+). The oscillatory excitations appear to later emerge at the border of the illuminated region and non-stimulated surrounding tissue, which is likely an area of high source-sink mismatch. The authors appear to acknowledge differences in this oscillatory behavior and previous sub-cellular triggered activity research in their discussion of ectopic pacemaker activity, which are canonically observed in genetic, pharmacologic, or pathological ionic conditions. Regardless, it is exciting to see new ground being broken in this difficult-to-characterize experimental space, even if the method illustrated here may not necessarily be broadly applicable.

Comments on revisions:

I have read the authors' rebuttal to our earlier comments and do not have any further questions or comments. Thank you for implementing the minor improvements to Figure visualizations and for creating Video S1 to accompany the article.

Reviewer #1 (Public review):

Petrovic et al. investigate CCR5 endocytosis via arrestin2, with a particular focus on clathrin and AP2 contributions. The study is thorough and methodologically diverse. The NMR titration data clearly demonstrate chemical shift changes at the canonical clathrin-binding site (LIELD), present in both the 2S and 2L arrestin splice variants. To assess the effect of arrestin activation on clathrin binding, the authors compare: truncated arrestin (1-393), full-length arrestin, and 1-393 incubated with CCR5 phosphopeptides. All three bind clathrin comparably, whereas controls show no binding. These findings are consistent with prior crystal structures showing peptide-like binding of the LIELD motif, with disordered flanking regions. The manuscript also evaluates a non-canonical clathrin binding site specific to the 2L splice variant. Though this region has been shown to enhance beta2-adrenergic receptor binding, it appears not to affect CCR5 internalization.

Similar analyses applied to AP2 show a different result. AP2 binding is activation-dependent and influenced by the presence and level of phosphorylation of CCR5-derived phosphopeptides. These findings are reinforced by cellular internalization assays.

In sum, the results highlight splice-variant-dependent effects and phosphorylation-sensitive arrestin-partner interactions. The data argue against a (rapidly disappearing) one-size-fits-all model for GPCR-arrestin signaling and instead support a nuanced, receptor-specific view, with one example summarized effectively in the mechanistic figure.

Weaknesses:

Figure 1 shows regions alphaFold model that are intrinsically disordered without making it clear that this is not an expected stable position. The authors NMR titration data are n=1. Many figure panels require that readers pinch and zoom to see the data.

Reviewer #2 (Public review):

Summary:

Based on extensive live cell assays, SEC, and NMR studies of reconstituted complexes, these authors explore the roles of clathrin and the AP2 protein in facilitating clathrin mediated endocytosis via activated arrestin-2. NMR, SEC, proteolysis, and live cell tracking confirm a strong interaction between AP2 and activated arrestin using a phosphorylated C-terminus of CCR5. At the same time a weak interaction between clathrin and arrestin-2 is observed, irrespective of activation.

These results contrast with previous observations of class A GPCRs and the more direct participation by clathrin. The results are discussed in terms of the importance of short and long phosphorylated bar codes in class A and class B endocytosis.

Strengths:

The 15N,1H and 13C,methyl TROSY NMR and assignments represent a monumental amount of work on arrestin-2, clathrin, and AP2. Weak NMR interactions between arrestin-2 and clathrin are observed irrespective of activation of arrestin. A second interface, proposed by crystallography, was suggested to be a possible crystal artifact. NMR establishes realistic information on the clathrin and AP2 affinities to activated arrestin with both kD and description of the interfaces.

Weaknesses:

This reviewer has identified only minor weaknesses with the study.

(1) I don't observe two overlapping spectra of Arrestin2 (1-393) +/- CLTC NTD in Supp Figure 1

(2) Arrestin-2 1-418 resonances all but disappear with CCR5pp6 addition. Are they recovered with Ap2Beta2 addition and is this what is shown in Supp Fig 2D

(3) I don't understand how methyl TROSY spectra of arrestin2 with phosphopeptide could look so broadened unless there are sample stability problems?

(4) At one point the authors added excess fully phosphorylated CCR5 phosphopeptide (CCR5pp6). Does the phosphopeptide rescue resolution of arrestin2 (NH or methyl) to the point where interaction dynamics with clathrin (CLTC NTD) are now more evident on the arrestin2 surface?

(5) Once phosphopeptide activates arrestin-2 and AP2 binds can phosphopeptide be exchanged off? In this case, would it be possible for the activated arrestin-2 AP2 complex to re-engage a new (phosphorylated) receptor?

(6) I'd be tempted to move the discussion of class A and class B GPCRs and their presumed differences to the intro and then motivate the paper with specific questions.

(7) Did the authors ever try SEC measurements of arrestin-2 + AP2beta2+CCR5pp6 with and without PIP2, and with and without clathrin (CLTC NTD? The question becomes what the active complex is and how PIP2 modulates this cascade of complexation events in class B receptors.

Reviewer #3 (Public review):

Summary:

Overall, this is a well-done study, and the conclusions are largely supported by the data, which will be of interest to the field.

Strengths:

Strengths of this study include experiments with solution NMR that can resolve high-resolution interactions of the highly flexible C-terminal tail of arr2 with clathrin and AP2. Although mainly confirmatory in defining the arr2 CBL 376LIELD380 as the clathrin binding site, the use of the NMR is of high interest (Fig. 1). The 15N-labeled CLTC-NTD experiment with arr2 titrations reveals a span from 39-108 that mediates an arr2 interaction, which corroborates previous crystal data, but does not reveal a second area in CLTC-NTD that in previous crystal structures was observed to interact with arr2.

SEC and NMR data suggest that full-length arr2 (1-418) binding with 2-adaptin subunit of AP2 is enhanced in the presence of CCR5 phospho-peptides (Fig. 3). The pp6 peptide shows the highest degree of arr2 activation, and 2-adaptin binding, compared to less phosphorylated peptide or not phosphorylated at all. It is interesting that the arr2 interaction with CLTC NTD and pp6 cannot be detected using the SEC approach, further suggesting that clathrin binding is not dependent on arrestin activation. Overall, the data suggest that receptor activation promotes arrestin binding to AP2, not clathrin, suggesting the AP2 interaction is necessary for CCR5 endocytosis.

To validate the solid biophysical data, the authors pursue validation experiments in a HeLa cell model by confocal microscopy. This requires transient transfection of tagged receptor (CCR5-Flag) and arr2 (arr2-YFP). CCR5 displays a "class B"-like behavior in that arr2 is rapidly recruited to the receptor at the plasma membrane upon agonist activation, which forms a stable complex that internalizes onto endosomes (Fig. 4). The data suggest that complex internalization is dependent on AP2 binding not clathrin (Fig. 5).

The addition of the antagonist experiment/data adds rigor to the study.

Overall, this is a solid study that will be of interest to the field.

Reviewer #1 (Public review):

Summary:

In the manuscript "Identification and classification of ion-channels across the tree of life: Insights into understudied CALHM channels" Taujale et al describe an interdisciplinary approach to mine the human channelome and further discover orthologues across diverse organisms, culminating in delineating co-conserved patterns in an example ion channel: CALHM. Overall, this paper comes in two sections, one where 419 human ion channels and 48,000+ channels from diverse organisms are found through a multidisciplinary data mining approach, and a second where this data is used to find co-conserved sequences, whose functional significance is validated via experiments on CALHM1 and CALHM6. Overall, this is an intriguing data-first approach to better understand even understudied ion channels like CALHM6. However, more needs to be done to pull this story together into a single coherent narrative.

Strengths:

This manuscript takes advantage of modern-day LLM tools to better mine the literature for ion channel sequences in humans and other species with orthologous ion channel sequences. They explore the 'dark channome' of understudied ion channels to better reveal the information evolution has to tell us about our own proteins, and illustrate the information this provides access to in experimental studies in the final section of the paper. Finally, they provide a wealth of information in the supplementary tables (in the form of Excel spreadsheets and a dataset on Zenodo) for others to explore. Overall, this is a creative approach to a wide-reaching problem that can be applied to other families of proteins.

Weaknesses:

Overall, while a considerable amount of work has been done for this manuscript, the presentation, both in terms of writing and figures, still can use more work even after a first round of revisions. While they have improved their discussion to more clearly describe the need for a better-curated sequence database of ion channels, and how existing resources fall short, some aspects of this process and the motivation remain unclear, especially when it comes to the CALHM sequences.

Overall, this manuscript is a valuable contribution to the field, but requires a few main things to make it truly useful. Namely, how has this approach really improved their ability to identify conserved residues in CALHM over a less-involved approach? And better organization of the first results section of the paper, which is critical to the downstream understanding of the paper, as well as some cosmetic improvements.

Reviewer #2 (Public review):

Summary:

In this paper, the authors defined the "channelome," consisting of 419 predicted human ion channels as well as 48,000 ion channel orthologs from other organisms. Using this information, the ion channels were clustered into groups, which can potentially be used to make predictions about understudied ion channels in the groups. The authors then focused on the CALHM ion channel family, mutating conserved residues and assessing channel function.

Strengths:

The curation of the channelome provides an excellent resource for researchers studying ion channels. Supplemental Table 1 is well organized with an abundance of useful information.

Comments on revisions:

The authors have thoroughly addressed my concerns and the manuscript is substantially improved. I have just a few suggestions regarding wording/clarification.

In Supplemental Figure 4, the Western blots (n=3) were quantitated, but the surface biotinylation was not. While I suppose that it is fine to just show one representative experiment for the biotinylation assay, the authors should indicate in the legend how many times this was done. It is essential to know whether these data in Supplemental Figure 4E, F are reproducible as they are absolutely critical for interpretation of all of the data in Figure 5.

Reviewer #1 (Public review):

The manuscript by Ivan et al aimed to identify epitopes on the Abeta peptide for a large set of anti-Abeta antibodies, including clinically relevant antibodies. The experimental work was well done and required a major experimental effort including peptide mutational scanning, affinity determinations, molecular dynamics simulations, IP-MS, WB and IHC. The first part of the work is focused on an assay in which peptides (15-18-mers) based on the human Abeta sequence, including some containing known PTMs, are immobilized, thus preventing aggregation and for this reason provide limited biologically-relevant information. Although some results are in agreement with previous experimental structural data (e.g. for 3D6), and some responses to disease-associated mutations were different when compared to wild-type sequences (e.g. in the case of Aducanumab) - which may have implications for personalized treatment. On the other hand, the contribution of conformation (as in oligomers and large aggregates) in antibody recognition patterns was took into consideration in the second part of the study, in which both full-length Abeta in monomeric or aggregated forms and human CSF was employed to investigate the differential epitope interaction between Aducanumab, donanemab and lecanemab. Interestingly, these results confirmed the expected preference of these antibodies for aggregated Abeta. Overall, I understand that the work is of interest to the field.

Comments on revisions:

I have no additional recommendations.

Reviewer #1 (Public review):

Summary:

This paper describes experiments with alpha-synuclein (aS) with acetylated lysines (acK) at various positions. Their findings on how to use non-canonical amino acid (ncAA) mutagenesis to generate aS with acetylated lysines are valuable. The paper then continues with a range of experiments to characterise the acetylated alpha-synuclein constructs at different positions, with the aim of providing insights into which sites are relevant to disease or their function inside cells. The paper concludes these experiments with the suggestion that inhibiting the Zn2+-dependent histone deacetylase HDAC8 to potentially increase acetylation at lysine 80 may have therapeutic benefit. However, the relevance of most of these experiments is unclear, mainly as the filaments that form from these constructs are different from those observed in human disease (but see below for more details). Moreover, using the recombinantly produced acetylated versions of alpha-synuclein to normalise mass-spectrometry data, the authors themselves report that acetylation of alpha-synuclein does not differ between individuals with Parkinson's disease or healthy controls.

Strengths:

The authors report difficulties with chemical synthesis, and then decide to make these constructs using non-canonical amino acid (ncAA) mutagenesis, which seems to work reasonably well (yields vary somewhat). In the Conclusion section, the authors report that they used these recombinant proteins to obtain quantitative insights into the levels of acetylation of lysines in individuals with PD versus healthy controls, for which they find no significant differences. This part of the work is valuable.

Weaknesses:

The authors then use circular dichroism to show that aSyn with acK at position 43 has less alpha-helical content. From this result, they deduce that "only this site could potentially perturb aS function in neurotransmitter trafficking", but no experiments on neurotransmitter trafficking were performed.

Subsequently, they measure the aggregation speed of the variants in seeded aggregation experiments with preformed fibrils (PFFs) from WT aSyn, and conclude that acK at positions 12, 43, and 80 yields slower aggregation. They reach similar conclusions when measuring seeded aggregation in primary cultures. As far as I understand it, the seeding experiments in cells use seeds that are assembled from partially acetylated alpha-synuclein, but that are made of non-acetylated wildtype alpha-synuclein, and the alpha-synuclein that is endogenous in the cells is also non-acetylated (or at least not beyond what happens in these cells at endogenous levels). It is therefore unclear how the cellular seeding experiments relate to the in vitro aggregation assays with (partially) acetylated substrates. Anyway, both aggregation experiments ignore that the structures of aSyn filaments in Parkinson's disease (PD) or multiple system atrophy (MSA) are different from those formed in these experiments, and that, therefore, the observed aggregation kinetics are likely irrelevant for the speed with which disease-relevant filaments form in the brain.

NMR and FCS experiments show that acK at positions 12 and 43 may reduce binding to vesicles, which then leaves only acK80.

Finally, the authors describe the cryo-EM structure of mixtures of acK80:WT aSyn filaments, which are predominantly made of WT aSyn, with a previously described structure. Filaments made of only acK80 aSyn have a modified arrangement of this structure, where the now neutral side chain of residue 80 packs inside a hydrophobic pocket. The authors discuss differences between the acK80 structures and those of other structures from in vitro assembled aSyn filaments, none of which are the same as those observed from PD or MSA brains, nor are any attempts made to transfer observations from the in vitro experiments to the structures of disease. The relevance of the cryo-EM structures for human disease, therefore, remains unclear.

The Conclusion on p.20 mentions an interesting and valuable result: the authors used the acetylated recombinant proteins to determine the extent of acetylation within human protein samples by quantitative liquid chromatography MS (SI, Figures S41-S49). Their conclusion is that "The level of acetylation was variable - no clear trend was observed between healthy control and patients - nor between patients of different diseases (SI, Table S4, Supplementary Data 1)" This result implies that acetylation of aS is not directly related to its pathogenicity, which again adds doubts on the disease-relevance of the results described in the rest of the paper.

Reviewer #2 (Public review):

Summary:

Shimogawa et al. studied the effect of lysine acetylation at different sites in the alpha-synuclein (aS) sequence on the protein-membrane affinity, seeding capacity in the test tube and in cells, and on the structure of fibrils, using a range of biophysical methods. They use non-canonical amino acid (ncAA) mutagenesis to prepare aS lysine acetylated variant at different sites.

Strengths:

The major strength of this paper is the approach used for the production of site-specific lysine acetylated variants of aS using ncAA mutagenesis, as well as the combination of a range of biophysical methods together with cellular assays and structure biology to decipher the effect of lysine acetylation on aS-membrane binding, seeding propensity, and fibril structure. This approach allowed the author to find that lysine acetylation at positions 12, 43, and 80 led to lower seeding capacity of aS in the test tube and in cells, but only acetylation at lysine 80 did not affect aS-membrane interaction. These results suggest that lysine acetylation at position 80 may be protective against aggregation without perturbing the proposed functional role of aS in synaptic plasticity.

Weaknesses:

SDS is not a good membrane model to investigate the effect of lysine acetylation on aS membrane-binding because it is a harsh detergent and solubilizes membranes. Negatively charged vesicles or vesicles made of a mixture of lipids mimicking the lipid composition of synaptic vesicles are more accepted in the field to study aS-membrane interactions. The authors used such vesicles for the FCS experiments, and they could be used for the initial screening of the 12 lysine acetylated variants of aS.

It would help the reader to have the experimental details (e.g., buffer, protein/lipid concentrations) for the different assays written in the figure legend.

The authors use an assay consisting of mixing 10% fibrils + 90% monomer to investigate the effect of lysine acetylation on aS. However, the assay only probes fibril elongation and/or secondary processes. The current wording can be misleading, and the term aggregation could be replaced by seeding capacity for clarity. For example, the authors state that lysine acetylation at sites 12, 43, and 80 each inhibits aggregation, but this statement is not supported by the data. Instead, the data show that the acetylation at these sites slows down the fibril elongation and thus decreases the seeding capacity of aS fibrils. In order to state that lysine acetylation has an effect on aS aggregation, fibril formation, the author should use an assay where the de novo formation of fibrils is assessed, such as in the presence of lipid vesicles or under shaking conditions.

It is not clear from the EM data that the structures of the different lysine acetylated variants are different, unlike what is stated in the text.

Reviewer #3 (Public review):

Shimogawa et al. describe the generation of acetylated aSyn variants by genetic code expansion to elucidate effects on vesicle binding, aggregation, and seeding effects. The authors compared a semi-synthetic approach to obtain acetylated aSyn variants with genetic code expansion and concluded that the latter was more efficient in generating all 12 variants studied here, despite the low yields for some of them. Selected acetylated variants were used in advanced NMR, FCS, and cryo-EM experiments to elucidate structural and functional changes caused by acetylation of aSyn. Finally, site-specific differences in deacetylation by HDAC 8 were identified.

The study is of high scientific quality, andthe results are convincingly supported by the experimental data provided. The challenges the authors report regarding semi-synthetic access to aSyn are somewhat surprising, as this protein has been made by a variety of different semi-synthesis strategies in satisfactory yields and without similar problems being reported.

The role of PTMs such as acetylation in neurodegenerative diseases is of high relevance for the field, and a particular strength of this study is the use of authentic acetylated aSyn instead of acetylation-mimicking mutations. The finding that certain lysine acetylations can slow down aggregation even when present only at 10-25% of total aSyn is exciting and bears some potential for diagnostics and therapeutic intervention.

Reviewer #1 (Public review):

Summary:

The study by Akita B. Jaykumar et al. explored an interesting and relevant hypothesis whether serine/threonine With-No-lysine (K) kinases (WNK)-1, -2, -3, and -4 engage in insulin-dependent glucose transporter-4 (GLUT4) signaling in the murine central nervous system. The authors especially focused on the hippocampus as this brain region exhibits high expression of insulin and GLUT4. Additionally, disrupted glucose metabolism in the hippocampus has been associated with anxiety disorders, while impaired WNK signaling has been linked to hypertension, learning disabilities, psychiatric disorders or Alzheimer's disease. The study took advantage of selective pan-WNK inhibitor WNK 643 as the main tool to manipulate WNK 1-4 activity both in vivo by daily, per-oral drug administration to wild-type mice, and in vitro by treating either adult murine brain synaptosomes, hippocampal slices, primary cortical cultures, and human cell lines (HEK293, SH-SY5Y). Using a battery of standard behavior paradigms such as open field test, elevated plus maze test, and fear conditioning, the authors convincingly demonstrate that the inhibition of WNK1-4 results in behavior changes, especially in enhanced learning and memory of WNK643-treated mice. To shed light on the underlying molecular mechanism, the authors implemented multiple biochemical approaches including immunoprecipitation, glucose-uptake assay, surface biotylination assay, immunoblotting, and immunofluorescence. The data suggest that simultaneous insulin stimulation and WNK1-4 inhibition results in increased glucose uptake and the activity of insulin's downstream effectors, phosphorylated Akt and phosphorylated AS160. Moreover, the authors demonstrate that insulin treatment enhances the physical interaction of the WNK effector OSR1/SPAK with Akt substrate AS160. As a result, combined treatment with insulin and the WNK643 inhibitor synergistically increases the targeting of GLUT4 to the plasma membrane. Collectively, these data strongly support the initial hypothesis that neuronal insulin- and WNK-dependent pathways do interact and engage in cognitive functions.

In response to our initial comments, the authors mildly revised the manuscript, which did not improve the weaknesses to a sufficient level. Our follow-up comments are labeled under "Revisions 1".

Strengths:

The insulin-dependent signaling in the central nervous system is relatively understudied. This explorative study delves into several interesting and clinically relevant possibilities, examining how insulin-dependent signaling and its crosstalk with WNK kinases might affect brain circuits involved in memory formation and/or anxiety. Therefore, these findings might inspire follow-up studies performed in disease models for disorders that exhibit impaired glucose metabolism, deficient memory, or anxiety, such as Diabetes mellitus, Alzheimer's disease, or most of psychiatric disorders.

The graphical presentation of the figures is of high quality, which helps the reader to obtain a good overview and to easily understand the experimental design, results, and conclusions.

The behavioral studies are well conducted and provide valuable insights into the role of WNK kinases in glucose metabolism and their effect on learning and memory. Additionally, the authors evaluate the levels of basal and induced anxiety in Figures 1 and 2, enhancing our understanding of how WNK signaling might engage in cognitive function and anxiety-like behavior, particularly in the context of altered glucose metabolism.

The data presented in Figures 3 and 4 are notably valuable and robust. The authors effectively utilize a variety of in vivo and in vitro models, combining different treatments in a clear manner. The experimental design is well-controlled, efficiently communicated, and well-executed, providing the reader with clear objectives and conclusions. Overall, these data represent particularly solid and reproducible evidence on the enhanced glucose uptake, GLUT4 targeting, and downstream effectors' activation upon insulin and WNK/OSR1 signaling crosstalk.

Weaknesses:

(1) The study used a WNK643 inhibitor as the only tool to manipulate WNK1-4 activity. This inhibitor seems selective; however, it has been reported that it exhibits different efficiency in inhibiting the individual WNK kinases among each other (e.g. PMID: 31017050, PMID: 36712947). Additionally, the authors do not analyze nor report the expression profiles or activity levels of WNK1, WNK2, WNK3, and WNK4 within the relevant brain regions (i.e. hippocampus, cortex, amygdala). Combined, these weaknesses raise concerns about the direct involvement of WNK kinases within the selected brain regions and behavior circuits. It would be beneficial if the authors provided gene profiling for WNK1, 2, 3, and -4 (e.g. using Allen brain atlas). To confirm the observations, the authors should either add results from using other WNK inhibitors or, preferentially, analyze knock-down or knock-out animals/tissue targeting the single kinases.

Revisions 1: The authors added Fig. S1A during the revisions to show expression of Wnt1-4. While the expression data from humans is interesting, the experimental part of the study is performed in mice. It would be more informative for the authors to add expression profiles from mice or overview the expression pattern with suitable references in the introduction to address this point. The authors did not add data from knock down or knockout tissue targeting the single kinases.

(2) The authors do not report any data on whether the global inhibition of WNKs affects insulin levels as such. Since the authors demonstrate the synergistic effect of simultaneous insulin treatment and WNK1-4 inhibition, such data are missing.

Revisions 1: The authors added Fig. S5A to address this point. It is appreciated that authors performed the needed experiment. Unfortunately, no significant change was found, therefore, the authors still cannot conclude that they demonstrate a synergistic effect of simultaneous insulin treatment and WNT1-4 inhibition. It is a missed opportunity that the authors did not measure insulin in the CSF or tissue lysate to support the data.

(3) The study discovered that the Sortilin receptor binds to OSR1, leading the authors to speculate that Sortilin may be involved in the insulin-dependent GLUT4 surface trafficking. The authors conclude in the result section that "WNK/OSR1/SPAK influences insulin-sensitive GLUT4 trafficking by balancing GLUT4 sequestration in the TGN via regulation of Sortilin with GLUT4 release from these vesicles upon insulin stimulation via regulation of AS160." However, the authors do not provide any evidence supporting Sortilin's involvement in such regulation, thus, this conclusion should be removed from the section. Accordingly, the first paragraph of the discussion should be also rephrased or removed.

Revisions 1: The authors added Fig. 5M-N to address this point. The new experiment is appreciated. However, the authors still do not show that sortilin is involved in insulin or WNK-dependent GLUT4 trafficking in their set up since the authors do not demonstrate any changes in GLUT4 sorting or binding. The conclusions should therefore be rephrased or included purely in the discussion. Moreover, the discussion was not adjusted either, leading to over interpretation based on the available data.

(4) The background relevant to Figure 5, as well as the results and conclusions presented in Figure 5 are quite challenging to follow due to the lack of a clear introduction to the signaling pathways. Consequently, understanding the conclusions drawn from the data is also difficult. It would be beneficial if the authors addressed this issue with either reformulations or additional sections in the introduction. Furthermore, the pulldown experiments in this figure lack some of the necessary controls.

Revisions 1: The Authors insufficiently addressed this point during the revisions and did not rewrite the introduction as suggested.

(5) The authors lack proper independent loading controls (e.g. GAPDH levels) in their immunoblots throughout the paper, and thus their quantifications lack this important normalization step. The authors also did not add knock-out or knock-down controls in their co-IPs. This is disappointing since these improvements were central and suggested during the revision process.

(6) The schemes that represent only hypotheses (Fig. 1K, 4A) are unnecessary and confusing and thus should be omitted or placed at the end of each figure if the conclusions align.

(7) Low-quality images, such as Fig. 5H should be replaced with high-resolution photos, moved to the supplementary, or omitted.

Reviewer #2 (Public review):

This study by Jaykumar and colleagues seeks to expand the field's appreciation of insulin responses in the brain, specifically by implicating WNK kinase function in various neuronal responses, ranging from behavioral / memory changes to GLUT4 trafficking to the cell surface with subsequent glucose uptake. This revised study is now comprehensive and presents a logical and reasonably documented cascade of molecular interactions responsible in part for GLUT4 trafficking under the regulation of WKK and insulin. Additional data allow the authors to dissect a plausible WNK/OSR1/SPAK-sortilin pathway for the modulation of GLUT4 trafficking, in part by capitalizing on a overlay of various techniques and systems. The data - much of it in vivo or ex vivo - showing a potential role for WNK function in brain glucose utilization remains a compelling part of the story, with the dissection of the signaling cascade and a potential role for sortilin in mediating WNK function via effects on GLUT4 cellular localization now more convincing.

Initially, the group shows that oral WNK463 treatment - an inhibitor of WNKs broadly - in mice augments a number of memory readouts. These findings fit within the context of the overall story the authors present: that WNK function is critical to brain glucose utilization, which impacts learning. Multiple approaches are used to show that WNK463 treatment, i.e. inhibition of WNKs, increases glucose uptake, including labeled 2-deoxyglucose uptake in vivo in the brain and in isolated synaptosome, and uptake in ex vivo hippocampal slices. These findings are solid and consistent. With the exception of some relatively minor comments regarding the data presentation made to the authors and now fully addressed, the findings showing that WNK463 treatment increases GLUT4-mediated glucose uptake and surface localization of GLUT4 are reasonable, with the hippocampal slice data being particularly relevant.

While the details of the WNK signaling cascade is dense, in the revised application one clearly appreciates the molecular interrogation and interactions the group is dissecting, supported by the use of multiple models. With the additional findings, these systems and the data now reinforce each other, presenting a strongly documented overall story.

A limitation of the study with the initial submission was the authors' reliance upon a single pharmacological tool (WNK463) to inhibit WNK kinases. WNK463 apparently has substantial specificity for WNKs and WNK463 treatment lessened OSR1 phosphorylation (a WNK substrate). Nevertheless, the cohesiveness of the findings in terms of the broader pathway engagement (GLUT4 trafficking, glucose uptake) is consistent with the author's proposed mechanisms and conclusions. The authors have additionally addressed this concern in the revised manuscript with more information supporting the specificity of WNK463 as well as the multiple approaches to confirm the effect of WNK463 on the WNK signaling pathway of interest.

The final few paragraphs of the discussion that weave the author's findings into the field more broadly, including Sortilin function and neurological disorders, are appreciated. Additional clarity in the Methods section is also helpful.

Reviewer #1 (Public review):

Summary:

This study identifies HSD17B7 as a cholesterol biosynthesis gene enriched in sensory hair cells, with demonstrated importance for auditory behavior and potential involvement in mechanotransduction. Using zebrafish knockdown and rescue experiments, the authors show that loss of hsd17b7 reduces cholesterol levels and impairs hearing behavior. They also report a heterozygous nonsense variant in a patient with hearing loss. The gene mutation has a complex and somewhat inconsistent phenotype, appearing to mislocalize, reduce mRNA and protein levels, and alter cholesterol distribution, supporting HSD17B7 as a potential deafness gene.

While the study presents an interesting candidate and highlights an underexplored role for cholesterol in hair cell function, several important claims are insufficiently supported, and the mechanistic interpretations remain somewhat murky.

Strengths:

(1) HSD17B7 is a new candidate deafness gene with plausible biological relevance.

(2) Cross-species RNAseq convincingly shows hair-cell enrichment.

(3) Lipid metabolism, particularly cholesterol homeostasis, is an emerging area of interest in auditory function.

(4) The connection between cholesterol levels and MET is potentially impactful and, if substantiated, would represent a significant advance.

Weaknesses:

(1) The pathogenic mechanism of the E182STOP variant is unclear: The mutant protein presumably does not affect WT protein localization, arguing against a dominant-negative effect. Yet, overexpression of HSD17B7-E182* alone causes toxicity in zebrafish, and it binds and mislocalizes cholesterol in HEI-OC1 cells, suggesting some gain-of-function or toxic effect. In addition, the mRNA of the variant has a low expression level, suggesting nonsense-mediated decay. This complexity and inconsistency need clearer explanation.

(2) The link to human deafness is based on a single heterozygous patient with no syndromic features. Given that nearly all known cholesterol metabolism disorders are syndromic, this raises concerns about causality or specificity. The term "novel deafness gene" is premature without additional cases or segregation data.

(3) The localization of HSD17B7 should be clarified better: In HEI-OC1 cells, HSD17B7 localizes to the ER, as expected. In mouse hair cells, the staining pattern is cytosolic and almost perfectly overlaps with the hair cell marker used, Myo7a. This needs to be discussed. Without KO tissue, HSD17B7 antibody specificity remains uncertain.

Reviewer #2 (Public review):

A summary of what the authors were trying to achieve.

The authors aim to determine whether the gene Hsb17b7 is essential for hair cell function and, if so, to elucidate the underlying mechanism, specifically the HSB17B7 metabolic role in cholesterol biogenesis. They use animal, tissue, or data from zebrafish, mouse, and human patients.

Strengths:

(1) This is the first study of Hsb17b7 in the zebrafish (a previous report identified this gene as a hair cell marker in the mouse utricle).

(2) The authors demonstrate that Hsb17b7 is expressed in hair cells of zebrafish and the mouse cochlea.

(3) In zebrafish larvae, a likely KO of the Hsb17b7 gene causes a mild phenotype in an acoustic/vibrational assay, which also involves a motor response.

(4) In zebrafish larvae, a likely KO of the Hsb17b7 gene causes a mild reduction in lateral line neuromast hair cell number and a mild decrease in the overall mechanotransduction activity of hair cells, assayed with a fluorescent dye entering the mechanotransduction channels.

(5) When HSB17B7 is overexpressed in a cell line, it goes to the ER, and an increase in Cholesterol cytoplasmic puncta is detected. Instead, when a truncated version of HSB17B7 is overexpressed, HSB17B7 forms aggregates that co-localize with cholesterol.

(6) It seems that the level of cholesterol in crista and neuromast hair cells decreases when Hsb17b7 is defective (but see comment below).

Weakness:

(1) The statement that HSD17B7 is "highly" expressed in sensory hair cells in mice and zebrafish seems incorrect for zebrafish:

(a) The data do not support the notion that HSB17B7 is "highly expressed" in zebrafish. Compared to other genes (TMC1, TMIE, and others), the HSB17B7 level of expression in neuromast hair cells is low (Figure 1F), and by extension (Figure 1C), also in all hair cells. This interpretation is in line with the weak detection of an mRNA signal by ISH (Figure 1G I"). On this note, the staining reported in I" does not seem to label the cytoplasm of neuromast hair cells. An antisense probe control, along with a positive control (such as TMC1 or another), is necessary to interpret the ISH signal in the neuromast.

(b) However, this is correct for mouse cochlear hair cells, based on single-cell RNA-seq published databases and immunostaining performed in the study. However, the specificity of the anti-HSD17B7 antibody used in the study (in immunostaining and western blot) is not demonstrated. Additionally, it stains some supporting cells or nerve terminals. Was that expression expected?

(2) A previous report showed that HSD17B7 is expressed in mouse vestibular hair cells by single-cell RNAseq and immunostaining in mice, but it is not cited:

Spatiotemporal dynamics of inner ear sensory and non-sensory cells revealed by single-cell transcriptomics.

Jan TA, Eltawil Y, Ling AH, Chen L, Ellwanger DC, Heller S, Cheng AG.

Cell Rep. 2021 Jul 13;36(2):109358. doi: 10.1016/j.celrep.2021.109358.

(3) Overexpressed HSD17B7-EGFP C-terminal fusion in zebrafish hair cells shows a punctiform signal in the soma but apparently does not stain the hair bundles. One limitation is the consequence of the C-terminal EGFP fusion to HSD17B7 on its function, which is not discussed.

(4) A mutant Zebrafish CRISPR was generated, leading to a truncation after the first 96 aa out of the 340 aa total. It is unclear why the gene editing was not done closer to the ATG. This allele may conserve some function, which is not discussed.

(5) The hsd17b7 mutant allele has a slightly reduced number of genetically labeled hair cells (quantified as a 16% reduction, estimated at 1-2 HC of the 9 HC present per neuromast). On a note, it is unclear what criteria were used to select HC in the picture. Some Brn3C:mGFP positive cells are apparently not included in the quantifications (Figure 2F, Figure 5A).

(6) The authors used FM4-64 staining to evaluate the hair cell mechanotransduction activity indirectly. They found a 40% reduction in labeling intensity in the HCs of the lateral line neuromast. Because the reduction of hair cell number (16%) is inferior to the reduction of FM4-64 staining, the authors argue that it indicates that the defect is primarily affecting the mechanotransduction function rather than the number of HCs. This argument is insufficient. Indeed, a scenario could be that some HC cells died and have been eliminated, while others are also engaged in this path and no longer perform the MET function. The numbers would then match. If single-cell staining can be resolved, one could determine the FM4-64 intensity per cell. It would also be informative to evaluate the potential occurrence of cell death in this mutant. On another note, the current quantification of the FM4-64 fluorescence intensity and its normalization are not described in the methods. More importantly, an independent and more direct experimental assay is needed to confirm this point. For example, using a GCaMP6-T2A-RFP allele for Ca2+ imaging and signal normalization.

(7) The authors used an acoustic startle response to elicit a behavioral response from the larvae and evaluate the "auditory response". They found a significative decrease in the response (movement trajectory, swimming velocity, distance) in the hsd17b7 mutant. The authors conclude that this gene is crucial for the "auditory function in zebrafish".

This is an overstatement:

(a) First, this test is adequate as a screening tool to identify animals that have lost completely the behavioral response to this acoustic and vibrational stimulation, which also involves a motor response. However, additional tests are required to confirm an auditory origin of the defect, such as Auditory Evoked Potential recordings, or for the vestibular function, the Vestibulo-Ocular Reflex.

(b) Secondly, the behavioral defects observed in the mutant compared to the control are significantly different, but the differences are slight, contained within the Standard Deviation (20% for velocity, 25% for distance). To this point, the Figure 2 B and C plots are misleading because their y-axis do not start at 0.

(8) Overexpression of HSD17B7 in cell line HEI-OC1 apparently "significantly increases" the intensity of cholesterol-related signal using a genetically encoded fluorescent sensor (D4H-mCherry). However, the description of this quantification (per cell or per surface area) and the normalization of the fluorescent signal are not provided.

(9) When this experiment is conducted in vivo in zebrafish, a reduction in the "DH4 relative intensity" is detected (same issue with the absence of a detailed method description). However, as the difference is smaller than the standard deviation, this raises questions about the biological relevance of this result.

(10) The authors identified a deaf child as a carrier of a nonsense mutation in HSB17B7, which is predicted to terminate the HSB17B7 protein before the transmembrane domain. However, as no genetic linkage is possible, the causality is not demonstrated.

(11) Previous results obtained from mouse HSD17B7-KO (citation below) are not described in sufficient detail. This is critical because, in this paper, the mouse loss-of-function of HSD17B7 is embryonically lethal, whereas no apparent phenotype was reported in heterozygotes, which are viable and fertile. Therefore, it seems unlikely that heterozygous mice exhibit hearing loss or vestibular defects; however, it would be essential to verify this to support the notion that the truncated allele found in one patient is causal.

Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos.

Jokela H, Rantakari P, Lamminen T, Strauss L, Ola R, Mutka AL, Gylling H, Miettinen T, Pakarinen P, Sainio K, Poutanen M.<br /> Endocrinology. 2010 Apr;151(4):1884-92. doi: 10.1210/en.2009-0928. Epub 2010 Feb 25.

(12) The authors used this truncated protein in their startle response and FM4-64 assays. First, they show that contrary to the WT version, this truncated form cannot rescue their phenotypes when overexpressed. Secondly, they tested whether this truncated protein could recapitulate the startle reflex and FM4-64 phenotypes of the mutant allele. At the homozygous level (not mentioned by the way), it can apparently do so to a lesser degree than the previous mutant. Again, the differences are within the Standard Deviation of the averages. The authors conclude that this mutation found in humans has a "negative effect" on hearing, which is again not supported by the data.

(13) The authors looked at the distribution of the HSB17B7 in a cell line. The WT version goes to the ER, while the truncated one forms aggregates. An interesting experiment consisted of co-expressing both constructs (Figure S6) to see whether the truncated version would mislocalize the WT version, which could be a mechanism for a dominant phenotype. However, this is not the case.

(14) Through mass spectrometry of HSB17B7 proteins in the cell line, they identified a protein involved in ER retention, RER1. By biochemistry and in a cell line, they show that truncated HSB17B7 prevents the interaction with RER1, which would explain the subcellular localization.

Hydroxysteroid (17beta) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos.

Jokela H, Rantakari P, Lamminen T, Strauss L, Ola R, Mutka AL, Gylling H, Miettinen T, Pakarinen P, Sainio K, Poutanen M.<br /> Endocrinology. 2010 Apr;151(4):1884-92. doi: 10.1210/en.2009-0928. Epub 2010 Feb 25.

(15) Information and specificity validation of the HSB17B7 antibody are not presented. It seems that it is the same used on mice by IF and on zebrafish by Western. If so, the antibody could be used on zebrafish by IF to localize the endogenous protein (not overexpression as done here). Secondly, the specificity of the antibody should be verified on the mutant allele. That would bring confidence that the staining on the mouse is likely specific.

Reviewer #1 (Public review):

Summary:

Davis and co-authors used many mouse models to investigate mechanisms that regulate the contractility of mouse popliteal collecting vessels, primarily chronotropy. Many of the mechanisms studied were previously shown to regulate pressure-induced constriction in small arteries. The authors use prior literature from the vasculature as a framework to test similar concepts in lymphatic vessels. The mouse models used provide evidence for and against the involvement of multiple proteins in regulating chronotropy and other contractile properties in lymphatic vessels. They propose that mechano-activation of GNAQ/GNA11-coupled GPCRs generates IP3, which induces Ca2+ release through IP3R1 and drives depolarization through the activation of ANO1 Cl- channels. Major concerns include the author's major conclusion that GNAQ/GNA11-coupled GPCRs contribute to chronotropy. This conclusion is not supported by the data presented.

Strengths:

One major strength of the study lies in the vast number of mouse knockout models that were used to test the importance of ion channels and G protein signaling pathways in the regulation of lymphatic vessel contractility. In this regard, the study is a valiant effort. The authors achieved several objectives to find that ANO1 and IP3R1 regulate chronotropy, and many other potential proteins do not regulate chronotropy. This study will have a major impact on the field if additional support for G proteins is provided.

Weaknesses:

Major conclusions concerning the involvement of G proteins are drawn from the global Gna11 knockout mouse models. This conclusion is weak. Global Gna11 knockout mice are highly likely to have a multifactorial phenotype that could create significant differences in the data. Control experiments need to be performed on vessels from the global knockout mice if these major conclusions are to be made. Similarly, pharmacological tools or alternative approaches to manipulate G proteins should be used to support the data from these mouse models to draw these major conclusions.

The Gnaq smKO mice are the most specific G protein model studied here. However, there is no phenotype. Do not discuss trends in the data. If the data are not significant, conclude so. If more experiments are required to reach significance, provide more data in the manuscript.

The conclusions repeatedly refer to a signaling pathway wherein the upstream component is GPCRs, which activate G proteins. While this may be the case, no GPCRs were identified here, and the involvement of G proteins is questionable, as the authors outline in lines 693-695 and noted above. The conclusions should be tempered, including in the abstract, unless additional experiments are performed to support the involvement of G proteins. Perhaps then the authors may be able to infer that GPCRs are involved.

Line 318. The point regarding the choice to use popliteal vessels versus IALVs will be unclear to the uninitiated, particularly as the authors previously used IALVs. Including additional justification in the text and/or data from IALVs in Figure 1, which compares IALVs to popliteal vessels, would better explain the logic.

The conclusions drawn for TRPC6 and TRPC3 are less convincing. Germline global knockout mice, which are known to undergo compensation, were used, and high data variability is apparent. Using TRPC3 and TRPC6 blockers in the mouse models studied in Figure 4 would strengthen the arguments made regarding these proteins.

Did you perform power analysis to ensure that experimental numbers were sufficient to conclude that no statistical difference exists between datasets? If not, this needs to be done. For example, data shown in Figure 5C for tone and 6C for frequency and tone appear to be significantly different, but are concluded not to be so.

At the end of each result section, a concluding statement is made regarding the effects on pressure-induced chronotrophy. In many cases, there are additional effects of manipulating protein expression on other contractile properties. One example is for TRPC3 and TRPC6 (lines 414-416), but others are TRPV4, TRPV3, ENaC, Kir, Cav3.1/3.2, etc. Some interpretation is in the Discussion, but the concluding statements at the end of each result section should be expanded to summarize what the authors think the other significant differences in the data represent.

Kv7.4 channels. You state you have data (not shown) with linopiridine and XE991. Why not show those results here to support the experiments with the Kcnq4 smKO mice? Otherwise, I suggest you remove the statement from the unpublished data.

Figure 13A. Kcnj2 is modestly expressed in LECs, but very little is present in LMCs. This likely underlies the effect of barium. If you remove the endothelium, does the effect of barium disappear? While this is not the major focus of the study, the effects of barium are dramatic, and it should be made clear whether this is due to inhibition of Kir channels in smooth muscle or endothelial cells.

Figure 18C tone. Several values for losartan look different but are not labelled as such. Please clarify and discuss if different.

The manuscript should include raw data traces in figures that show the major pathways that you conclude regulate chronotropy.

Reviewer #2 (Public review):

Summary:

In this study, Davis et al. embarked on the quest for the molecular elements responsible for the regulation of lymphatic phasic contractile activity in response to variation of transmural pressure, a mechanism (termed pressure-induced lymphatic chronotropy by the authors) critical for drainage of interstitial fluid from the tissue and transport of lymph back to the blood circulation. Their aim was to investigate the mechanism(s) involved in the pressure-induced regulation of lymphatic pumping, and test whether activation of cation channels, shown in other systems to play mechanosensitive roles are directly at play, and/or whether mechano-activation of GNAQ/GNA11-coupled GPCRs is necessary to generate second messengers to activate those channels, as it has been suggested for the regulation of myogenic tone in arteries. To achieve their goal, the authors used their well-described, highly reliable protocols of mouse lymphatic vessel isolation, pressure myography, and data acquisition to obtain frequency-pressure relationships and other contractile function parameters from transgenic mice where specific channels or molecular elements of interest have been ablated. They combined these data with scRNAseq analysis of these gene targets to determine their respective role and levels of expression in lymphatic muscle cells. Their conclusion is that none of the exhaustive list of tested ion channels was critical, except ANO1 Cl channels, part of the contractile pacemaker mechanism, but that transmural pressure activates GNAQ/GNA11-coupled GPCRs, which generate IP3 to induce SR Ca2+ release through IP3R1 and activate ANO1-mediated depolarization.

Strengths:

The manuscript's strengths reside primarily in very robust, clean, and unequivocal pressure myography data and analysis. The research team is mastering these techniques they developed more than a decade ago and have implemented in mouse lymphatics to study their contractile properties, with consistent and convincing outcomes. They also provide data from an impressive list of transgenic mice in order to determine the role of the targeted gene in pressure-induced lymphatic chronotropy, relying on pharmacological small molecule inhibitors only when necessary. Finally, the use of scRNAseq analysis they gathered from previously published datasets brings novelty with respect to the expression of the genes of interest in all populations of cells comprising the lymphatic vessels, but more critically, to validate or contrast the potential impact of genetic alteration of the given gene on the ability of lymphatic muscles to respond to a change in pressure.

Weaknesses:

The main weakness may reside in the fact that while the authors provide a convincing demonstration that GNAQ/GNA11 are involved in the regulation of the F-P relationship, they give little evidence of the involvement of "upstream" receptors. Indeed, inhibition of AT1R, shown to be involved in myogenic regulation of arteries (a phenomenon the authors rightfully compare to pressure-induced lymphatic chronotropy), didn't lead toa similar effect (decrease in F-P) in lymphatic vessels. Arguably, other GPCRs might be involved in lymphatic vessels, but as such information is not provided in the manuscript, the author's conclusions should be dampened. More in-depth discussion would be required. In fact, it can be argued that the discussion is very restricted with respect to the amount of data and information the manuscript provides.

Overall, the authors convincingly achieved their aim by performing an impressive number of technically challenging experiments, leading to solid datasets. While these support their main conclusions, a more elaborate discussion might be required to refine them.

This study is likely to have an important impact on the field as it provides some answers to the lingering question of how lymphatic vessels regulate their contractile activity to variation in transmural pressure and certainly proposes an experimental means to further explore and address that question.

Reviewer #3 (Public review):

In this manuscript, Davis and colleagues aimed to identify the molecular sensors and signaling cascade that enable collecting lymphatic vessels to increase their spontaneous contraction frequency in response to intraluminal pressure (pressure-induced chronotropy). They tested whether the process is similar to blood vessel myogenic constriction by relying on cation channels (TRPC6, TRPM4, PKD2, PIEZO1, etc.) or instead require the activation of G-protein-coupled receptors (presumably mechanosensitive GNAQ/GNA11-coupled receptors), using ex vivo pressure myography of mouse popliteal lymphatics, smooth muscle-specific conditional knockouts, quantitative PCR validation, and single-cell RNA sequencing for target prioritization. The authors convincingly demonstrate that pressure-induced chronotropy does not require the cation channels implicated in arterial myogenic tone but is blunted by deletion of GNAQ/GNA11 or IP3 receptor 1, supporting a model of GPCR > IP3 > Ca2+ release > Cl⁻ channel activation > depolarization. The core conclusion is robust. The work redefines lymphatic pacemaking as G-protein-coupled receptor-dependent mechanotransduction, distinct from arterial mechanisms, and provides a genetically validated toolkit that is useful for studying lymphatic function and dysfunction.

Strengths:

(1) The data are of high quality and highly sensitive functional readouts

(2) The systematic genetic targeting is a major strength that overcomes pharmacological artifacts

(3) Careful quantitative analyses of frequency-pressure slopes

Weaknesses:

(1) The use of inguinal-axillary vessels for single-cell RNA sequencing rather than the popliteal segment studied functionally.

(2) No direct testing of the specific G-protein-coupled receptor involved.

https://www.instagram.com/reel/DG6om2UyUNX/

Reviewer #1 (Public review):

This work by Antonnen et al. was triggered by claims of auditory-mediated effects on altricial avian embryos, which were published without any direct evidence that the relevant parental vocalizations were actually heard. I agree with Anttonen et al. that, based on the available evidence about avian auditory development, those claims are highly speculative and therefore necessitate more direct experimental verification.

Attonen et al. have embarked on a comprehensive series of experiments to:

(1) Better characterize acoustically the relevant parental vocalizations (heat whistles; in a separate preprint, not reviewed here)

(2) Characterize the auditory sensitivity of zebra finches at various stages of their posthatching development. Despite the long-standing importance of the zebra finch as a songbird model in neuroethology of learned vocalizations, the auditory development of the species has not been studied so far.

(3) Explore an alternative hypothesis of how the parental vocalizations might be perceived.

The principal method used here is the non-invasive recording of ABR (auditory brainstem response), a standard neurophysiological method in auditory research. The click-evoked ABR provides a quick and objective assessment of basic hearing sensitivity that does not require animal training. Weaknesses of the technique include its limited frequency specificity and low signal-to-noise ratio. The authors are experienced with ABR measurements and well aware of those issues. ABR responses in zebra finches are shown to gradually appear during the first week posthatching and to mature in subsequent weeks, consistent with the auditory development in other altricial bird species studied previously. When matching the acoustic properties of parental heat whistles and auditory sensitivities, hearing of the parental heat whistles by zebra finch hatchlings was convincingly excluded. Although not directly measured, this also convincingly extrapolates to zebra finch embryos. Finally, the authors tested the hypothesis that parental heat whistles could induce perceptible vibrations of the egg and thus stimulate the embryo via a different modality. The method used here was laser doppler vibrometry, an appropriate, state-of-the-art technique that the authors also have proven experience with. The induced vibrations were shown to be several orders of magnitude below known vibrotactile sensitivities in mammals and birds. Thus, although zebra finch vibrotactile thresholds were not obtained directly, the hypothesis of vibrotactile perception of parental heat whistles by zebra finch embryos could also be rejected convincingly.

In summary, even when considering some weaknesses of the techniques (which the authors are aware of), the conclusions of the paper are well supported: Auditory and/or vibration perception of parental heat whistles can be excluded as an explanation for previous reports of developmental programming for high ambient temperatures. As a constructive suggestion towards resolving the apparent paradox, the authors recommend repeating some of the crucial, previous playback experiments at lower sound levels that better match the natural parental vocalizations.

Reviewer #2 (Public review):

This study by Anttonen, Christensen-Dalsgaard, and Elemans describes the development of hearing thresholds in an altricial songbird species, the zebra finch. The results are very clear and along what might have been expected for altricial birds: at hatch (2 days post-hatch), the chicks are functionally deaf. Auditory evoked activity in the form of auditory brainstem responses (ABR) can start to be detected at 4 days post-hatch, but only at very loud sound levels. The study also shows that ABR response matures rapidly and reaches adult-like properties around 25 days post-hatch. The functional development of the auditory system is also frequency dependent, with a low-to-high frequency time course. All experiments are very well performed. The careful study throughout development and with the use of multiple time-points early in development is important to further ensure that the negative results found right after hatching are not the result of the experimental manipulation. The results themselves could be classified as somewhat descriptive, but, as the authors point out, they are particularly relevant and timely. Since 2016, there have been a series of studies published in high-profile journals that have presumably shown the importance of prenatal acoustic communication in altricial birds, mostly in zebra finches. This early acoustic communication would serve various adaptive functions. Although acoustic communication between embryos in the egg and parents has been shown in precocial birds (and crocodiles), finding an important function for prenatal communication in altricial birds came as a surprise. Unfortunately, none of those studies performed a careful assessment of the chicks' hearing abilities. This is done here, and the results are clear: zebra finches at 2 and 6 days post-hatch are functionally deaf. Since it is highly improbable that the hearing in the egg is more developed than at birth, one can only conclude that zebra finches in the egg (or at birth) cannot hear the heat whistles. The paper also ruled out the detection on egg vibrations as an alternative path. The prior literature will have to be corrected, or further studies conducted to solve the discrepancies. For this purpose, the "companion" paper on bioRxiv that studies the bioacoustical properties of heat calls from the same group will be particularly useful. Researchers from different groups will be able to precisely compare their stimuli.

Beyond the quality of the experiments, I also found that the paper was very well written. The introduction was particularly clear and complete (yet concise).

Weaknesses:

My only minor criticism is that the authors do not discuss potential differences between behavioral audiograms and ABRs. Optimally, one would need to repeat the work of Okanoya and Dooling with your setup and using the same calibration. The ~20dB difference might be real, or it might be due to SPL measured with different instruments, at different distances, etc. Either way, you could add a sentence in the discussion that states that even with the 20 dB difference in audiogram heat whistles would not be detected during the early days post-hatch. But adding a (novel) behavioral assay in young birds could further resolve the issue.

More Minor Points:

(1) As mentioned in the main text, the duration of pips (from pips to bursts) affects the effective bandwidth of the stimulus. I believe that the authors could give an estimate of this effective bandwidth, given what is known from bird auditory filters. I think that this estimate could be useful to compare to the effective bandwidth of the heat-call, which can now also be estimated.

(2) Figure 5b. Label the green and pink areas as song and heat-call spectrum. Also note that in the legend the authors say: "Green and red areas display the frequency windows related to the best hearing sensitivity of zebra finches and to heat calls, respectively". I don't think this is what they meant. I agree that 1-4 kHz is the best frequency sensitivity of zebra finches, but they probably meant green == "song frequency spectrum" and pink == "heat call spectrum". In either case, the figure and the legend need clarification.

(3) Figure 5c. Here also, I would change the song and heat-call labels to "song spectrum", "heat call spectrum". The authors would not want readers to think that they used song and heat calls in these experiments (maybe next time?). For the same reason, maybe in 5a you could add a cartoon of the oscillogram of a frequency sweep next to your speaker.

(4) Methods. In the description of the stimulus, the authors describe "5ms long tone bursts", but these are the tone pips in the main part of the manuscript. Use the same terms.

Reviewer #3 (Public review):

Summary

Following recent findings that exposure to natural sounds and anthropogenic noise before hatching affects development and fitness in an altricial songbird, this study attempts to estimate the hearing capacities of zebra finch nestlings and the perception of high frequencies in that species. It also tries to estimate whether airborne sound can make zebra finch eggs vibrate, although this is not relevant to the question.

Strength

That prenatal sounds can affect the development of altricial birds clearly challenges the long-held assumption that altricial avian embryos cannot hear. However, there is currently no data to support that expectation. Investigating the development of hearing in songbirds is therefore important, even though technically challenging. More broadly, there is accumulating evidence that some bird species use sounds beyond their known hearing range (especially towards high frequencies), which also calls for a reassessment of avian auditory perception.

Weaknesses

Rather than following validated protocols, the study presents many experimental flaws and two major methodological mistakes (see below), which invalidate all results on responses to frequency-specific tones in nestlings and those on vibration transmission to eggs, as well as largely underestimating hearing sensitivity. Accordingly, the study fails to detect a response in the majority of individuals tested with tones, including adults, and the results are overall inconsistent with previous studies in songbirds. The text throughout the preprint is also highly inaccurate, often presenting only part of the evidence or misrepresenting previous findings (both qualitatively and quantitatively; some examples are given below), which alters the conclusions.

Conclusion and impact

The conclusion from this study is not supported by the evidence. Even if the experiment had been performed correctly, there are well-recognised limitations and challenges of the method that likely explain the lack of response. The preprint fails to acknowledge that the method is well-known for largely underestimating hearing threshold (by 20-40dB in animals) and that it may not be suitable for a 1-gram hatchling. Unlike what is claimed throughout, including in the title, the failure to detect hearing sensitivity in this study does not invalidate all previous findings documenting the impacts of prenatal sound and noise on songbird development. The limitations of the approach and of this study are a much more parsimonious explanation. The incorrect results and interpretations, and the flawed representation of current knowledge, mean that this preprint regrettably creates more confusion than it advances the field.

Detailed assessment

For brevity, only some references are included below as examples, using, when possible, those cited in the preprint (DOI is provided otherwise). A full review of all the studies supporting the points below is beyond the scope of this assessment.

(A) Hearing experiment

The study uses the Auditory Brainstem Response (ABR), which measures minute electrical signals transmitted to the surface of the skull from the auditory nerve and nuclei in the brainstem. ABR is widely used, especially in humans, because it is non-invasive. However, ABR is also a lot less sensitive than other methods, and requires very specific experimental precautions to reliably detect a response, especially in extremely small animals and with high-frequency sounds, as here.

(1) Results on nestling frequency sensitivity are invalid, for failing to follow correct protocols:

The results on frequency testing in nestlings are invalid, since what might serve as a positive control did not work: in adults, no response was detected in a majority of individuals, at the core of their hearing range, with loud 95dB sounds (Figure S1), when testing frequency sensitivity with "tone burst".

This is mostly because the study used a stimulation duration 5 times larger than the norm. It used 25ms tone bursts, when all published avian studies (in altricial or precocial birds) used stimulation of 5ms or less (when using subdermal electrodes as here; e.g., cited: Brittan-Powell et al 2004; not cited: Brittan-Powell et al 2002 (doi: 10.1121/1.1494807), Henry & Lucas 2008 (doi: 10.1016/j.anbehav.2008.08.003)). Long stimulations do not make sense and are indeed known to interfere with the detection of an ABR response, especially at high frequencies, as, for example, explicitly tested and stated in Lauridsen et al 2021 (cited).

Adult response was then re-tested with a correct 5ms tone duration ("tone-pip"), which showed that, for the few individuals that responded to 25ms tones, thresholds were abnormally high (c.a. by 30dB; Figure 2C).<br /> Yet, no nestlings were retested with a correct protocol. There is therefore no valid data to support any conclusion on nestling frequency hearing. Under these circumstances, the fact that some nestlings showed a response to 25ms tones from day 8 would argue against them having very low sensitivity to sound.

(2) Responses to clicks underestimate hearing onset by several days:

Without any valid nestling responses to tones (see # 1), establishing the onset of hearing is not possible based on responses to clicks only, since responses to clicks occur at least 4 days after responses to tones during development (Saunders et al, 1973). Here, 60% of 4-day-old individuals responding to clicks means most would have responded to tones at and before 2 days post-hatch, had the experiment been done correctly.<br /> Responses to tones are indeed observed in other songbirds at 1day post-hatch (see #6).

In budgerigars, hearing onset occurs before 5 days post hatch, since responses to both clicks and tones were detectable at the first age tested at 5dph (Brittan-Powell et al, 2004).

(3) Experimental parameters chosen lower ABR detectability, specifically in younger birds:

Very fast stimulus repetition rate inhibits the ABR response, especially in young:

(a) The stimulus presentation rate (25 stim/ sec) is 6 times faster than zebra finch heat-calls, and 5 to 25 times faster than most previous studies in young birds (e.g., cited: Saunders et al 1973, 1974: 1 stim/sec or less; Katayama 1985: 3.3 clicks/sec; Brittan-Powell et al 2004: 4 stim/sec). Faster rates saturate the neurons and accordingly are known to decrease ABR amplitude and increase ABR latency, especially in younger animals with an immature nervous system. In birds, this occurs especially in the range from 5 to 30 stim/sec (e.g., cited: Saunder et al 1973, Brittan-Powell et al 2004). Values here with 25 rather than 1-4 stim/min are therefore underestimating true sensitivity.

(b) Averaging over only 400 measures is insufficient to reliably detect weak ABR signals:

The study uses 2 to 3 times fewer measures per stimulation type than the recommended value of 1,000 (e.g., Brittan-Powell et al 2002, 2024; Henry & Lucas 2008). This specifically affects the detection of weak signals, as in small hatchlings with tiny brains (adult zebra finches are 12-14g).

(c) Body temperature is not specified and strongly affects the ABR:

Controlling the body temperature of hatchlings of 1-4 grams (with a temperature probe under a 5mm-wide wing) would be very challenging. Low body temperature entirely eliminates the ABR, and even slight deviance from optimal temperature strongly increases wave latency and decreases wave amplitude (e.g., cited: Katayama 1985).

(d) Other essential information is missing on parameters known to affect the ABR:

This includes i) the weight of the animals, ii) whether and how the response signal was amplified and filtered, iii) how the automatised S/N>2 criteria compared to visual assessment for wave detection, and iv) what measures were taken to allow the correct placement of electrodes on hatchlings less than 5 grams.

(4) Results in adults largely underestimate sensitivity at high frequencies, and are not the correct reference point:

(a) Thresholds measured here at high frequencies for adults (using the correct stimulus duration, only done on adults) are 10-30dB higher than in all 3 other published ABR studies in adult zebra finches (cited: Zevin et al 2004; Amin et al 2007; not cited: Noirot et al 2011 (10.1121/1.3578452)), for both 4 and 6 kHz tone pips.

(b) The underlying assumption used throughout the preprint that hearing must be adult-like to be functional in nestlings does not make sense. Slower and smaller neural responses are characteristic of immature systems, but it does not mean signals are not being perceived.

(5) Failure to account for ABR underestimation leads to false conclusions:

(a) Whether the ABR method is suitable to assess hearing in very small hatchlings is unknown. No previous avian study has used ABR before 5 days post-hatch, and all have used larger bird species than the zebra finch.

(b) Even when performed correctly on large enough animals, the ABR systematically underestimates actual auditory sensitivity by 20-40 dB, especially at high frequencies, compared to behavioural responses (e.g., none cited: Brittan-Powell et al 2002, Henry & Lucas 2008, Noirot et al 2011). Against common practice, the preprint fails to account for this, leading to wrong interpretations. For example, in Figure 1G (comparing to heat call levels), actual hearing thresholds would be 30-40dB below those displayed. In addition, the "heat whistle" level displayed here (from the same authors) is 15dB lower than their second measure that they do not mention, and than measures obtained by others (unpublished data). When these two corrections are made - or even just the first one - the conclusion that heat-call sound levels are below the zebra finch hearing threshold does not hold.

(c) Rather than making appropriate corrections, the preprint uses a reference in humans (L180), where ABR is measured using a much more powerful method (multi-array EEG) than in animals, and from a larger brain. The shift of "10-20dB" obtained in humans is not applicable to animals.

(6) Results are inconsistent with previous findings in developing songbirds:

As expected from all of the above, results and conclusions in the preprint are inconsistent with findings in other songbirds, which, using other methods, show for example, auditory sensitivity in:

(a) zebra finch embryos, in response to song vs silence (not cited: Rivera et al 2018, doi: 10.1097/WNR.0000000000001187)

(b) flycatcher hatchlings at 2-3d post hatch (first age tested), across a wide range of frequencies (0.3 to 5kHz), at low to moderate sound levels (45-65dB) (cited: Aleksandrov and Dmitrieva 1992, not cited: Korneeva et al 2006 (10.1134/S0022093006060056)).

(c) songbird nestlings at 2-6d post hatch, which discriminate and behaviourally respond to relevant parental calls or even complex songs. This level of discrimination requires good hearing across frequencies (e.g., not cited: Korneeva et al 2006; Schroeder & Podos 2023 (doi: 10.1016/j.anbehav.2023.06.015)).

(d) zebra finch nestlings at 13d post-hatch, which show adult-like processing of songs in the auditory cortex (CNM) (Schroeder & Remage‐Healey 2021, doi: 10.1002/dneu.22802).

(e) zebra finch juveniles, which are able to perceive and learn song syllables at 5-7kHz (fundamental frequency) with very similar acoustic properties to heat calls, and also produced during inspiration (Goller & Daley 2001, doi: 10.1098/rspb.2001.1805).

NONE of these results - which contradict results and claims in the preprint - are mentioned. Instead, the preprint focuses on very slow-developing species (parrots and owls), which take 2-4 times longer than songbirds to fledge (cited: Brittan-Powell et al 2004; Köppl & Nickel 2007; Kraemer et al 2017).

(7) Results in figures are misreported in the text, and conclusions in the abstract and headers are not supported by the data:

For example:

(a) The data on Figure 1E shows that at 4 days old, 8 out of 13 nestlings (60%) responded to clicks, but the text says only 5/13 responded (L89). When 60% (4dph) and 90% (6dph) of individuals responded, the correct term would be that "most animals", rather than "some animals" responded (L89). Saying that ABR to loud sound appeared "in the majority only after one week" (L93) is also incorrect, given the data. It follows that the title of the paragraph is also erroneous.

(b) The hearing threshold is underestimated by 40dB at 6 and 8Kz on Fig 2C, not by "10-20dB" as reported in the text (L178).

(B) Egg vibration experiment

(8) Using airborne sound to vibrate eggs is biologically irrelevant:

The measurement of airborne sound levels to vibrate eggs misunderstands bone conduction hearing and is not biologically meaningful: zebra finch parents are in direct contact with the eggs when producing heat calls during incubation, not hovering in front of the nest. This misunderstanding affects all extrapolations from this study to findings in studies on prenatal communication.

(C) Misrepresentation of current knowledge

(9) Values from published papers are misreported, which reverses the conclusions:

Most critical examples:

(a) Preprint: "Zebra finch most sensitive hearing range of 1-to-4 kHz (Amin et al., 2007; Okanoya and Dooling, 1987; Yeh et al., 2023)" (L173).<br /> Actual values in the studies cited are:

1-to-7kHz, in Amin et al 2007 (threshold [=50dB with ABR] is the same at 7kHz and 1KHz).

1-to-6 kHz, in Okanoya and Dooling (the threshold [=30dB with behaviour] is actually lower at 6kHz than at 1KHz).

1-to-7kHz, in Yeh et al (threshold [=35-38dB with behaviour] is the same at 7kHz and 1KHz).

Note that zebra finch nestlings' begging calls peaking at 6kHz (Elie & Theunissen 2015, doi: 10.1007/s10071-015-0933-6), would fall 2kHz above the parents' best hearing range if it were only up to 4kHz.

(b) The preprint incorrectly states throughout (e.g., L139, L163, L248) that heat-calls are 7-10kHz, when the actual value is 6-10kHz in the paper cited (Katsis et al, 2018).

(c) Using the correct values from these studies, and heat-calls at 45 dB SLP (as measured by others (unpublished data), or as measured by the authors themselves, but which is not reported here (Anttonen et a,l 2025), the correct conclusion is that heat calls fall within the known zebra finch hearing range.

(10) Published evidence towards high-frequency hearing, including in early development, is systematically omitted:

(a) Other studies showing birds use high frequencies above the known avian hearing range are ignored. This includes oilbirds (7-23kHz; Brinklov et al 2017; by 1 of the preprint authors, doi: 10.1098/rsos.170255) and hummingbirds (10-20kHz; Duque et al 2020, doi: 10.1126/sciadv.abb9393), and in a lesser extreme, zebra finches' inspiratory song syllables at 5-7kHz (Goller & Dalley, 2001).

(b) The discussion of anatomical development (L228-241) completely omits the well-known fact that the avian basilar papilla develops from high to low frequencies (i.e., base to apex), which - as many have pointed out - is opposite to the low-to-high development of sensitivity (e.g., cited: Cohen & Fermin 1978; Caus Capdevila et al 2021).

(c) High frequency hearing in songbirds at hatching is several orders of magnitude better than in chickens and ducks at the same age, even though songbirds are altricial (e.g., at 4kHz, flycatcher: 47dB, chicken-duck: 90dB; at 5kHz, flycatcher: 65dB, chicken-duck: 115dB; Korneeva et al 2006, Saunders et al 1974). That is because Galliformes are low-frequency specialists, according to both anatomical and ecological evidence, with calls peaking at 0.8 to 1.2kHz rather than 2-6kHz in songbirds. It is incorrect to conclude that altricial embryos cannot perceive high frequencies because low-frequency specialist precocial birds do not (L250;261).

The references used to support the statement on a very high threshold for precocial birds above 6kHz are also wrong (L250). Katayama 1985 did not test embryos, nor frequency tones. Neither of these two references tested ducks.

(11) Incorrect statements do not reflect findings from the references cited

For example:

(a) "in altricial bird species hearing typically starts after hatching" (L12, in abstract), "with little to no functional hearing during embryonic stages (Woolley, 2017)." (L33).

There is no evidence, in any species, to support these statements. This is only a - commonly repeated - assumption, not actually based on any data. On the contrary, the extremely limited evidence to date shows the opposite, with zebra finch embryos showing ZENK activation in the auditory cortex in response to song playback (Rivera et al, 2018, not cited).

The book chapter cited (Woolley 2017) acknowledges this lack of evidence, and, in the context of song learning, provides as only references (prior to 2018), 2 studies showing that songbirds do not develop a normal song if the song tutor is removed before 10d post-hatch. That nestlings cannot memorise (to later reproduce) complex signals heard before d10 does not mean that they are deaf to any sound before day 10.

Studies showing hearing in young songbird nestlings (see point 6 above) also contradict these statements.

(b) "Zebra finch embryos supposedly are epigenetically guided to adapt to high temperatures by their parents high-frequency "heat calls" " (L36 and L135).

This is an extremely vague and meaningless description of these results, which cannot be assessed by readers, even though these results are presented as a major justification for the present study. Rather than giving an interpretation of what "supposedly" may occur, it would be appropriate to simply synthesize the empirical evidence provided in these papers. They showed that embryonic exposure to heat-calls, as opposed to control contact calls, alters a suite of physiological and behavioural traits in nestlings, including how growth and cellular physiology respond to high temperatures. This also leads to carry-over effects on song learning and reproductive fitness in adulthood.

(c) "The acoustic communication in precocial mallard ducks depends specifically on the low-frequency auditory sensitivity of the embryo (Gottlieb, 1975)" (L253)

The study cited (Gottlieb, 1975) demonstrates exactly the opposite of this statement: it shows that duckling embryos, not only perceive high frequency sounds (relative to the species frequency range), but also NEED this exposure to display normal audition and behaviour post-hatch. Specifically, it shows that duckling embryos deprived of exposure to their own high-frequency calls (at 2 kHz), failed to identify maternal calls post-hatch because of their abnormal insensitivity to higher frequencies, which was later confirmed by directly testing their auditory perception of tones (Dimitrieva & Gottlieb, 1994).

(12) Considering all of the mistakes and distortions highlighted above, it would be very premature to conclude, based on these results and statements, that altricial avian embryos are not sensitive to sound. This study provides no actual scientific ground to support this conclusion.

Reviewer #1 (Public review):

Summary:

Dorrego-Rivas et al. investigated two different DA neurons and their neurotransmitter release properties in the main olfactory bulb. They found that the two different DA neurons in mostly glomerular layers have different morphologies as well as electrophysiological properties. The anaxonic DA neurons are able to self-inhibit but the axon-bearing ones are not. The findings are interesting and important to increase the understanding both of the synaptic transmissions in the main olfactory bulb and the DA neuron diversity. However, there are some major questions that the authors need to address to support their conclusions.

(1) It is known that there are two types of DA neurons in the glomerular layer with different diameters and capacitances (Kosaka and Kosaka, 2008; Pignatelli et al., 2005; Angela Pignatelli and Ottorino Belluzzi, 2017). In this manuscript, the authors need to articulate better which layer the imaging and ephys recordings took place, all glomerular layers or with an exception. Meanwhile, they have to report the electrophysiological properties of their recordings, including capacitances, input resistance, etc.

(2) It is understandable that recording the DA neurons in the glomerular layer is not easy. However, the authors still need to increase their n's and repeat the experiments at least three times to make their conclusion more solid. For example (but not limited to), Fig 3B, n=2 cells from 1 mouse. Fig.4G, the recording only has 3 cells.

(3) The statistics also use pseudoreplicates. It might be better to present the biology replicates, too.

(4) In Figure 4D, the authors report the values in the manuscript. It is recommended to make a bar graph to be more intuitive.

(5) In Figure 4F and G, although the data with three cells suggest no phenotype, the kinetics looked different. So, the authors might need to explore that aside from increasing the n.

(6) Similarly, for Figure 4I and J, L and M, it is better to present and analyze it like F and G, instead of showing only the after-antagonist effect.

Comments on revisions:

In the rebuttal, the authors argued that it had been extremely hard to obtain recordings stable enough for before-and-after effects on the same cell. Alternatively, they could perform the before-and-after comparison on different cells.

Reviewer #2 (Public review):

Summary:

This study provides novel insights into the neurotransmitter release mechanisms employed by two distinct subclasses of dopaminergic neurons in the olfactory bulb (OB). The findings suggest that anaxonic neurons primarily release neurotransmitters through their dendrites, whereas axon-bearing neurons predominantly release neurotransmitters via their axons. Furthermore, the study reveals that anaxonic neurons exhibit self-inhibitory behavior, indicating that closely related neuronal subclasses may possess specialized roles in sensory processing.

Strengths:

This study introduces a novel and significant concept, demonstrating that two closely related neuron subclasses can exhibit distinct patterns of neurotransmitter release. Therefore, this finding establishes a valuable framework for future investigations into the functional diversity of neuronal subclasses and their contributions to sensory processing. Furthermore, these findings offer fundamental insights into the neural circuitry of the olfactory bulb, enhancing our understanding of sensory information processing within this critical brain region.

Weaknesses:

The reliance on synaptophysin-based presynaptic structures raises minor concerns about whether these structures represent functional synapses.

Comments on revisions:

Most of the concerns have been addressed by the authors, and there are no further comments about this manuscript.

Reviewer #1 (Public review):

Summary:

This paper investigates the physical mechanisms underlying cell intercalation, which then enables collective cell flows in confluent epithelia. The authors show that T1 transitions (the topological transitions responsible for cell intercalation) correspond to the unbinding of groups of hexatic topological defects. Defect unbinding, and hence cell intercalation and collective cell flows, are possible when active stresses in the tissue are extensile. This result helps to rationalize the observation that many epithelial cell layers have been found to exhibit extensile active nematic behavior.

Strengths:

The authors obtain their results based on a combination of active hexanematic hydrodynamics and a multiphase field (MPF) model for epithelial layers, whose connection is a strength of the paper. With the hydrodynamic approach, the authors find the active flow fields produced around hexatic topological defects, which can drive defect unbinding. Using the MPF simulations, the authors show that T1 transitions tend to localize close to hexatic topological defects.

Reviewer #2 (Public review):

Summary:

This paper studies the role of hexatic defects in the collective migration of epithelia. The authors emphasize that epithelial migration is driven by cell intercalation events and not just isolated T1 events, and analyze this through the lens of hexatic topological defects. Finally, the authors study the effect of active and passive forces on the dynamics of hexatic defects using analytical results, and numerical results in both continuum and phase-field models. The results are very interesting, and highlight new ways of studying epithelial cell migration through the analysis of the binding and unbinding of hexatic defects.

Strengths:

(1) The authors convincingly argue that intercalation events are responsible for collective cell migration, and that these events are accompanied by the formation and unbinding of hexatic topological defects. (2) The authors clearly explain the dynamics of hexatic defects during T1 transitions, and demonstrate the importance of active and passive forces during cell migration. (3) The paper thorougly studies the T1 transition throught the viewpoint of hexatic defects. A continuum model approach to study T1 transitions in cell layers is novel and can lead to valuable new insights.

Reviewer #1 (Public Review):

Summary:

This study by Park and colleagues uses longitudinal saliva viral load data from two cohorts (one in the US and one in Japan from a clinical trial) in the pre-vaccine era to subset viral shedding kinetics and then use machine learning to attempt to identify clinical correlates of different shedding patterns. The stratification method identifies three separate shedding patterns discriminated by peak viral load, shedding duration, and clearance slope. The authors also assess micro-RNAs as potential biomarkers of severity but do not identify any clear relationships with viral kinetics.

Strengths:

The cohorts are well developed, the mathematical model appears to capture shedding kinetics fairly well, the clustering seems generally appropriate, and the machine learning analysis is a sensible, albeit exploratory approach. The micro-RNA analysis is interesting and novel.

Reviewer #2 (Public Review):

Summary:

This study argues it has found that it has stratified viral kinetics for saliva specimens into three groups by the duration of "viral shedding"; the authors could not identify clinical data or microRNAs that correlate with these three groups.

Strengths:

The question of whether there is a stratification of viral kinetics is interesting.

Reviewer #3 (Public Review):

The article presents a comprehensive study on the stratification of viral shedding patterns in saliva among COVID-19 patients. The authors analyze longitudinal viral load data from 144 mildly symptomatic patients using a mathematical model, identifying three distinct groups based on the duration of viral shedding. Despite analyzing a wide range of clinical data and micro-RNA expression levels, the study could not find significant predictors for the stratified shedding patterns, highlighting the complexity of SARS-CoV-2 dynamics in saliva. The research underscores the need for identifying biomarkers to improve public health interventions and acknowledges several limitations, including the lack of consideration of recent variants, the sparsity of information before symptom onset, and the focus on symptomatic infections.

The manuscript is well-written, with the potential for enhanced clarity in explaining statistical methodologies. This work could inform public health strategies and diagnostic testing approaches.

Comments on the revised version from the editor:

The authors comprehensively addressed the concerns of all 3 reviewers. We are thankful for their considerable efforts to do so. Certain limitations remain unavoidable such as the lack of immunologic diversity among included study participants and lack of contemporaneous variants of concern.

One remaining issue is the continued use of the target cell limited model which is sufficient in most cases, but misses key datapoints in certain participants. In particular, viral rebound is poorly described by this model. Even if viral rebound does not place these cases in a unique cluster, it is well understood that viral rebound is of clinical significance.

In addition, the use of microRNAs as a potential biomarker is still not fully justified. In other words, are there specific microRNAs that have a pre-existing mechanistic basis for relating to higher or lower viral loads? As written it still feels like microRNA was included in the analysis simply because the data existed.

Reviewer #2 (Public review):

This study investigated the impact of early HIV specific CD8 T cell responses on the viral reservoir size after 24 weeks and 3 years of follow up in individuals who started ART during acute infection. Viral reservoir quantification showed that total and defective HIV DNA, but not intact, declined significantly between 24 weeks and 3 years post-ART. The authors also showed that functional HIV-specific CD8⁺ T-cell responses persisted over three years and that early CD8⁺ T-cell proliferative capacity was linked to reservoir decline, supporting early immune intervention in the design of curative strategies.

The paper is well written, easy to read, and the findings are clearly presented. The study is novel as it demonstrates the effect of HIV specific CD8 T cell responses on different states of the HIV reservoir, that is HIV-DNA (intact and defective), the transcriptionally active and inducible reservoir. Although small, the study cohort was relevant and well-characterized as it included individuals who initiated ART during acute infection, 12 of whom were followed longitudinally for 3 years, providing unique insights into the beneficial effects of early treatment on both immune responses and the viral reservoir. The study uses advanced methodology. I enjoyed reading the paper.

The study's limitations are minor and well acknowledged. While the cohort included only male participants-potentially limiting generalizability-the authors have clarified this limitation in the discussion. Although a chronic infection control group was not yet available, the authors explained that their protocol includes plans to add this comparison in future studies. These limitations are appropriately addressed and do not undermine the strength or validity of the study's conclusions.

Reviewer #1 (Public review):

Summary:

The authors attempt to study how oocyte incomplete cytokinesis occurs in the mouse ovary.

Strengths:

The finding that UPR components are highly expressed during zygotene is an interesting result that has broad implications for how germ cells navigate meiosis. The findings that proteasome activity increases in germ cells compared to somatic cells suggest that the germline might have a quantitatively different response for protein clearance.

Weaknesses:

(1) The microscopy images look saturated, for example, Figure 1a, b, etc? Is this a normal way to present fluorescent microscopy?

(2) The authors should ensure that all claims regarding enrichment/lower vs lower values have indicated statistical tests.

(a) In Figure 2f, the authors should indicate which comparison is made for this test. Is it comparing 2 vs 6 cyst numbers?

(b) Figures 4d and 4e do not have a statistical test indicated.

(3) Because the system is developmentally dynamic, the major conclusions of the work are somewhat unclear. Could the authors be more explicit about these and enumerate them more clearly in the abstract?

(4) The references for specific prior literature are mostly missing (lines 184-195, for example).

(5) The authors should define all acronyms when they are first used in the text (UPR, EGAD, etc).

(6) The jumping between topics (EMA, into microtubule fragmentation, polarization proteins, UPR/ERAD/EGAD, GCNA, ER, balbiani body, etc) makes the narrative of the paper very difficult to follow.

(7) The heading title "Visham participates in organelle rejuvenation during meiosis" in line 241 is speculative and/or not supported. Drawing upon the extensive, highly rigorous Drosophila literature, it is safe to extrapolate, but the claim about regeneration is not adequately supported.

Reviewer #2 (Public review):

This study identifies Visham, an asymmetric structure in developing mouse cysts resembling the Drosophila fusome, an organelle crucial for oocyte determination. Using immunofluorescence, electron microscopy, 3D reconstruction, and lineage labeling, the authors show that primordial germ cells (PGCs) and cysts, but not somatic cells, contain an EMA-rich, branching structure that they named Visham, which remains unbranched in male cysts. Visham accumulates in regions enriched in intercellular bridges, forming clusters reminiscent of fusome "rosettes." It is enriched in Golgi and endosomal vesicles and partially overlaps with the ER. During cell division, Visham localizes near centrosomes in interphase and early metaphase, disperses during metaphase, and reassembles at spindle poles during telophase before becoming asymmetric. Microtubule depolymerization disrupts its formation.

Cyst fragmentation is shown to be non-random, correlating with microtubule gaps. The authors propose that 8-cell (or larger) cysts fragment into 6-cell and 2-cell cysts. Analysis of Pard3 (the mouse ortholog of Par3/Baz) reveals its colocalization with Visham during cyst asymmetry, suggesting that mammalian oocyte polarization depends on a conserved system involving Par genes, cyst formation, and a fusome-like structure.

Transcriptomic profiling identifies genes linked to pluripotency and the unfolded protein response (UPR) during cyst formation and meiosis, supported by protein-level reporters monitoring Xbp1 splicing and 20S proteasome activity. Visham persists in meiotic germ cells at stage E17.5 and is later transferred to the oocyte at E18.5 along with mitochondria and Golgi vesicles, implicating it in organelle rejuvenation. In Dazl mutants, cysts form, but Visham dynamics, polarity, rejuvenation, and oocyte production are disrupted, highlighting its potential role in germ cell development.

Overall, this is an interesting and comprehensive study of a conserved structure in the germline cells of both invertebrate and vertebrate species. Investigating these early stages of germ cell development in mice is particularly challenging. Although primarily descriptive, the study represents a remarkable technical achievement. The images are generally convincing, with only a few exceptions.

Major comments:

(1) Some titles contain strong terms that do not fully match the conclusions of the corresponding sections.

(1a) Article title "Mouse germline cysts contain a fusome-like structure that mediates oocyte development":

The term "mediates" could be misleading, as the functional data on Visham (based on comparing its absence to wild-type) actually reflects either a microtubule defect or a Dazl mutant context. There is no specific loss-of-function of visham only.

(1b) Result title, "Visham overlaps centrosomes and moves on microtubules":

The term "moves" implies dynamic behavior, which would require live imaging data that are not described in the article.

(1c) Result title, "Visham associates with Golgi genes involved in UPR beginning at the onset of cyst formation":

The presented data show that the presence of Visham in the cyst coincides temporally with the expression and activity of the UPR response; the term "associates" is unclear in this context.

(1d) Result title, "Visham participates in organelle rejuvenation during meiosis":

The term "participates" suggests that Visham is required for this process, whereas the conclusion is actually drawn from the Dazl mutant context, not a specific loss-of-function of visham only.

(2) The authors aim to demonstrate that Visham is a fusome-like structure. I would suggest simply referring to it as a "fusome-like structure" rather than introducing a new term, which may confuse readers and does not necessarily help the authors' goal of showing the conservation of this structure in Drosophila and Xenopus germ cells. Interestingly, in a preprint from the same laboratory describing a similar structure in Xenopus germ cells, the authors refer to it as a "fusome-like structure (FLS)" (Davidian and Spradling, BioRxiv, 2025).

Reviewer #3 (Public review):

This manuscript provides evidence that mice have a fusome, a conserved structure most well studied in Drosophila that is important for oocyte specification. Overall, a myriad of evidence is presented demonstrating the existence of a mouse fusome that the authors term visham. This work is important as it addresses a long-standing question in the field of whether mice have fusomes and sheds light on how oocytes are specified in mammals. Concerns that need to be addressed revolve around several conclusions that are overstated or unclear and are listed below.

(1) Line 86 - the heading for this section is "PGCs contain a Golgi-rich structure known as the EMA granule" but there is nothing in this section that shows it is Golgi-rich. It does show that the structure is asymmetric and has branches.

(2) Line 105-106, how do we know if what's seen by EM corresponds to the EMA1 granule?

(3) Line 106-107-states "Visham co-stained with the Golgi protein Gm130 and the recycling endosomal protein Rab11a1". This is not convincing as there is only one example of each image, and both appear to be distorted.

(4) Line 132-133---while visham formation is disrupted when microtubules are disrupted, I am not convinced that visham moves on microtubules as stated in the heading of this section.

(5) Line 156 - the heading for this section states that Visham associates with polarity and microtubule genes, including pard3, but only evidence for pard3 is presented.

(6) Lines 196-210 - it's strange to say that UPR genes depend on DAZ, as they are upregulated in the mutants. I think there are important observations here, but it's unclear what is being concluded.

(7) Line 257-259---wave 1 and 2 follicles need to be explained in the introduction, and how this fits with the observations here clarified.

Reviewer #1 (Public review):

Summary:

In this paper, the authors conduct both experiments and modeling of human cytomegalovirus (HCMV) infection in vitro to study how the infectivity of the virus (measured by cell infection) scales with the viral concentration in the inoculum. A naïve thought would be that this is linear in the sense that doubling the virus concentration (and thus the total virus) in the inoculum would lead to doubling the fraction of infected cells. However, the authors show convincingly that this is not the case for HCMV, using multiple strains, two different target cells, and repeated experiments. In fact, they find that for some regimens (inoculum concentration), infected cells increase faster than the concentration of the inoculum, which they term "apparent cooperativity". The authors then provided possible explanations for this phenomenon and constructed mathematical models and simulations to implement these explanations. They show that these ideas do help explain the cooperativity, but they can't be conclusive as to what the correct explanation is. In any case, this advances our knowledge of the system, and it is very important when quantitative experiments involving MOI are performed.

Strengths:

Careful experiments using state-of-the-art methodologies and advancing multiple competing models to explain the data.

Weaknesses:

There are minor weaknesses in explaining the implementation of the model. However, some specific assumptions, which to this reviewer were unclear, could have a substantial impact on the results. For example, whether cell infection is independent or not. This is expanded below.

Suggestions to clarify the study:

(1) Mathematically, it is clear what "increase linearly" or "increase faster than linearly" (e.g., line 94) means. However, it may be confusing for some readers to then look at plots such as in Figure 2, which appear linear (but on the log-log scale) and about which the authors also say (line 326) "data best matching the linear relationship on a log-log scale".

(2) One of the main issues that is unclear to me is whether the authors assume that cell infection is independent of other cells. This could be a very important issue affecting their results, both when analyzing the experimental data and running the simulations. One possible outcome of infection could be the generation of innate mediators that could protect (alter the resistance) of nearby cells. I can imagine two opposite results of this: i) one possibility is that resistance would lead to lower infection frequencies and this would result in apparent sub-linear infection (contrary to the observations); or ii) inoculums with more virus lead to faster infection, which doesn't allow enough time for the "resistance" (innate effect) to spread (potentially leading to results similar to the observations, supra-linear infection).

(3) Another unclear aspect of cell infection is whether each cell only has one chance to be infected or multiple chances, i.e., do the authors run the simulation once over all the cells or more times?

(4) On the other hand, the authors address the complementary issue of the virus acting independently or not, with their clumping model (which includes nice experimental measurements). However, it was unclear to me what the assumption of the simulation is in this case. In the case of infection by a clump of virus or "viral compensation", when infection is successful (the cell becomes infected), how many viruses "disappear" and what happens to the rest? For example, one of the viruses of the clump is removed by infection, but the others are free to participate in another clump, or they also disappear. The only thing I found about this is the caption of Figure S10, and it seems to indicate that only the infected virus is removed. However, a typical assumption, I think, is that viruses aggregate to improve infection, but then the whole aggregate participates in infection of a single cell, and those viruses in the clump can't participate in other infections. Viral cooperativity with higher inocula in this case would be, perhaps, the result of larger numbers of clumps for higher inocula. This seems in agreement with Figure S8, but was a little unclear in the interpretation provided.

(5) In algorithm 1, how does P_i, as defined, relate to equation 1?

(6) In line 228, and several other places (e.g., caption of Table S2), the authors refer to the probability of a single genome infecting a cell p(1)=exp(-lambda), but shouldn't it be p(1)=1-exp(-lambda) according to equation 1?

(7) In line 304, the accrued damage hypothesis is defined, but it is stated as a triggering of an antiviral response; one would assume that exposure to a virion should increase the resistance to infection. Otherwise, the authors are saying that evolution has come up with intracellular viral resistance mechanisms that are detrimental to the cell. As I mentioned above, this could also be a mechanism for non-independent cell infection. For example, infected cells signal to neighboring cells to "become resistance" to infection. This would also provide a mechanism for saturation at high levels.

(8) In Figure 3, and likely other places, t-tests are used for comparisons, but with only an n=5 (experiments). Many would prefer a non-parametric test.

Reviewer #2 (Public review):

In their article, Peterson et al. wanted to show to what extent the classical "single hit" model of virion infection, where one virion is required to infect a cell, does not match empirical observations based on human cytomegalovirus in vitro infection model, and how this would have practical impacts in experimental protocols.

They first used a very simple experimental assay, where they infected cells with serially diluted virions and measured the proportion of infected cells with flow cytometry. From this, they could elegantly show how the proportion of infected cells differed from a "single hit" model, which they simulated using a simple mathematical model ("powerlaw model"), and better fit a model where virions need to cooperate to infect cells. They then explore which mechanism could explain this apparent cooperation:

(1) Stochasticity alone cannot explain the results, although I am unsure how generalizable the results are, because the mathematical model chosen cannot, by design, explain such observations only by stochasticity.

(2) Virion clumping seemed not to be enough either to generally explain such a pattern. For that, they first use a mathematical model showing that the apparent cooperation would be small. However, I am unsure how extreme the scenario of simulated virion clumping is. They then used dynamic light scattering to measure the distribution of the sizes of clumps. From these estimates, they show that virion clumps cannot reproduce the observed virion cooperation in serial dilution assays. However, the authors remain unprecise on how the uncertainty of these clumps' size distribution would impact the results, as most clumps have a size smaller than a single virion, leaving therefore a limited number of clumps truly containing virions.

The two models remain unidentifiable from each other but could explain the apparent virion cooperativity: either due to an increase in susceptibility of the cell each time a virion tries to infect it, or due to viral compensation, where lesser fit viruses are able to infect cells in co-infection with a better fit virion. Unfortunately, the authors here do not attempt to fit their mathematical model to the experimental data but only show that theoretical models and experimental data generate similar patterns regarding virion apparent cooperation.

Finally, the authors show that this virions cooperation could make the relationship between the estimated multiplicity of infection and viruses/cell deviate from the 1:1 relationship. Consequently, the dilution of a virion stock would lead to an even stronger decrease in infectivity, as more diluted virions can cooperate less for infection.

Overall, this work is very valuable as it raises the general question of how the estimate of infectivity can be biased if extrapolated from a single virus titer assay. The observation that HCMV virions often cooperate and that this cooperation varies between contexts seems robust. The putative biological explanations would require further exploration.

This topic is very well known in the case of segmented viruses and the semi-infectious particles, leading to the idea of studying "sociovirology", but to my knowledge, this is the first time that it was explored for a nonsegmented virus, and in the context of MOI estimation.

Reviewer #3 (Public review):

Summary:

The authors dilute fluorescent HCMV stocks in small steps (df ≈ 1.3-1.5) across 23 points, quantify infections by flow cytometry at 3 dpi, and fit a power-law model to estimate a cooperativity parameter n (n > 1 indicates apparent cooperativity). They compare fibroblasts vs epithelial cells and multiple strains/reporters, and explore alternative mechanisms (clumping, accrued damage, viral compensation) via analytical modeling and stochastic simulations. They discuss implications for titer/MOI estimation and suggest a method for detecting "apparent cooperativity," noting that for viruses showing this behavior, MOI estimation may be biased.

Strengths:

(1) High-resolution titration & rigor: The small-step dilution design (23 serial dilutions; tailored df) improves dose-response resolution beyond conventional 10× series.

(2) Clear quantitative signal: Multiple strain-cell pairs show n > 1, with appropriate model fitting and visualization of the linear regime on log-log axes.

(3) Mechanistic exploration: Side-by-side modeling of clumping vs accrued damage vs compensation frames testable hypotheses for cooperativity.

Weaknesses:

(1) Secondary infection control: The authors argue that 3 dpi largely avoids progeny-mediated secondary infection; this claim should be strengthened (e.g., entry inhibitors/control infections) or add sensitivity checks showing results are robust to a small secondary-infection contribution.

(2) Discriminating mechanisms: At present, simulations cannot distinguish between accrued damage and viral compensation. The authors should propose or add a decisive experiment (e.g., dual-color coinfection to quantify true coinfection rates versus "priming" without coinfection; timed sequential inocula) and outline expected signatures for each mechanism.

(3) Decline at high genomes/cell: Several datasets show a downturn at high input. Hypotheses should be provided (cytotoxicity, receptor depletion, and measurement ceiling) and any supportive controls.

(4) Include experimental data: In Figure 6, please include the experimentally measured titers (IU/mL), if available.

(5) MOI guidance: The practical guidance is important; please add a short "best-practice box" (how to determine titer at multiple genomes/cell and cell densities; when single-hit assumptions fail) for end-users.

Reviewer #1 (Public review):

Summary:

The authors use high-resolution ribosome profiling (Ezra-seq) and eRF1 pulldown-based ribosome profiling (eRF1-seq) developed in their lab to identify a GA rich sequence motif located upstream of the stop codon responsible for translation termination pausing. They then perform a massively parallel assay with randomly generated sequences to further characterize this motif. Using mouse tissues, they show that termination pausing signatures can be tissue-specific. They use a series of published ribosome structures and 18S rRNA mutants, and eS26 knockdown experiments to propose that the GA rich sequence interacts with the 3′-end of the 18S rRNA.

Strengths:

(1) Robust ribosome profiling data and clear analyses clarify the subtle behavior of terminating ribosomes near the stop codon.

(2) Novel termination or "false termination" sites revealed by eRF1-seq in the 5′-UTR, 3′-UTR, and CDS highlight a previously underappreciated facet of translation dynamics.

Weakness:

(1) Modest effects seen in ABCE1 knockdown do not seem to add up to the level of regulation. The authors state "ABCE1 regulates terminating ribosomes independent of the sequence context" on pg 9, and "ABCE1 modulates termination pausing independent of the mRNA sequence context" in the figure caption for Figure S4. Given the modest effect of the knockdown, such phrasing is most likely not supported. Further clarification of "ABCE1 plays a generic role in translation termination" is necessary.

(2) The authors propose that the GA rich sequence element upstream of the stop codon on the mRNA could potentially base pair with the 3′-end of the 18S rRNA. In the PDBs the authors reference in their paper and also in 3JAG, 3JAH, 3JAI (structures of terminating ribosomes with the stop codon in the A-site and eRF1), the mRNA exiting the ribosome and the 3′-end of the 18S rRNA are about 25-30 A apart. In addition, a segment of eS26 is wedged in between these two RNA segments. This reviewer noted this arrangement in a random sampling of 5 other PDBs of mammalian and human ribosome 80S structures. How do the authors anticipate the base pairing they have proposed to occur in light of these steric hindrances? RpsS26 is known to be released by Tsr2 in yeast during very specific stresses. Is it their expectation that termination pausing in human/mammalian cells happens during stressful conditions only?

(3) The authors say, "It is thus likely that mRNA undergoes post-decoding scanning by 18S rRNA." (pg. 10). It is unclear what the authors mean by "scanning." Do they mean that the mRNA gets scanned in a manner similar to scanning during initiation? There is no evidence presented to support that particular conclusion.

(4) Role of termination pausing in the testis is highly speculative. The authors state: "It is thus conceivable that the wide range of ribosome density at stop codons in testis facilitates functional division of ribosome occupancy beyond the coding region." It is unclear what type of functional division they are referring to.

Reviewer #2 (Public review):

Summary:

This paper presents results interpreted to indicate that sequences upstream of stop codons capable of base-pairing with the 3' end of 18S rRNA prolong the dwell time of 80S ribosomes at stop codons in a manner impeded by Rps26 in the 40S subunit exit channel, which leads to the proper completion of termination and ribosome recycling and prevents spurious translation of 3'UTR sequences by one or more unconventional mechanisms.

Strengths:

The standard 80S and selective eRF1 80S ribosome profiling data obtained using EZRA-Seq are of high quality, allowing the authors to detect an enrichment for purine-rich sequences upstream of stop codons at sites where termination is relatively slow and ribosomal complexes are paused with eRF1 still engaged in the A site.

Weaknesses:

There are many weaknesses in the experimental design, interpretation of results, and description of assay design and assumptions, the data obtained, and the interpretation of results, all of which detract from the scientific quality and significance of this work. In fact, a large proportion of paragraphs in the text and figure panels present some difficulty either in understanding how the experiment or data analysis was conducted or what the authors wish to conclude from the results, or that stem from an overinterpretation of findings or failure to consider other equally likely explanations.

Reviewer #3 (Public review):

Summary:

This study from Jia et al carried out a variety of analyses of terminating ribosomes, including the development of eRF1-seq to map termination sites, identification of a GA-rich motif that promotes ribosome pausing, characterization of tissue-specific termination dynamics, and elucidation of the regulatory roles of 18S rRNA and RPS26. Overall, the study is thoughtfully designed, and its biological conclusions are well supported by complementary experiments. The tools and datasets generated provide valuable resources for researchers investigating the mechanisms of RNA translation.

Strengths:

(1) The study introduces eRF1-seq, a novel approach for mapping translation termination sites, providing a methodological advance for studying ribosome termination.

(2) Through integrative bioinformatic analyses and complementary MPRA experiments, the authors demonstrate that GA-rich motifs promote ribosome pausing at termination sites and reveal possible regulatory roles of 18S rRNA in this process.

(3) The study characterizes tissue-specific ribosome termination dynamics, showing that the testis exhibits stronger ribosome pausing at stop codons compared to other tissues. Follow-up experiments suggest that RPS26 may contribute to this tissue specificity.

Weaknesses:

The biological significance of ribosome pausing regulation at translation termination sites or of translational readthrough, for example, across different tissue types, remains unclear. Nevertheless, this question lies beyond the primary scope of the current study.

Reviewer #4 (Public review):

Summary:

This manuscript by Qian and colleagues utilizes ribosome profiling, and reporter assays to dissect translation termination. Unfortunately, the data do not support the conclusions of the paper, controls are missing and several assays are not well validated and do not reproduce previous findings from others.

Specific comments:

• Translation termination has been studied in several organisms including mammalian cells and yeast. In those cases what is analyzed is not the peak height at the stop codon, but rather the difference in the ribosome density before and after the stop. Thus, analyzing peak height is not validated. I understand that this is relevant only for the ribosome profiling experiments (and Ezra-seq) not the RF1 profiling. But much of the data was acquired that way.

• Moreover, the data do not reproduce previous findings and no effort is made to connect them to previous data. Previous data has shown that stop codon efficacy varies. This is not reproduced (S1C). Similarly, an effect from the +1 residue is not reproduced. The data isn't even stratified by different stop codons as previous work has shown that different surrounding residues have different effects in the context of different stop codons. Thus, none of the sequencing data is validated or trusted and does not reproduce previous findings.

• The GA-rich sequence identified by Ezra-Seq and RF1 seq is not the same and it differs from previous sequences (Wangen &Green).

• The authors claim that the majority of Rf1 peaks is at stop codons, but that is not true. It is only about 30% of the peaks. Also, not all mRNAs have peaks at the stop codons. That is at best problematic. Finally, there are mRNAs that are known to "suffer" from NMD, what do these look like in the Ezra-Seq and RF1-Seq? How about mRNAs that have programmed frameshifts? This raises questions on the validity of the eRF1 data.

• Figure 4: First, instead of M/P ratio, one should analyze M/M+P, to normalize out differences in the loading and effects from collisions, which are guaranteed to occur here, but not considered or analyzed. Second, the data are analyzed as if what matters are codons in the P and E site (and beyond, where there are definitely NOT recognized codons). While there is evidence for some interactions, one would think that an additional analysis based on sequence would be helpful. Also, the supplemental data indicates that very rarely are there reciprocal changes (as should be the case), and as seen for stop codons.

• Regarding the HiBit reporter assay: The two sequecnes clearly have effects on translation without considering stop codon context (Figure 4C), which need to be taken into account. Also, the effect from the sequences varies in the context of the assay in 4C and 4D (2-fold vs .5 fold), further questioning the assay. Moreover, the authors claim that re-initiation cannot account for Hibit levels, but that is clearly incorrect. The western in Figure 4E does not reproduce the data in 4D. While Hibit goes up (as in 4D, the putative GFP-fusion goes down. Finally, while the second reading frame should be more efficient is not explained and further argues for an artifact. Previous work (and work herein) suggests that read-through occurs equally in each reading frame. No controls for these assays are presented: e.g. stimulation by antibiotics, ABCE1 depletion, etc.

• Figure 5 has similar problems. I don't understand how the Figure in 5A is made, but when you overlay the cited structures on Rps26, the molecules are identical. I guess the authors used some fantasy to build non-existing sequences differently into the structure. There is no basis for that. In panel C and the same in Figure 7, the number of analyzed mRNAs varies. This could influence the outcome and the EXACT same set of mRNAs should be analyzed. But the main problem here is that the authors need to analyze readthrough and not peak height as detailed above. Essential controls are missing that show what fraction of the 18S rRNA is mutated. Previous work has shown that 2 nt truncated 18S rRNA is actively degraded. It is hard to believe how 15% of altered ribosomes can abolish 100% of the effect from the C-rich sequences. Important validation is missing: the authors should analyze rRNA sequences in their ribo-seq dataset to demonstrate that they have the mutated rRNAs, and that these enrich and de-enrich as predicted.

• In Figure 5-7 the authors develop a model that the sequence selectivity arises from base pairing between 18S rRNA and the mRNA. If so, then they should really stratify the data by number of WC pairs that can be formed. And only WC pairs, as GU pairs have a totally different geometry that will likely be discriminated against in this context. Also, the mutation is in a part of the helix that has no effect (Figure S3G). Thus, the data within the manuscript are inconsistent.

• Figure 6 does not agree with published data (Li et al., Nature 2022). Previous work did not show testis-depletion of Rps26 in purified ribosomes. This is the critical difference as the authors here did not purify ribosomes. Also, another Rps is an essential control, even if purified ribosomes are used. The validity of this dataset is thus questionable . Depletion from polysomes is hard to believe, as overall there is less signal in the polysomes.

• Figure 7 has similar problems as figure 5. Different pools of mRNAs are analyzed; peak height is not validated. Overexpression of Rps26 is not shown, as only Myc is shown, not Rps26. Beyond that, increased occupancy in ribosomes needs to be shown for the effect to come from ribosomes. Given how sick the cells are it is most likely that all effects are secondary and arise from whatever else is going on in the overexpression or depletion of Rps26. No controls are presented to show specific effects from Rps26.

• The authors need to check Rli1/ABCE levels in their cells. Their data have features that are indicative of low ABCE1 levels. These include a very small effect from ABCE1 depletion. These could be responsible for some of the effects they observe.

Reviewer #1 (Public review):

Microglia are mononuclear phagocytes in the CNS and play essential roles in physiology and pathology. In some conditions, circulating monocytes may infiltrate in the CNS and differentiated into microglia or microglia-like cells. However, the specific mechanism is large unknown. In this study, the authors explored the epigenetic regulation of this process. The quality of this study will be significantly improved if a few questions are addressed.

(1) The capacity of circulating myeloid cell-derived microglia are controversial. In this study, the authors utilized CX3CR1-GFP/CCR2-DsRed (hetero) mice as a lineage tracing line. However, this animal line is not an appropriate approach for this purpose. For example, when the CX3CR1-GFP/CCR2-DsRed as the undifferentiated donor cell, they are GFP+ and DsRed+. When the cell fate has been changed to microglia, they will change into GFP+ and DsRed- cells. However, this process is mediated with busulfan and artificially introduced bone marrow cells in the circulating cell, which is not existed in physiological and pathological conditions. These artifacts will potentially bring in artifacts and confound the conclusion, as the classical wrong text book knowledge of the bone marrow derived microglia theory and subsequently corrected by Fabio Rossi lab1,2. This is the most risk for drawing this conclusion. The top evidence is from the parabiosis animal model. Therefore, A parabiosis study before making this conclusion, combining a CX3CR1-GFP (hetero) mouse with a WT mouse without busulfan conditioning and looking at whether there are GFP+ microglia in the GFP- WT mouse brain. If there are no GFP+ microglia, the author should clarify this is not a physiological or pathological condition, but a defined artificial host condition, as previously study did3.

(2) In some conditions, peripheral myeloid cells can infiltrate and replace the brain microglia4,5. Discuss it would be helpful to better understand the mechanism of microglia replacement.

References:

(1) Ajami, B., Bennett, J.L., Krieger, C., Tetzlaff, W., and Rossi, F.M. (2007). Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature neuroscience 10, 1538-1543. 10.1038/nn2014.

(2) Ajami, B., Bennett, J.L., Krieger, C., McNagny, K.M., and Rossi, F.M.V. (2011). Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nature neuroscience 14, 1142-1149. http://www.nature.com/neuro/journal/v14/n9/abs/nn.2887.html#supplementary-information.

(3) Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.K., Mack, M., Heikenwalder, M., Bruck, W., Priller, J., and Prinz, M. (2007). Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions. Nature neuroscience 10, 1544-1553. 10.1038/nn2015.

(4) Wu, J., Wang, Y., Li, X., Ouyang, P., Cai, Y., He, Y., Zhang, M., Luan, X., Jin, Y., Wang, J., et al. (2025). Microglia replacement halts the progression of microgliopathy in mice and humans. Science 389, eadr1015. 10.1126/science.adr1015.

(5) Xu, Z., Rao, Y., Huang, Y., Zhou, T., Feng, R., Xiong, S., Yuan, T.F., Qin, S., Lu, Y., Zhou, X., et al. (2020). Efficient strategies for microglia replacement in the central nervous system. Cell reports 32, 108041. 10.1016/j.celrep.2020.108041.

Reviewer #2 (Public review):

Mouse fate mapping studies have established that the bulk of microglia derives from cells that seed the brain early during development. However, monocytes were also shown to give rise to parenchymal CNS macrophages and thus are potential candidates for microglia replacement therapy. Whether monocyte-derived cells adopt bona fide microglia identities has remained under debate. The study of Liu et al addresses this important outstanding question, focusing on the retina.

Specifically, the authors investigate monocyte-derived macrophages that arise upon challenges in the murine retina using scRNAseq and ATACseq analyses, combined with flow cytometry and histology. They complement this approach with an analysis of BM chimeras and analyses of the latter. The authors conclude that monocyte-derived cells acquire markers that have originally been proposed to be microglia-specific, including P2ry12, Tmem119, and Fcrls.

In 2018, four comprehensive independent studies reported the analyses of monocyte-derived CNS macrophages (PMID 30451869, 30523248, 29643186, 29861285). Following transcriptome and epigenome analyses, these teams came to the collective conclusion that HSC-derived cells remain distinct from microglia. Using advanced fate mapping and better isolation and profiling tools, a more recent study, however, concluded that, if given sufficient time of CNS residence, most monocyte-derived macrophages can, at the transcriptome level, become essentially identical to microglia (PMID 40279248, https://www.biorxiv.org/content/10.1101/2023.11.16.567402v1).

Given this controversy, the study of Paschalis and colleagues, which focuses largely on retinal monocyte-derived cells, could have been a valuable resource and complement for clarification. Indeed, interestingly, their data suggest that microglia adaptation of monocyte-derived macrophages might be faster in the retina than in the CNS. However, for the reasons outlined below, the study falls in its present form short of providing significant new insight and is a missed opportunity.

Comments:

The major shortcoming of the study is that the authors decided to focus on a very limited number of genes to make their case, rather than performing a more informative, unbiased, and detailed global analysis. In contrast to what the authors state, much of the microglia community is, I believe, aware of experimental limitations and the problem with markers. Showing gain of microglia marker expression on monocyte-derived cells, or loss of monocyte markers, such as Ly6C, is not novel.

This is highlighted Fig. 3F. No one argues today that monocyte-derived tissue macrophages differ from blood monocytes (although the authors repeatedly emphasize this as novelty). However, the heatmap shows that the engrafted cells clearly differ from naïve and injured microglia. What are these genes, their associated pathways ?

Also, how about expression of the Sall1 gene that encodes a repressor that is considered important to maintain microglia identity (PMID37322178, 27776109). Somewhat surprisingly, Sall1 was recently also shown to be expressed by monocyte-derived CNS macrophages (PMID 40279248). It would be valuable information if the authors can corroborate this finding.

The authors state in their discussion that monocyte-derived macrophages seem 'hardwired for inflammatory responses'. While this is an interesting suggestion, the NFkB motif enrichment is insufficient and should be complemented with a target list. Again, it would be important to be aware of heterogeneity.

A critical factor when analyzing CNS macrophages is the exclusion of perivascular CNS border-associated cells, which also holds for the retina (see PMID 38596358). This should be addressed. Can the authors discriminate BAM from microglia in their scRNAseq data set, for instance, by their CD206 expression or other markers ? BAM have been shown to display distinct transcriptomes and even as a contamination could introduce significant bias.

Even for the genes the authors focus on, it is hard to understand from the way the authors present the data what fraction of cells are positive. This would be critical information since there could be some heterogeneity. Flowcytometry analysis, including double staining for P2ry12, Tmem119, and Fcrls to see correlations, would here be valuable.

The authors state in their title that 'epigenetic adaptation drives monocyte differentiation'. However, since all gene expression is governed by the epigenome, this is trivial. I would argue that to gain meaningful insight and justify such a statement, it would require an in-depth global comparative analysis of the chromatin status of yolk sac microglia and monocyte-derived CNS macrophages, including CUT&RUN analysis for specific histone marks and methylation patterns.

Please cite and discuss PMID 30451869, 30523248, 29643186, 29861285, and in particular the more recent highly relevant study PMID 40279248.

Reviewer #1 (Public review):

This paper investigates how heparan sulfate (HS) engagement functions in the cellular entry of SARS-CoV-2. A prevailing model that has been developed over the last five years by work from many laboratories using a variety of biochemical, structural, and microscopic approaches is that HS acts a co-receptor for SARS-CoV-2; its binding to SARS-CoV-2 both concentrates virus on the surface of target cells and allosterically alters the spike protein to promote an "up/open" RBD conformation that enables engagement of the proteinaceous receptor human ACE2 on the cell surface (PMID: 32970989, 35926454, 38055954, 39401361, 40548749). These two events enable plasma membrane fusion (after a cleavage event promoted by plasma membrane TMPSS2) or endocytosis and subsequent pH-dependent fusion (which requires a cathepsin L-mediated cleavage of the spike).

The authors in this study used a series of microscopy techniques, labeled pseudoviruses and authentic SARS-CoV-2 strains, and cells lacking or expressing HS and/or hACE2 to re-examine the specific stage(s) HS and hACE2 function in the entry process. They suggest that HS mediates SARS-CoV-2 cell-surface attachment and endocytosis, and that hACE2 functions "downstream" of this to facilitate productive infection. Their results also suggest that SARS-CoV-2 binds clusters of HS molecules projecting 60-410 nm, which act as docking sites for viral attachment. Blocking HS binding with pixantrone, a drug under clinical evaluation for cancer (due to its anti-topoisomerase II activity), inhibited SARS-CoV-2 Omicron JN.1 variant from attaching to and infecting human airway cells. The authors conclude that their work establishes a revised entry paradigm in which HS clusters mediate SARS-CoV-2 attachment and endocytosis, with ACE2 acting at some stage downstream. They speculate this idea might apply broadly to other viruses known to engage HS and has translational implications for developing antiviral agents that target HS interactions.

The strengths of the interesting and technically well-executed study include the use of multiple high-resolution microscopy modalities, the tracking of labelled viruses, the use of both pseudoviruses and authentic SARS-CoV-2, and the use of primary airway cells. Nonetheless, there are issues that need to be addressed to buttress the proposed model compared to earlier ones. These include: (a) the distinction between macropinocytosis and receptor-mediated endocytosis and what this might mean for productive SARS-CoV-2 infection; (b) the need to account for TMPRSS2 expression and plasma membrane fusion; (c) addition of genetic studies in which hACE2 is expressed in cells lacking HS; (d) an unclear picture of exactly where downstream hACE2 functions; and (e) and a need for comparative/additional study of earlier SARS-CoV-2 variants, which preferentially fuse at the plasma membrane.

Reviewer #2 (Public review):

In this manuscript by Han et al, the authors assess the binding of SARS-CoV-2 to heparan sulfate clusters via advanced light microscopy of viral particles. The authors claim that the SARS-CoV-2 spike (in the context of pseudovirus and in authentic virus) engages heparan sulfate clusters on the cell surface, which then promotes endocytosis and subsequent infection. The finding that HSPGs are important for SARS-CoV-2 entry in some cell types is well-described, but the authors attempt to make the claim here that HS represents an alternative "receptor" and that HS engagement is far more important than the field appreciates. The data itself appears to be of appropriate quality and would be of interest to the field, but the overly generalized conclusions lack adequate experimental support. This significantly diminishes enthusiasm for this manuscript as written. The manuscript is imprecise and far overstates the actual findings shown by the data. Additional controls would be of great benefit.

Further, it is this reviewer's opinion that the findings do not represent a novel paradigm as claimed. HS has been well described for SARS-CoV-2 and other viruses to serve as attachment factors to promote initial virus attachment. While the manuscript provides new insight into the details of this process, the manuscript attempts to oversell this finding by applying new words rather than new molecular details. The authors would be better served by presenting a more balanced and nuanced view of their interesting data. In this reviewer's opinion, the salesmanship significantly detracts from the data and manuscript.

Major Comments:

The authors need to rigorously define a "receptor" vs an "attachment factor." They also should avoid ambiguous terms such as "receptor underlying ...attachment" and "attachment receptor" (or at least clearly define them). Much of their argument hinges on the specific definition of these terms. This reviewer would argue that a receptor is a host factor that is necessary and sufficient for active promotion of viral entry (genome release into the cytoplasm), while an attachment factor is a host factor that enhances initial viral attachment/endocytosis but is neither necessary nor sufficient. The evidence does NOT implicate HS as a receptor under this fairly textbook definition. This is proven in Figure 1 (and elsewhere) in which ACE2 is absolutely required for viral entry.

The authors should genetically perturb HS biosynthesis in their key assays to demonstrate necessity. HS biosynthesis genes have been shown to be important for SARS-CoV-2 entry into some cells but not others (Huh7.5 cells PMID 33306959, but not in Vero cells PMID 33147444, Calu3 cells 35879413, A549 cells 33574281, and others 36597481. The authors need to discuss this important information and reconcile it with their data and model if they want to claim that HS is broadly important.

Is targeting HS really a compelling anti-viral strategy? The data show a ~5-fold reduction, which likely won't excite a drug company. The strengths and limitations of HS targeting should be presented in a more balanced discussion. Animal data showing anti-viral activity of PIX is warranted. This would enhance this claim and also provide key evidence of a relevant role for HS in a more physiologic model.

The authors provide little discussion of the fact that these studies rely exclusively on cell lines (which also happen to be TMPRSS2-deficient). The role of proteases in the role of HS should be tested in the cell lines and primary cells used, as protease expression is a key determinant of the site of fusion.

The claim that "SARS-CoV2 JN.1 variant binds to heparan sulfate, not hACE2, in primary human airway cells" is extraordinary and thus requires extraordinary evidence.

First, PIX reduces attachment by 5-fold, which is not the same as "nearly abolished." Also, anti-ACE2 "nearly abolished" entry in 7D, while PIX did not. If the authors want to make these claims, an alternative method to disrupt HS (other than PIX) is needed in primary airway cells. A genetic approach would be much more convincing. The authors should also demonstrate whether entry in their primary cell assays is TMPRSS2 vs Cathepsin L dependent (using E64d and camostat, for instance) as mentioned above.

Each figure should clearly state how many independent experiments and replicates per experiment were performed. What does "3 experiments" mean? Are these three independent experiments or three wells on one day?

Reviewer #3 (Public review):

Summary:

In this manuscript, the authors define a new paradigm for the attachment and endocytosis of SARS-CoV-2 in which cell surface heparan sulfate (HS) is the primary receptor, with ACE2 having a downstream role within endocytic vesicles. This has implications for the importance of targeting virion-HS interactions as a therapeutic strategy.

Strengths:

The authors show that viruses are internalized via dynamin-dependent endocytosis and that endocytic internalization is the major pathway for pseudotyped SARS-CoV-2 genome expression. They show that HS-mediated viral attachment is a critical step preceding viral endocytosis and also subsequent genome expression. Further, they show that hACE2 acts downstream of endocytosis to promote viral infection, and may be co-internalised with virions after HS attachment. Pseudotyped virus and authentic SARS-CoV-2 provide similar results. In addition, the authors demonstrate that remarkable clusters of multiple HS chains exist on the cell surface, visualised by a number of elegant microscopy methods, and that these represent the docking sites for virions. These visualisations are an important general contribution in themselves to understanding the nanoscale interactions of HS at the cell surface.

The use of a complementary range of methods, virus constructs, and cell models is a strength, and the results clearly support the conclusions.

Overall, the results convincingly demonstrate a different model to the currently accepted mechanism in which the ACE2 protein is regarded as the cell surface receptor for SARS-CoV-2. Here, the authors provide compelling evidence that cell surface clusters of HS are the primary docking site, with ACE2 interactions occurring later, after endocytosis (whilst still being essential for viral genome expression). This is an exciting and important landmark evidence which supports the view that HS-virion interactions should be viewed as a key site for anti-viral drug targeting, likely in strategies that also target the downstream ACE2-based mechanism of viral entry within endosomes.

Weaknesses:

This reviewer identified only minor points regarding citing and discussing other studies and typos, which can be corrected.

Reviewer #1 (Public review):

Summary:

In this manuscript, Bisht et al address the hypothesis that protein folding chaperones may be implicated in aggregopathies and in particular Tau aggregation, as a means to identify novel therapeutic routes for these largely neurodegenerative conditions.

The authors conducted a genetic screen in the Drosophila eye, which facilitates identification of mutations that either enhance or suppress a visible disturbance in the nearly crystalline organization of the compound eye. They screened by RNA-interference all 64 known Drosophila chaperones and revealed that mutations in 20 of them exaggerate the Tau-dependent phenotype, while 15 ameliorated it. The enhancer of degeneration group included 2 subunits of the typically heterohexameric prefoldin complex and other co-translational chaperones.

The authors characterized in depth one of the prefoldin subunits, Pfdn5 and convincingly demonstrated that this protein functions in regulation of microtubule organization, likely due to its regulation of proper folding of tubulin monomers. They demonstrate convincingly using both immunohistochemistry in larval motor neurons and microtubule binding assays that Pfdn5 is a bona fide microtubule associated protein contributing to the stability of the axonal microtubule cytoskeleton, which is significantly disrupted in the mutants.

Similar phenotypes were observed in larvae expressing the Frontotemporal dementia with Parkinsonism on chromosome 17-associated mutations of the human Tau gene V377M and R406W. On the strength of the phenotypic evidence and the enhancement of the TauV377M-induced eye degeneration they demonstrate that loss of Pfdn5 exaggerates the synaptic deficits upon expression of the Tau mutants. Conversely, overexpression of Pfdn5 or Pfdn6 ameliorates the synaptic phenotypes in the larvae, the vacuolization phenotypes in the adult, even memory defects upon TauV377M expression.

Strengths:

The phenotypic analyses of the mutant and its interactions with TauV377M at the cell biological, histological, and behavioral levels are precise, extensive, and convincing and achieve the aims of characterization of a novel function of Pfdn5.

Regarding this memory defect upon V377M tau expression. Kosmidis et al (2010) pmid: 20071510, demonstrated that pan-neuronal expression of TauV377M disrupts the organization of the mushroom bodies, the seat of long-term memory in odor/shock and odor/reward conditioning. If the novel memory assay the authors use depends on the adult brain structures, then the memory deficit can be explained in this manner.

If the mushroom bodies are defective upon TauV377M expression does overexpression of Pfdn5 or 6 reverse this deficit? This would argue strongly in favor of the microtubule stabilization explanation.

The discovery that Pfdn5 (and 6 most likely) affect tauV377M toxicity is indeed a novel and important discovery for the Tauopathies field. It is important to determine whether this interaction affects only the FTDP-17-linked mutations, or also WT Tau isoforms, which are linked to the rest of the Tauopathies. Also, insights on the mode(s) that Pfdn5/6 affect Tau toxicity, such as some of the suggestions above are aiming at, will likely be helpful towards therapeutic interventions.

Weaknesses:

What is unclear however is how Pfdn5 loss or even overexpression affects the pathological Tau phenotypes.

Does Pfdn5 (or 6) interact directly with TauV377M? Colocalization within tissues is a start, but immunoprecipitations would provide additional independent evidence that this is so.

Does Pfdn5 loss exacerbate TauV377M phenotypes because it destabilizes microtubules, which are already at least partially destabilized by Tau expression?<br /> Rescue of the phenotypes by overexpression of Pfdn5 agrees with this notion.

However, Cowan et al (2010) pmid: 20617325 demonstrated that wild-type Tau accumulation in larval motor neurons indeed destabilizes microtubules in a Tau phosphorylation-dependent manner.

So, is TauV377M hyperphosphorylated in the larvae?? What happens to TauV377M phosphorylation when Pfdn5 is missing and presumably more Tau is soluble and subject to hyperphosphorylation as predicted by the above?

Expression of WT human Tau (which is associated with most common Tauopathies other than FTDP-17) as Cowan et al suggest has significant effects on microtubule stability, but such Tau-expressing larvae are largely viable. Will one mutant copy of the Pfdn5 knockout enhance the phenotype of these larvae?? Will it result in lethality? Such data will serve to generalize the effects of Pfdn5 beyond the two FDTP-17 mutations utilized.

Does the loss of Pfdn5 affect TauV377M (and WTTau) levels?? Could the loss of Pfdn5 simply result in increased Tau levels? And conversely, does overexpression of Pfdn5 or 6 reduce Tau levels?? This would explain the enhancement and suppression of TauV377M (and possibly WT Tau) phenotypes. It is an easily addressed, trivial explanation at the observational level, which if true begs for a distinct mechanistic approach.

Finally, the authors argue that TauV377M forms aggregates in the larval brain based on large puncta observed especially upon loss of Pfdn5. This may be so, but protocols are available to validate this molecularly the presence of insoluble Tau aggregates (for example, pmid: 36868851) or soluble Tau oligomers as these apparently differentially affect Tau toxicity. Does Pfdn5 loss exaggerate the toxic oligomers and overexpression promotes the more benign large aggregates??

Comments on revisions:

In the revised manuscript Βisht et al have provided extensive new experimental evidence in support of previously more tenuous claims. These fully satisfy my comments and suggestions, and in my view, have significantly strengthened the manuscript with compelling new evidence.

Reviewer #2 (Public review):

Bisht et al detail a novel interaction between the chaperone, Prefoldin 5, microtubules, and tau-mediated neurodegeneration, with potential relevance for Alzheimer's disease and other tauopathies. Using Drosophila, the study shows that Pfdn5 is a microtubule-associated protein, which regulates tubulin monomer levels and can stabilize microtubule filaments in the axons of peripheral nerves. The work further suggests that Pfdn5/6 may antagonize Tau aggregation and neurotoxicity. While the overall findings may be of interest to those investigating the axonal and synaptic cytoskeleton, the detailed mechanisms for the observed phenotypes remain unresolved and the translational relevance for tauopathy pathogenesis is yet to be established. Further, a number of key controls and important experiments are missing that are needed to fully interpret the findings.

The strength of this study is the data showing that Pfdn5 localizes to axonal microtubules and the loss-of-function phenotypic analysis revealing disrupted synaptic bouton morphology. The major weakness relates to the experiments and claims of interactions with Tau-mediated neurodegeneration. In particular, it is unclear whether knockdown of Pfdn5 may cause eye phenotypes independent of Tau. Further, the GMR>tau phenotype appears to have been incorrectly utilized to examine age-dependent, neurodegeneration.

This manuscript argues that its findings may be relevant to thinking about mechanisms and therapies applicable to tauopathies; however, this is premature given that many questions remain about the interactions from Drosophila, the detailed mechanisms remain unresolved, and absent evidence that tau and Pfdn may similarly interact in the mammalian neuronal context. Therefore, this work would be strongly enhanced by experiments in human or murine neuronal culture or supportive evidence from analyses of human data.

Comments on revisions:

The revision adequately addresses most of the previously raised concerns, resulting in a significantly improved manuscript.

Reviewer #2 (Public review):

Summary:

The role of PRC2 in post neural crest induction was not well understood. This work developed an elegant mouse genetic system to conditionally deplete EED upon SOX10 activation. Substantial developmental defects were identified for craniofacial and bone development. The authors also performed extensive single-cell RNA sequencing to analyze differentiation gene expression changes upon conditional EED disruption.

Strengths:

(1) Elegant genetic system to ablate EED post neural crest induction.

(2) Single-cell RNA-seq analysis is extremely suitable for studying the cell type specific gene expression changes in developmental systems.

Original Weaknesses:

(1) Although this study is well designed and contains state-of-art single cell RNA-seq analysis, it lacks the mechanistic depth in the EED/PRC2-mediated epigenetic repression. This is largely because no epigenomic data was shown.

(2) The mouse model of conditional loss of EZH2 in neural crest has been previously reported, as the authors pointed out in the discussion. What is novelty in this study to disrupt EED? Perhaps a more detailed comparison of the two mouse models would be beneficial.

(3) The presentation of the single-cell RNA-seq data may need improvement. The complexity of the many cell types blurs the importance of which cell types are affected the most by EED disruption.

(4) While it's easy to identify PRC2/EED target genes using published epigenomic data, it would be nice to tease out the direct versus indirect effects in the gene expression changes (e.g Fig. 4e)

Comments on latest version:

The authors have addressed weaknesses 2 and 3 of my previous comment very well. For weaknesses 1 and 4, the authors have added a main Fig 5 and its associated supplemental materials, which definitely strengthen the mechanistic depth of the story. However, I think the audience would appreciate if the following questions/points could be further addressed regarding the Cut&Tag data (mostly related to main Figure 5):

(1) The authors described that Sox10-Cre would be expressed at E8.75, and in theory, EED-FL would be ablated soon after that. Why would E16.5 exhibit a much smaller loss in H3K27me3 compared to E12.5? Shouldn't a prolong loss of EED lead to even worse consequence?

(2) The gene expression change at E12.5 upon loss of EED (shown in Fig. 4h) seems to be massive, including many PRC2-target genes. However, the H3K27me3 alteration seems to be mild even at E12.5. Does this infer a PRC2 or H3K27 methylation - independent role of EED? To address this, I suggest the authors re-consider addressing my previously commented weakness #4 regarding the RNA-seq versus Cut&Tag change correlation. For example, a gene scatter plot with X-axis of RNA-seq changes versus Y-axis of H3K27me3 level changes.

(3) The CUT&Tag experiments seem to contain replicates according to the figure legend, but no statistical analysis was presented including the new supplemental tables. Also, for Fig. 5c-d, instead of showing the MRR in individual conditions, I think the audience would really want to know the differential MRR between Fl/WT and Fl/Fl. In other words, how many genes/ MRR have statistically lower H3K27me3 level upon EED loss.

Reviewer #1 (Public review):

Summary:

The authors validate the contribution of RAP2A to GB progression. RAp2A participates in asymetric cell division, and the localization of several cell polarity markers including cno and Numb.

Strengths:

The use of human data, Drosophila models and cell culture or neurospheres is a good scenario to validate the hypothesis using complementary systems.

Moreover, the mechanisms that determine GB progression, and in particular glioma stem cells biology, are relevant for the knowledge on glioblastoma and opens new possibilities to future clinical strategies.

Weaknesses:

While the manuscript presents a well-supported investigation into RAP2A's role in GBM, some methodological aspects could benefit from further validation. The major concern is the reliance on a single GB cell line (GB5), including multiple GBM lines, particularly primary patient-derived 3D cultures with known stem-like properties, would significantly enhance the study's robustness.

Several specific points raised in previous reviews have improved this version of the manuscript:

• The specificity of Rap2l RNAi has been further confirmed by using several different RNAi tools.

• Quantification of phenotypic penetrance and survival rates in Rap2l mutants would help determine the consistency of ACD defects. The authors have substantially increased the number of samples analyzed including three different RNAi lines (both the number of NB lineages and the number of different brains analyzed) to confirm the high penetrance of the phenotype.

• The observations on neurosphere size and Ki-67 expression require normalization (e.g., Ki-67+ cells per total cell number or per neurosphere size). This is included in the manuscript and now clarified in the text.

• The discrepancy in Figures 6A and 6B requires further discussion. The authors have included a new analysis and further explanations and they can conclude that in 2 cell-neurospheres there are more cases of asymmetric divisions in the experimental condition (RAP2A) than in the control.

• Live imaging of ACD events would provide more direct evidence. Live imaging was not done due to technical limitations. Despite being a potential contribution to the manuscript, the current conclusions of the manuscript are supported by the current data, and live experiments can be dispensable

• Clarification of terminology and statistical markers (e.g., p-values) in Figure 1A would improve clarity. This has been improved.

Comments on revisions:

The manuscript has improved the clarity in general, and I think that it is suitable for publication. However, for future experiments and projects, I would like to insist in the relevance of validating the results in vivo using xenografts with 3D-primary patient-derived cell lines or GB organoids.

Reviewer #2 (Public review):

This study investigates the role of RAP2A in regulating asymmetric cell division (ACD) in glioblastoma stem cells (GSCs), bridging insights from Drosophila ACD mechanisms to human tumor biology. They focus on RAP2A, a human homolog of Drosophila Rap2l, as a novel ACD regulator in GBM is innovative, given its underexplored role in cancer stem cells (CSCs). The hypothesis that ACD imbalance (favoring symmetric divisions) drives GSC expansion and tumor progression introduces a fresh perspective on differentiation therapy. However, the dual role of ACD in tumor heterogeneity (potentially aiding therapy resistance) requires deeper discussion to clarify the study's unique contributions against existing controversies.

Comments on revisions:

More experiments as suggested in the original assessment of the submission are needed to justify the hypothesis drawn in the manuscript.

Reviewer #1 (Public review):

Summary:

This study builds on previous work demonstrating that several beta connexins (Cx26, Cx30 and Cx32) have a carbamylation motif which renders them sensitive to CO2. In response to CO2, hemichannels composed of these connexins open, enabling diffusion of small molecules (such as ATP) between the cytosol and extracellular environment. Here, the authors have identified that an alpha connexin, Cx43, also contains a carbamylation motif, and they demonstrate that CO2 opens Cx43 hemichannels. Most of the study involves using transfected cells expressing wild-type and mutant Cx43 to define amino acids required for CO2 sensitivity. Hippocampal tissue slices in culture were used to show that CO2-induced synaptic transmission was affected by Cx43 hemichannels, providing a physiological context. The authors point out that the Cx43 gene significantly diverges from the beta connexins that are CO2 sensitive, suggesting that the conserved carbamylation motif was present before the alpha and beta connexin genes diverged.

Strengths:

The molecular analysis defining the amino acids which contribute to the CO2 sensitivity of Cx43 is a major strength of the study. The rigor of analysis was strengthened by using three independent assays for hemichannel opening: dye uptake, patch clamp channel measurements and ATP secretion. The resulting analysis identified key lysines in Cx43 that were required for CO2-mediated hemichannel opening. A double K to E Cx43 mutant produced a construct that produced hemichannels that were constitutively open, which further strengthened the analysis.

Using hippocampal tissue sections to demonstrate that CO2 can influence field excitatory postsynaptic potentials (fEPSPs) provides a native context for CO2 regulation of Cx43 hemichannels. Cx43 mutations associated with Oculodentodigital Dysplasia (ODDD) inhibited CO2-induced hemichannel opening, although the mechanism by which this occurs was not elucidated.

Cytosolic pH was measured and it was further demonstrated that Cx43 hemichannels composed of untagged Cx43 are sensitive to CO2.

A molecular phylogenetic survey was performed which identified several other non-beta connexins that have a putative carbamylation motif. How this relates to connexin evolution was added to the discussion.

Weaknesses:

Cultured cells are typically grown in incubators containing 5% CO2 which is ~40 mmHg. Determining compensatory mechanisms that enable the cells to be viable if Cx43 hemichannels are open at this PCO2 would strengthen the study.

Experiments using Gap26 to inhibit Cx43 hemichannels in fEPSP measurements used a scrambled peptide as a control. Including gap peptides specifically targeting Cx26, Cx30 and Cx32 as additional controls would strengthen the study, since the tissue sections have a complex pattern of connexin expression.

Reviewer #2 (Public review):

Summary:

This paper examines the CO2 sensitivity of Cx43 hemichannels and gap junctional channels in transiently transfected Hela cells using several different assays including ethidium dye uptake, ATP release, whole cell patch clamp recordings and an imaging assay of gap junctional dye transfer. The results show that raising pCO2 from 20 to 70 mmHg (at a constant pH of 7.3) cause an increase in opening of Cx43 hemichannels but did not block Cx43 gap junctions. This study also showed that raising pCO2 from 20 to 35 mm Hg resulted in an increase in synaptic strength in hippocampal rat brain slices, presumably due to downstream ATP release, suggesting that the CO2 sensitivity of Cx43 may be physiologically relevant. As a further test of the physiological relevance of the CO2 sensitivity of Cx43, it was shown that two pathological mutations of Cx43 that are associated with ODDD caused loss of Cx43 CO2-sensitivity. Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26. To understand the structural changes involved in CO2 sensitivity, a number of mutations were made in Cx43 sites thought to be the equivalent of those known to be involved in the CO2 sensitivity of Cx26 and the CO2 sensitivity of these mutants was investigated.

Strengths:

This study shows that the apparent lack of functional Cx43 hemichannels observed in a number of previous in vitro function studies may be due to the use of HEPES to buffer the external pH. When Cx43 hemichannels were studied in external solutions in which CO2/bicarbonate was used to buffer pH instead of HEPES, Cx43 hemichannels showed significantly higher levels of dye uptake, ATP release, and ionic conductance. These findings may have major physiological implications since Cx43 hemichannels are found in many organs throughout the body including the brain, heart and immune system.

Weaknesses:

Interpretation of the site-directed mutation studies is complicated. Although Cx43 has a potential carbamylation motif that is homologous to the motif in Cx26, the results of site-directed mutation studies were inconsistent with a simple model in which K144 and K105 interact following carbamylation to cause the opening of Cx43 hemichannels.

Secondly, although it is shown that two Cx43 ODDD associated mutations show a loss of CO2 sensitivity, there is no evidence that the absence of CO2 sensitivity is involved in the pathology of ODDD.

Reviewer #3 (Public review):

In this paper, authors aimed to investigate carbamylation effects on the function of Cx43-based hemichannels. Such effects have previously been characterized for other connexins, e.g. for Cx26, which display increased hemichannel (HC) opening and closure of gap junction channels upon exposure to increased CO2 partial pressure (accompanied by increased bicarbonate to keep pH constant). The authors used HeLa cells transiently transfected with Cx43 to investigate CO2-dependent carbamylation effects on Cx43 HC function. In contrast to Cx43-based gap junction channels that are here reported to be insensitive to PCO2 alterations, they provide evidence that Cx43 HC opening is highly dependent on the PCO2 pressure in the bath solution, over a range of 20 up to 70 mmHg encompassing the physiologically normal resting level of around 40 mmHg. They furthermore identified several Cx43 residues involved in Cx43 HC sensitivity to PCO2: K105, K109, K144 & K234; mutation of 2 or more of these AAs is necessary to abolish CO2 sensitivity. The subject is interesting and the results indicate that a fraction of HCs is open at a physiological 40 mmHg PCO2, which differs from the situation under HEPES buffered solutions where HCs are mostly closed under resting conditions. The mechanism of HC opening with CO2 gassing is linked to carbamylation and authors pinpointed several Lys residues involved in this process. Overall, the work is interesting as it shows that Cx43 HCs have a significant open probability under resting conditions of physiological levels of CO2 gassing, probably applicable to/relevant for brain, heart and other Cx43 expressing organs. The paper gives a detailed account on various experiments performed (dye uptake, electrophysiology, ATP release to assess HC function) and results concluded from those. They further consider many candidate carbamylation sites by mutating them to negatively charged Glu residues. The paper finalizes with hippocampal slice work showing evidence for connexin-dependent increases of the EPSP amplitude that could be inhibited by HC inhibition with Gap26 (Fig. 10). Another line of evidence comes from the Cx43-linked ODDD genetic disease whereby L90V as well as the A44V mutations of Cx43 prevented the CO2 induced hemichannel opening response (Fig. 11). Although the paper is interesting, in its present state it suffers from (i) a problematic Fig. 3, precluding interpretation of the data shown, and (ii) the poor use of hemichannel inhibitors that are necessary to strengthen the evidence in the crucial experiment of Fig. 2 and others.

Comments on revisions:

The traces in Fig.2B show that the HC current is inward at 20 mmHg PCO2, while it switches to an outward current at 55mmHg PCO2. HCs are non-selective channels, so their current should switch direction around 0 mV but not around -50 mV. As such, the -50 mV switching point indicates involvement of another channel distinct from non-selective Cx43 hemichannels. In the revised version, this problem has not been solved nor addressed. Additionally, I identified another problem in that the experimental traces shown lack a trace at the baseline condition of PCO2 35mmHg, while the summary graph depicts a data point. Not showing a trace at baseline PCO2 35mmHg renders data interpretation in the summary graph questionable.

Reviewer #1 (Public review):

Summary:

The work by Pinon et al describes the generation of a microvascular model to study Neisseria meningitidis interactions with blood vessels. The model uses a novel and relatively high throughput fabrication method that allows full control over the geometry of the vessels. The model is well characterized from the vascular standpoint and shows improvements when exposed to flow. The authors show that Neisseria binds to the 3D model in a similar geometry that in the animal xenograft model, induces an increase in permeability short after bacterial perfusion, and endothelial cytoskeleton rearrangements including a honeycomb actin structure. Finally, the authors show neutrophil recruitment to bacterial microcolonies and phagocytosis of Neisseria.

Strengths:

The article is overall well written, and it is a great advancement in the bioengineering and sepsis infection field. The authors achieved their aim at establishing a good model for Neisseria vascular pathogenesis and the results support the conclusions. I support the publication of the manuscript. I include below some clarifications that I consider would be good for readers.

One of the most novel things of the manuscript is the use of a relatively quick photoablation system. Could this technique be applied in other laboratories? While the revised manuscript includes more technical details as requested, the description remains difficult to follow for readers from a biology background. I recommend revising this section to improve clarity and accessibility for a broader scientific audience.

The authors suggest that in the animal model, early 3h infection with Neisseria do not show increase in vascular permeability, contrary to their findings in the 3D in vitro model. However, they show a non-significant increase in permeability of 70 KDa Dextran in the animal xenograft early infection. As a bioengineer this seems to point that if the experiment would have been done with a lower molecular weight tracer, significant increases in permeability could have been detected. I would suggest to do this experiment that could capture early events in vascular disruption.

One of the great advantages of the system is the possibility of visualizing infection-related events at high resolution. The authors show the formation of actin of a honeycomb structure beneath the bacterial microcolonies. This only occurred in 65% of the microcolonies. Is this result similar to in vitro 2D endothelial cultures in static and under flow? Also, the group has shown in the past positive staining of other cytoskeletal proteins, such as ezrin in the ERM complex. Does this also occur in the 3D system?

Significance:

The manuscript is comprehensive, complete and represents the first bioengineered model of sepsis. One of the major strengths is the carful characterization and benchmarking against the animal xenograft model. Beyond the technical achievement, the manuscript is also highly quantitative and includes advanced image analysis that could benefit many scientists. The authors show a quick photoablation method that would be useful for the bioengineering community and improved the state-of-the-art providing a new experimental model for sepsis.

My expertise is on infection bioengineered models.

Comments on revised version:

The authors have addressed all my concerns.

Reviewer #2 (Public review):

Pinon and colleagues have developed a Vessel-on-Chip model showcasing geometrical and physical properties similar to the murine vessels used in the study of systemic infections. The authors succeed on their aim of developing an complex, humanized, in vitro model that can faithfully recapitulate the hallmarks of systemic infections.

The vessel was created via highly controllable laser photoablation in a collagen matrix, subsequent seeding of human endothelial cells, and flow perfusion to induce mechanical cues. This model could be infected with Neisseria meningitidis as a model of systemic infection. In this model, microcolony formation and dynamics, and effects on the host were very similar to those described for the human skin xenograft mouse model (the current gold standard for systemic studies) and were consistent with observations made in patients. The model could also recapitulate the neutrophil response upon N. meningitidis systemic infection.

The claims and the conclusions are supported by the data, the methods are properly presented, and the data is analyzed adequately. The most important strength of this manuscript is the technology developed to build this model, which is impressive and very innovative. The Vessel-on-Chip can be tuned to acquire complex shapes and, according to the authors, the process has been optimized to produce models very quickly. This is a great advancement compared with the technologies used to produce other equivalent models. This model proves to be equivalent to the most advanced model used to date (skin xenograft mouse model). The human skin xenograft mouse model requires complex surgical techniques and has the practical and ethical limitations associated with the use of animals. However, the Vessel-on-chip model is free of ethical concerns, can be produced quickly, and allows to precisely tune the vessel's geometry and to perform higher resolution microscopy. Both models were comparable in terms of the hallmarks defining the disease, suggesting that the presented model can be an effective replacement of the animal use in this area. In addition, the Vessel-on-Chip allows to perform microscopy with higher resolution and ease, which can in turn allow more complex and precise image-based analysis. The authors leverage the image-based analysis to obtain further insights into the infection, highlighting the capabilities of the model in this aspect.

A limitation of this model is that it lacks the multicellularity that characterizes other similar models, which could be useful to research disease more extensively. However, the authors discuss the possibilities of adding other cells to the model, for example, fibroblasts. The methodology would allow for integrating many different types of cells into the model, which would increase the scope of scientific questions that can be addressed. In addition, the technology presented in the current paper is also difficult to adapt for standard biology labs. The methodology is complex and requires specialized equipment and personnel, which might hinder its widespread utilization of this model by researchers in the field.

This manuscript will be of interest for a specialized audience focusing on the development of microphysiological models. The technology presented here can be of great interest to researchers whose main area of interest is the endothelium and the blood vessels, for example, researchers on the study of systemic infections, atherosclerosis, angiogenesis, etc. This manuscript can have great applications for a broad audience focusing on vasculature research. Due to the high degree of expertise required to produce these models, this paper can present an interesting opportunity to begin collaborations with researchers dealing with a wide range of diseases, including atherosclerosis, cancer (metastasis), and systemic infections of all kinds.

Reviewer #3 (Public review):

Summary:

In this manuscript Pinon et al. describe the development of a 3D model of human vasculature within a microchip to study Neisseria meningitidis (Nm)- host interactions and validate it through its comparison to the current gold-standard model consisting of human skin engrafted onto a mouse. There is a pressing need for robust biomimetic models with which to study Nm-host interactions because Nm is a human-specific pathogen for which research has been primarily limited to simple 2D human cell culture assays. Their investigation relies primarily on data derived from microscopy and its quantitative analysis, which support the authors' goal of validating their Vessel-on-Chip (VOC) as a useful tool for studying vascular infections by Nm, and by extension, other pathogens associated with blood vessels.

Strengths:

• Introduces a novel human in vitro system that promotes control of experimental variables and permits greater quantitative analysis than previous models<br /> • The VOC model is validated by direct comparison to the state-of-the-art human skin graft on mouse model<br /> • The authors make significant efforts to quantify, model, and statistically analyze their data<br /> • The laser ablation approach permits defining custom vascular architecture<br /> • The VOC model permits the addition and/or alteration of cell types and microbes added to the model<br /> • The VOC model permits the establishment of an endothelium developed by shear stress and active infusion of reagents into the system

Weaknesses:

• The VOC model contains one cell type, human umbilical cord vascular endothelial cells (HUVECs), while true vasculature contains a number of other cell types that associate with and affect the endothelium, such as smooth muscle cells, pericytes, and components of the immune system. However, adding such complexity may be a future goal of this VOC model.

Impact:

The VOC model presented by Pinon et al. is an exciting advancement in the set of tools available to study human pathogens interacting with the vasculature. This manuscript focuses on validating the model, and as such sets the foundation for impactful research in the future. Of particular value is the photoablation technique that permits the custom design of vascular architecture without the use of artificial scaffolding structures described in previously published works.

Comments on revised version:

The authors have nicely addressed my (and other reviewers') comments.

Reviewer #1 (Public review):

The manuscript by Choi and colleagues investigates the impact of variation in cortical geometry and growth on cortical surface morphology. Specifically, the study uses physical gel models and computational models to evaluate the impact of varying specific features/parameters of the cortical surface. The study makes use of this approach to address the topic of malformations of cortical development and finds that cortical thickness and cortical expansion rate are the drivers of differences in morphogenesis.

The study is composed of two main sections. First, the authors validate numerical simulation and gel model approaches against real cortical postnatal development in the ferret. Next, the study turns to modelling malformations in cortical development using modified tangential growth rate and cortical thickness parameters in numerical simulations. The findings investigate three genetically linked cortical malformations observed in the human brain to demonstrate the impact of the two physical parameters on folding in the ferret brain.

This is a tightly presented study that demonstrates a key insight into cortical morphogenesis and the impact of deviations from normal development. The dual physical and computational modeling approach offers the potential for unique insights into mechanisms driving malformations. This study establishes a strong foundation for further work directly probing the development of cortical folding in the ferret brain.

Reviewer #2 (Public review):

Summary:

Based on MRI data of the ferret (a gyrencephalic non-primate animal, in whom folding happens postnatally), the authors create in vitro physical gel models and in silico numerical simulations of typical cortical gyrification. They then use genetic manipulations of animal models to demonstrate that cortical thickness and expansion rate are primary drivers of atypical morphogenesis. These observations are then used to explain cortical malformations in humans.

Strengths:

The paper is very interesting and original, and combines physical gel experiments, numerical simulations, as well as observations in MCD. The figures are informative, and the results appear to have good overall face validity.

Comment on the revised version from the Reviewing Editor:

The reviewers are happy with the authors replies and the eLife Assessment has been amended accordingly.

Reviewer #1 (Public review):

The authors investigated tactile spatial perception on the breast using discrimination, categorization, and direct localization tasks. They reach four main conclusions:

(1) The breast has poor tactile spatial resolution.

This conclusion is based on comparing just noticeable differences, a marker of tactile spatial resolution, across four body regions, two on the breast. The data compellingly support the conclusion; the study outshines other studies on tactile spatial resolution that tend to use problematic measures of tactile resolution, such as two-point-discrimination thresholds. The result will interest researchers in the field and possibly in other fields due to the intriguing tension between the finding and the sexually arousing function of touching the breast.

The manuscript incorrectly describes the result as poor spatial acuity. Acuity measures the average absolute error, and acuity is good when response biases are absent. Precision relates to the error variance. It is common to see high precision with low acuity or vice versa. Just noticeable differences assess precision or spatial resolution, while points of subjective equality evaluate acuity or bias. Similar confusions between these terms appear throughout the manuscript.<br /> A paragraph within the next section seems to follow up on this insight by examining the across-participant consistency of the differences in tactile spatial resolution between body parts. To this aim, pairwise rank correlations between body sites are conducted. This analysis raises red flags from a statistical point of view. 1) An ANOVA and its follow-up tests assume no variation in the size of the tested effect but varying base values across participants. Thus, if significant differences between conditions are confirmed by the original statistical analysis, most participants will have better spatial resolution in one condition than the other condition, and the difference between body sites will be similar across participants. 2) Correlations are power-hungry, and non-parametric tests are power-hungry. Thus, the number of participants needed for a reliable rank correlation analysis far exceeds that of the study. In sum, a correlation should emerge between body sites associated with significantly different tactile JNDs; however, these correlations might only be significant for body sites with pronounced differences due to the sample size.

(2) Larger breasts are associated with lower tactile spatial resolution

This conclusion is based on a strong correlation between participants' JNDs and the size of their breasts. The depicted correlation convincingly supports the conclusion. The sample size is below that recommended for correlations based on power analyses, but simulations show that spurious correlations of the reported size are extremely unlikely at N=18. Moreover, visual inspection rules out that outliers drive these correlations. Thus, they are convincing. This result is of interest to the field, as it aligns with the hypothesis that nerve fibers are more sparsely distributed across larger body parts.

(3) The nipple is a unit

The data do not support this conclusion. The conclusion that the nipple is perceived as a unit is based on poor tactile localization performance for touches on the nipple compared to the areola. The problem is that the localization task is a quadrant identification task with the center being at the nipple. Quadrants for the areola could be significantly larger due to the relative size of the areola and the nipple; the results section seems to suggest this was accounted for when placing the tactile stimuli within the quadrants, but the methods section suggests otherwise. Additionally, the areola has an advantage because of its distance from the nipple, which leads to larger Euclidean distances between the centers of the quadrants than for the nipple. Thus, participants should do better for the areola than for the nipple even if both sites have the same tactile resolution.

To justify the conclusion that the nipple is a unit, additional data would be required. 1) One could compare psychometric curves with the nipple as the center and psychometric curves with a nearby point on the areola as the center. 2) Performance in the quadrant task could be compared for the nipple and an equally sized portion of the areola and tactile locations that have the same distance to the border between quadrants in skin coordinates. 3) Tactile resolution could be directly measured for both body sites using a tactile orientation task with either a two-dot probe or a haptic grating.

Categorization accuracy in each area was tested against chance using a Monte Carlo test, which is fine, though the calculation of the test statistic, Z, should be reported in the Methods section, as there are several options. Localization accuracies are then compared between areas using a paired t-test. It is a bit confusing that once a distribution-approximating test is used, and once a test that assumes Gaussian distributions when the data is Bernoulli/Binomial distributed. Sampling-based and t-tests are very robust, so these surprising choices should have hardly any effect on the results.

A correlation based on N=4 participants is dangerously underpowered. A quick simulation shows that correlation coefficients of randomly sampled numbers are uniformly distributed at such a low sample size. This likely spurious correlation is not analyzed, but quite prominently featured in a figure and discussed in the text, which is worrisome.

(4) Localization of tactile events on the breast is biased towards the nipple

The conclusion that tactile percepts are drawn toward the nipple is based on localization biases for tactile stimuli on the breast compared to the back. Unfortunately, the way participants reported the tactile locations introduces a major confound. Participants indicated the perceived locations of the tactile stimulus on 3D models of these body parts. The nipple is a highly distinctive and cognitively represented landmark, far more so than the scapula, making it very likely that responses were biased toward the nipple regardless of the actual percepts. One imperfect but better alternative would have been to ask participants to identify locations on a neutral grey patch and help them relate this patch to their skin by repeatedly tracing its outline on the skin.

Participants also saw their localization responses for the previously touched locations. This is unlikely to induce bias towards the nipple, but it renders any estimate of the size and variance of the errors unreliable. Participants will always make sure that the marked locations are sufficiently distant from each other.

The statistical analysis is again a homebrew solution and hard to follow. It remains unclear why standard and straightforward measures of bias, such as regressing reported against actual locations, were not used.

Null-hypothesis significance testing only lets scientists either reject the null hypothesis or not. The latter does NOT mean the Null hypothesis is true, i.e., it can never be concluded that there is no effect. This rule applies to every NHST test. However, it raises particular concerns with distribution tests. The only conclusion possible is that the data are unlikely from a population with the tested distribution; these tests do not provide insight into the actual distribution of the data, regardless of whether the result is significant or not.

Reviewer #2 (Public review):

Summary:

The authors tested tactile acuity on the breast of females using several tasks.

Results:

Tactile acuity, assessed by just-noticeable differences in judging whether a touch was above or below a comparison stimulus, was lower on both the lateral and medial breast than on the hand and back. Acuity also scaled inversely with breast size, echoing earlier findings that larger hands exhibit lower acuity, presumably because a similar number of tactile receptors must be distributed over larger or smaller body surfaces. Observing this principle in the breast as on the hand strengthens the view that fixed innervation is a general organizing principle of the tactile system. Both methodology and analysis appear sound.

Most participants were unable to localize touch to a specific quadrant of the nipple, suggesting it is perceived as a single tactile unit. However, the study does not address whether touches to the nipple and areola are confused; conceptualizing the nipple as a perceptual (landmark) unit would suggest that such confusion should not take place. Aside from this limitation, the methodology and analysis appear sound.

Absolute touch localization, assessed by asking participants to indicate locations on a 3D rendering of their own torso, revealed a bias toward the nipple. The authors interpret this as evidence that the nipple serves as a landmark attracting perceived touch. However, as reviewers noted during review, alternative explanations cannot be fully ruled out: because the stimulus array was centered on the nipple, the observed bias may stem from stimulus distribution rather than landmark status. Aside from this caveat, the methodology and analysis appear sound.

Overall assessment:

The study offers a welcome exception to the prevailing bias in tactile research that limits investigation to the hand and arm. Its support for the fixed innervation hypothesis and its suggestion that the nipple may serve as a potential landmark-though requiring further scrutiny-illustrate the value of extending research to other body regions. By employing multiple tasks, the authors address several key aspects of tactile perception and create links to earlier findings.

Reviewer #1 (Public review):

General assessment of the work:

In this manuscript, Mohr and Kelly show that the C1 component of the human VEP is correlated with binary choices in a contrast discrimination task, even when the stimulus is kept constant and confounding variables are considered in the analysis. They interpret this as evidence for the role V1 plays during perceptual decision formation. Choice-related signals in single sensory cells are enlightening because they speak to the spatial (and temporal) scale of the brain computations underlying perceptual decision-making. However, similar signals in aggregate measures of neural activity offer a less direct window and thus less insight into these computations. For example, although I am not a VEP specialist, it seems doubtful that the measurements are exclusively picking up (an unbiased selection of) V1 spikes. Moreover, although this is not widely known, there is in fact a long history to this line of work. In 1972, Campbell and Kulikowski ("The Visual Evoked Potential as a function of contrast of a grating pattern" - Journal of Physiology) already showed a similar effect in a contrast detection task (this finding inspired the original Choice Probability analyses in the monkey physiology studies conducted in the early 1990's). Finally, it is not clear to me that there is an interesting alternative hypothesis that is somehow ruled out by these results. Should we really consider that simple visual signals such as spatial contrast are *not* mediated by V1? This seems to fly in the face of well-established anatomy and function of visual circuits. Or should we be open to the idea that VEP measurements are almost completely divorced from task-relevant neural signals? Why would this be an interesting technique then? In sum, while this work reports results in line with several single-cell and VEP studies and perhaps is technically superior in its domain, I find it hard to see how these findings would meaningfully impact our thinking about the neural and computational basis of spatial contrast discrimination.

Summary of substantive concerns:

(1) The study of choice probability in V1 cells is more extensive than portrayed in the paper's introduction. In recent years, choice-related activity in V1 has also been studied by Nienborg & Cumming (2014), Goris et al (2017), Jasper et al (2019), Lange et al (2023), and Boundy-Singer et al (2025). These studies paint a complex picture (a mixture of positive, absent, and negative results), but should be mentioned in the paper's introduction.

(2) The very first study to conduct an analysis of stimulus-conditioned neural activity during a perceptual decision-making task was, in fact, a VEP study: Campbell and Kulikowski (1972). This study never gained the fame it perhaps deserves. But it would be appropriate to weave it into the introduction and motivation of this paper.

(3) What are interesting alternative hypotheses to be considered here? I don't understand the (somewhat implicit) suggestion here that contrast representations late in the system can somehow be divorced from early representations. If they were, they would not be correlated with stimulus contrast.

(4) I find the arguments about the timing of the VEP signals somewhat complex and not very compelling, to be honest. It might help if you added a simulation of a process model that illustrated the temporal flow of the neural computations involved in the task. When are sensory signals manifested in V1 activity informing the decision-making process, in your view? And how is your measure of neural activity related to this latent variable? Can you show in a simulation that the combination of this process and linking hypothesis gives rise to inverted U-shaped relationships, as is the case for your data?

Reviewer #2 (Public review):

Summary:

Mohr and Kelly report a high-density EEG study in healthy human volunteers in which they test whether correlations between neural activity in the primary visual cortex and choice behavior can be measured non-invasively. Participants performed a contrast discrimination task on large arrays of Gabor gratings presented in the upper left and lower right quadrants of the visual field. The results indicate that single-trial amplitudes of C1, the earliest cortical component of the visual evoked potential in humans, predict forced-choice behavior over and beyond other behavioral and electrophysiological choice-related signals. These results constitute an important advance for our understanding of the nature and flexibility of early visual processing.

Strengths:

(1) The findings suggest a previously unsuspected role for aggregate early visual cortex activity in shaping behavioral choices.

(2) The authors extend well-established methods for assessing covariation between neural signals and behavioral output to non-invasive EEG recordings.

(3) The effects of initial afferent information in the primary visual cortex on choice behavior are carefully assessed by accounting for a wide range of potential behavioral and electrophysiological confounds.

(4) Caveats and limitations are transparently addressed and discussed.

Weaknesses:

(1) It is not clear whether integration of contrast information across relatively large arrays is a good test case for decision-related information in C1. The authors raise this issue in the Discussion, and I agree that it is all the more striking that they do find C1 choice probability. Nevertheless, I think the choice of task and stimuli should be explained in more detail.

(2) In a similar vein, while C1 has canonical topographical properties at the grand-average level, these may differ substantially depending on individual anatomy (which the authors did not assess). This means that task-relevant information will be represented to different degrees in individuals' single-trial data. My guess is that this confound was mitigated precisely by choosing relatively extended stimulus arrays. But given the authors' impressive track record on C1 mapping and modeling, I was surprised that the underlying rationale is only roughly outlined. For example, given the topographies shown and the electrode selection procedure employed, I assume that the differences between upper and lower targets are mainly driven by stimulus arms on the main diagonal. Did the authors run pilot experiments with more restricted stimulus arrays? I do not mean to imply that such additional information needs to be detailed in the main article, but it would be worth mentioning.

(3) Also, the stimulus arrangement disregards known differences in conduction velocity between the upper and lower visual fields. While no such differences are evident from the maximal-electrode averages shown in Figure 1B, it is difficult to assess this issue without single-stimulus VEPs and/or a dedicated latency analysis. The authors touch upon this issue when discussing potential pre-C1 signals emanating from the magnocellular pathway.

(4) I suspect that most of these issues are at least partly related to a lack of clarity regarding levels of description: the authors often refer to 'information' contained in C1 or, apparently interchangeably, to 'visual representations' before, during, or following C1. However, if I understand correctly, the signal predicting (or predicted by) behavioral choice is much cruder than what an RSA-primed readership may expect, and also cruder than the other choice-predictive signals entered as control variables: namely, a univariate difference score on single-trial data integrated over a 10 ms window determined on the basis of grand-averaged data. I think it is worth clarifying and emphasizing the nature of this signal as the difference of aggregate contrast responses that *can* only be read out at higher levels of the visual system due to the limited extent of horizontal connectivity in V1. I do not think that this diminishes the importance of the findings - if anything, it makes them more remarkable.

(5) Arguably even more remarkable is the finding that C1 amplitudes themselves appear to be influenced by choice history. The authors address this issue in the Discussion; however, I'm afraid I could not follow their argument regarding preparatory (and differential?) weighting of read-outs across the visual hierarchy. I believe this point is worth developing further, as it bears on the issue of whether C1 modulations are present and ecologically relevant when looking (before and) beyond stimulus-locked averages.

Reviewer #1 (Public review):

Summary:

CCK is the most abundant neuropeptide in the brain, and many studies have investigated the role of CCK and inhibitory CCK interneurons in modulating neural circuits, especially in the hippocampus. The manuscript presents interesting questions regarding the role of excitatory CCK+ neurons in the hippocampus, which has been much less studied compared to the well-known roles of inhibitory CCK neurons in regulating network function. The authors adopt several methods, including transgenic mice and viruses, optogenetics, chemogenetics, RNAi, and behavioral tasks to explore these less-studied roles of excitatory CCK neurons in CA3. They find that the excitatory CCK neurons are involved in hippocampal-dependent tasks such as spatial learning and memory formation, and that CCK-knockdown impairs these tasks.

However, these questions are very dependent on ensuring that the study is properly targeting excitatory CCK neurons (and thus their specific contributions to behavior).

There needs to be much more characterization of the CCK transgenic mice and viruses to confirm the targeting. Without this, it is unclear whether the study is looking at excitatory CCK neurons or a more general heterogeneous CCK neuron population.

Strengths:

This field has focused mainly on inhibitory CCK+ interneurons and their role in network function and activity, and thus, this manuscript raises interesting questions regarding the role of excitatory CCK+ neurons, which have been much less studied.

Weaknesses:

(1a) This manuscript is dependent on ensuring that the study is indeed investigating the role of excitatory CCK-expressing neurons themselves and their specific contribution to behavior. There needs to be much more characterization of the CCK-expressing mice (crossed with Ai14 or transduced with various viruses) to confirm the excitatory-cell targeting. Without this, it is unclear whether the study is looking at excitatory CCK neurons or a more general heterogeneous CCK neuron population.

(1b) For the experiments that use a virus with the CCK-IRES-Cre mouse, there is no information or characterization on how well the virus targets excitatory CCK-expressing neurons. (Additionally, it has been reported that with CaMKIIa-driven protein expression, using viruses, can be seen in both pyramidal and inhibitory cells.)

(2) The methods and figure legends are extremely sparse, leading to many questions regarding methodology and accuracy. More details would be useful in evaluating the tools and data. More details would be useful in evaluating the tools and data. Additionally, further quantification would be useful-e.g. in some places, only % values are noted, or only images are presented.

(3) It is unclear whether the reduced CCK expression is correlated, or directly causing the impairments in hippocampal function. Does the CCK-shRNA have any additional detrimental effects besides affecting CCK-expression (e.g., is the CCK-shRNA also affecting some other essential (but not CCK-related) aspect of the neuron itself?)? Is there any histology comparison between the shRNA and the scrambled shRNA?

Reviewer #2 (Public review):

Summary:

In this study, the authors have demonstrated, through a comprehensive approach combining electrophysiology, chemogenetics, fiber photometry, RNA interference, and multiple behavioral tasks, the necessity of projections from CCK+ CAMKIIergic neurons in the hippocampal CA3 region to the CA1 region for regulating spatial memory in mice. Specifically, authors have shown that CA3-CCK CAMKIIergic neurons are selectively activated by novel locations during a spatial memory task. Furthermore, authors have identified the CA3-CA1 pathway as crucial for this spatial working memory function, thereby suggesting a pivotal role for CA3 excitatory CCK neurons in influencing CA1 LTP. The data presented appear to be well-organized and comprehensive.

Strengths:

(1) This work combined various methods to validate the excitatory CCK neurons in the CA3 area; these data are convincing and solid.

(2) This study demonstrated that the CA3-CCK CAMKIIergic neurons are involved in the spatial memory tasks; these are interesting findings, which suggest that these neurons are important targets for manipulating the memory-related diseases.

(3) This manuscript also measured the endogenous CCK from the CA3-CCK CAMKIIergic neurons; this means that CCK can be released under certain conditions.

Weaknesses:

(1) The authors do not mention which receptors of the CCK modulate these processes.

(2) This author does not test the CCK gene knockout mice or the CCK receptor knockout mice in these neural processes.

(3) The author does not test the source of CCK release during the behavioral tasks.

Reviewer #3 (Public review):

Summary:

Fengwen Huang et al. used multiple neuroscience techniques (transgenetic mouse, immunochemistry, bulk calcium recording, neural sensor, hippocampal-dependent task, optogenetics, chemogenetics, and interfer RNA technique) to elucidate the role of the excitatory cholecystokinin-positive pyramidal neurons in the hippocampus in regulating the hippocampal functions, including navigation and neuroplasticity.

Strengths:

(1) The authors provided the distribution profiles of excitatory cholecystokinin in the dorsal hippocampus via the transgenetic mice (Ai14::CCK Cre mice), immunochemistry, and retrograde AAV.

(2) The authors used the neural sensor and light stimulation to monitor the CCK release from the CA3 area, indicating that CCK can be secreted by activation of the excitatory CCK neurons.

(3) The authors showed that the activity of the excitatory CCK neurons in CA3 is necessary for navigation learning.

(4) The authors demonstrated that inhibition of the excitatory CCK neurons and knockdown of the CCK gene expression in CA3 impaired the navigation learning and the neuroplasticity of CA3-CA1 projections.

Weaknesses:

(1) The causal relationship between navigation learning and CCK secretion?

(2) The effect of overexpression of the CCK gene on hippocampal functions?

(3) What are the functional differences between the excitatory and inhibitory CCK neurons in the hippocampus?

(4) Do CCK sources come from the local CA3 or entorhinal cortex (EC) during the high-frequency electrical stimulation?

Reviewer #1 (Public review):

Summary:

The study by Lemen et al. represents a comprehensive and unique analysis of gene networks in rat models of opioid use disorder, using multiple strains and both sexes. It provides a time-series analysis of Quantitative Trait Loci (QTLs) in response to morphine exposure.

Strengths:

A key finding is the identification of a previously unknown morphine-sensitive pathway involving Oprm1 and Fgf12, which activates a cascade through MAPK kinases in D1 medium spiny neurons (MSNs). Strengths include the large-scale, multi-strain, sex-inclusive design, the time-series QTL mapping provides dynamic insights, and the discovery of an Oprm1-Fgf12-MAPK signaling pathway in D1 MSNs, which is novel and relevant.

Weaknesses:

(1) The proposed involvement of Nav1.2 (SCN2A) as a downstream target of the Oprm1-Fgf12 pathway requires further analysis/evidence. Is Nav1.2 (SCN2A) expressed in D1 neurons?

The authors mentioned that SCN8A (Nav1.6) was tested as a candidate mediator of Oprm1-Fgf12 loci and variation in locomotor activity. However, the proposed model supports SCN2A as a target rather than SCN8A. This is somewhat unexpected since SCN8A is highly abundant in MSN.

Can the authors provide expression data for SCN2A, Oprm1, and Fgf12 in D1 vs. D2 MSNs?

(2) The authors should consider adding a reference to FGF12 in Schizophrenia (PMC8027596) in the Introduction.

(3) There is recent evidence supporting the druggability of other intracellular FGFs, such as FGF14 (PMC11696184) and FGF13 (PMC12259270), through their interactions with Nav channels. What are the implications of these findings for drug discovery in the context of the present study? Could FGF12 be considered a potential druggable therapeutic target for opioid use disorder (OUD)?

Reviewer #2 (Public review):

Summary:

This highly novel and significant manuscript re-analyzes behavioral QTL data derived from morphine locomotor activity in the BXD recombinant inbred panel. The combination of interacting behavioral-pharmacology (morphine and naltrexone) time course data, high-resolution mouse genetic analyses, genetic analysis of gene expression (eQTLs), cross-species analysis with human gene expression and genetic data, and molecular modeling approaches with Bayesian network analysis produces new information on loci modulating morphine locomotor activity.

Furthermore, the identification of time-wise epistatic interactions between the Oprm1 and Fgf12 loci is highly novel and points to methodological approaches for identifying other epistatic interactions using animal model genetic studies.

Strengths:

(1) Use of state-of-the art genetic tools for mapping behavioral phenotypes in mouse models.

(2) Adequately powered analysis incorporating both sexes and time course analyses.

(3) Detection of time and sex-dependent interactions of two QTL loci modulating morphine locomotor activity.

(4) Identification of putative candidate genes by combined expression and behavioral genetic analyses.

(5) Use of Bayesian analysis to model causal interactions between multiple genes and behavioral time points.

Weaknesses:

(1) There is a need for careful editing of the text and figures to eliminate multiple typographical and other compositional errors.

(2) There are multiple examples of overstating the possible significance of results that should be corrected or at least directly pointed out as weaknesses in the Discussion. These include:

a) Assumption that the Oprm1 gene is the causal candidate gene for the major morphine locomotor Chr10 QTL at the early time epochs. Oprm1 is 400,000 bp away from the support interval of the Mor10a QTL locus, and there is no mention as to whether the Oprm1 mRNA eQTL overlaps with Mor10a.

b) Although the Bayesian analysis of possible complex interactions between Oprm1, Fgf12, other interacting genes, and behaviors is very innovative and produces testable hypotheses, a more straightforward mediation analysis of causal relationships between genotype, gene expression, and phenotype would have added strength to the arguments for the causal role of these individual genes.

c) The GWAS data analysis for Oprm1 and Fgf12 is incomplete in not mentioning actual significance levels for Oprm1 and perhaps overstating the nominal significance findings for Fgf12.

Appraisal:

The authors largely succeeded in reaching goals with novel findings and methodology.

Significance of Findings:

This study will likely spur future direct experimental studies to test hypotheses generated by this complex analysis. Additionally, the broad methodological approach incorporating time course genetic analyses may encourage other studies to identify epistatic interactions in mouse genetic studies.

Reviewer #3 (Public review):

Summary:

This is a clearly written paper that describes the reanalysis of data from a BXD study of the locomotor response to morphine and naloxone. The authors detect significant loci and an epistatic interaction between two of those loci. Single-cell data from outbred rats is used to investigate the interaction. The authors also use network methods and incorporate human data into their analysis.

Strengths:

One major strength of this work is the use of granular time-series data, enabling the identification of time-point-specific QTL. This allowed for the identification of an additional, distinct QTL (the Fgf12 locus) in this work compared to previously published analysis of these data, as well as the identification of an epistatic effect between Oprm1 (driving early stages of locomotor activation) and Fgf12 (driving later stages).

Weaknesses:

(1) What criteria were used to determine whether the epistatic interaction was significant? How many possible interactions were explored?

(2) Results are presented for males and females separately, but the decision to examine the two sexes separately was never explained or justified. Since it is not standard to perform GWAS broken down by sex, some initial explanation of this decision is needed. Perhaps the discussion could also discuss what (if anything) was learned as a result of the sex-specific analysis. In the end, was it useful?

(3) The confidence intervals for the results were not well described, although I do see them in one of the tables. The authors used a 1.5 support interval, but didn't offer any justification for this decision. Is that a 95% confidence interval? If not, should more consideration have been given to genes outside that interval? For some of the QTLs that are not the focus of this paper, the confidence intervals were very large (>10 Mb). Is that typical for BXDs?

Reviewer #1 (Public review):

Summary:

This manuscript provides an open-source tool including hardware and software, and dataset to facilitate and standardize behavioral classification in laboratory mice. The hardware for behavioral phenotyping was extensively tested for safety. The software is GUI based facilitating the usage of this tool across the community of investigators that do not have a programming background. The behavioral classification tool is highly accurate, and the authors deposited a large dataset of annotations and pose tracking for many strains of mice. This tool has great potential for behavioral scientists that use mice across many fields, however there are many missing details that currently limit the impact of this tool and publication.

Strengths:

Software-hardware integration for facilitating cross-lab adaptation of the tool and minimizing the need to annotate new data for behavioral classification.

Data from many strains of mice was included in the classification and genetic analyses in this manuscript.

Large dataset annotated was deposited for the use of the community

GUI based software tool decreases barriers of usage across users with limited coding experience.

Weaknesses:

The GUI requires pose tracking for classification but, the software provided in JABS does not do pose tracking, so users must do pose tracking using a separate tool. The pose tracking quality directly impacts the classification quality, given that it is used for the feature calculation

Comments on revisions:

The authors addressed all my concerns.

Reviewer #2 (Public review):

Summary:

This manuscript presents the JAX Animal Behavior System (JABS), an integrated mouse phenotyping platform that includes modules for data acquisition, behavior annotation, and behavior classifier training and sharing. The manuscript provides details and validation for each module, demonstrating JABS as a useful open-source behavior analysis tool that removes barriers to adopting these analysis techniques by the community. In particular, with the JABS-AI module users can download and deploy previously trained classifiers on their own data, or annotate their own data and train their own classifiers. The JABS-AI module also allows users to deploy their classifiers on the JAX strain survey dataset and receive an automated behavior and genetic report.

Strengths:

(1) The JABS platform addresses the critical issue of reproducibility in mouse behavior studies by providing an end-to-end system from rig setup to downstream behavioral and genetic analyses. Each step has clear guidelines, and the GUIs are an excellent way to encourage best practices for data storage, annotation, and model training. Such a platform is especially helpful for labs without prior experience in this type of analysis.

(2) A notable strength of the JABS platform is its reuse of large amounts of previously collected data at JAX Labs, condensing this into pretrained pose estimation models and behavioral classifiers. JABS-AI also provides access to the strain survey dataset through automated classifier analyses, allowing large-scale genetic screening based on simple behavioral classifiers. This has the potential to accelerate research for many labs by identifying particular strains of interest.

(3) The ethograph analysis will be a useful way to compare annotators/classifiers beyond the JABS platform.

Weaknesses:

(1) The manuscript contains many assertions that lack references in both the Introduction and Discussion. For example, in the Discussion, the assertion "published research demonstrates that keypoint detection models maintain robust performance despite the presence of headstages and recording equipment" lacks reference.

(2) The provided GUIs lower the barrier to entry for labs that are just starting to collect and analyze mouse open field behavior data. However, users must run pose estimation themselves outside of the provided GUIs, which introduces a key bottleneck in the processing pipeline, especially for users without strong programming skills. The authors have provided pretrained pose estimation models and an example pipeline, which is certainly to be commended, but I believe the impact of these tools could be greatly magnified by an additional pose estimation GUI (just for running inference, not for labeling/training).

(3) While the manuscript does a good job of laying out best practices, there is an opportunity to further improve reproducibility for users of the platform. The software seems likely to perform well with perfect setups that adhere to the JABS criteria, but it is very likely there will be users with suboptimal setups - poorly constructed rigs, insufficient camera quality, etc. It is important, in these cases, to give users feedback at each stage of the pipeline so they can understand if they have succeeded or not. Quality control (QC) metrics should be computed for raw video data (is the video too dark/bright? are there the expected number of frames? etc.), pose estimation outputs (do the tracked points maintain a reasonable skeleton structure; do they actually move around the arena?), and classifier outputs (what is the incidence rate of 1-3 frame behaviors? a high value could indicate issues). In cases where QC metrics are difficult to define (they are basically always difficult to define), diagnostic figures showing snippets of raw data or simple summary statistics (heatmaps of mouse location in the open field) could be utilized to allow users to catch glaring errors before proceeding to the next stage of the pipeline, or to remove data from their analyses if they observe critical issues.

Comments on revisions:

I thank the authors for taking the time to address my comments. They have provided a lot of important context in their responses. My only remaining recommendation is to incorporate more of this text into the manuscript itself, as this context will also be interesting/important for readers (and potential users) to consider. Specifically:

the quality control/user feedback features that have already been implemented (these are extremely important, and unfortunately, not standard practice in many labs)

top-down vs bottom-up imaging trade-offs (you make very good points!)

video compression, spatial and temporal resolution trade-offs

more detail on why the authors chose pose-based rather than pixel-based classifiers

I believe the proposed system can be extremely useful for behavioral neuroscientists, especially since the top-down freely moving mouse paradigm is one of the most ubiquitous in the field. Many labs have reinvented the wheel here, and as a field it makes sense to coalesce around a set of pipelines and best practices to accelerate the science we all want to do. I make the above recommendation with this in mind: bringing together (properly referenced) observations and experiences of the authors themselves, as well as others in the field, provides a valuable resource for the community. Obviously, the main thrust of the manuscript should be about the tools themselves; it should not turn into a review paper, so I'm just suggesting some additional sentences/references sprinkled throughout as motivation for why the authors made the choices that they did.

Intro typo: "one link in the chainDIY rigs"

Reviewer #1 (Public review):

This paper by Poverlein et al reports the substantial membrane deformation around the oxidative phosphorylation super complex, proposing that this deformation is a key part of super complex formation. I found the paper interesting and well-written.

* Analysis of the bilayer curvature is challenging on the fine lengthscales they have used and produces unexpectedly large energies (Table 1). Additionally, the authors use the mean curvature (Eq. S5) as input to the (uncited, but it seems clear that this is Helfrich) Helfrich Hamiltonian (Eq. S7). If an errant factor of one half has been included with curvature, this would quarter the curvature energy compared to the real energy, due to the squared curvature. The bending modulus used (ca. 5 kcal/mol) is small on the scale of typically observed biological bending moduli. This suggests the curvature energies are indeed much higher even than the high values reported. Some of this may be due to the spontaneous curvature of the lipids and perhaps the effect of the protein modifying the nearby lipids properties.

* It is unclear how CDL is supporting SC formation if its effect stabilizing the membrane deformation is strong or if it is acting as an electrostatic glue. While this is a weakness for a definite quantification of the effect of CDL on SC formation, the study presents an interesting observation of CDL redistribution and could be an interesting topic for future work.

In summary, the qualitative data presented are interesting (especially the combination of molecular modeling with simpler Monte Carlo modeling aiding broader interpretation of the results). The energies of the membrane deformations are quite large. This might reflect the roles of specific lipids stabilizing those deformations, or the inherent difficulty in characterizing nanometer-scale curvature.

Reviewer #3 (Public review):

Summary:

In this contribution, the authors report atomistic, coarse-grained and lattice simulations to analyze the mechanism of supercomplex (SC) formation in mitochondria. The results highlight the importance of membrane deformation as one of the major driving forces for the SC formation, which is not entirely surprising given prior work on membrane protein assembly, but certainly of major mechanistic significance for the specific systems of interest.

Strengths:

The combination of complementary approaches, including an interesting (re)analysis of cryo-EM data, is particularly powerful, and might be applicable to the analysis of related systems. The calculations also revealed that SC formation has interesting impacts on the structural and dynamical (motional correlation) properties of the individual protein components, suggesting further functional relevance of SC formation. In the revision, the authors further clarified and quantified their analysis of membrane responses, leading to further insights into membrane contributions. They have also toned down the decomposition of membrane contributions into enthalpic and entropic contributions, which is difficult to do. Overall, the study is rather thorough, highly creative and the impact on the field is expected to be significant.

Weaknesses:

Upon revision, I believe the weakness identified in previous work has been largely alleviated.

Reviewer #1 (Public review):

Circannual timing is a phylogenetically widespread phenomenon in long-lived organisms and is central to the seasonal regulation of reproduction, hibernation, migration, fur color changes, body weight, and fat deposition in response to photoperiodic changes. Photoperiodic control of thyroid hormone T3 levels in the hypothalamus dictates this timing. However, the mechanisms that regulate these changes are not fully understood. The study by Stewart et al. reports that hypothalamic iodothyronine deiodinase 3 (Dio3), the major inactivator of the biologically active thyroid hormone T3, plays a critical role in circannual timing in the Djungarian hamster. Overall, the study yields important results for the field and is well-conducted, with the exception of the CRISPR/Cas9 manipulation.

Comments on revisions:

The authors have satisfactorily addressed all my comments. I no longer have concerns about the CRISPR/Cas9 experiments which have been conducted properly and are now reported appropriately.

Reviewer #2 (Public review):

Summary:

Several animals and plants adjust their physiology and behavior to seasons. These changes are timed to precede the seasonal transitions, maximizing chances of survival and reproduction. The molecular mechanisms used for this process are still unclear. Studies in mammals and birds have shown that the expression of deiodinase type-1, 2, and 3 (Dio1, 2, 3) in the hypothalamus spikes right before the transition to winter phenotypes. Yet, whether this change is required or an unrelated product of the seasonal changes has not been shown, particularly because of the genetic intractability of the animal models used to study seasonality. Here, the authors show for the first time a direct link between Dio3 expression and the modulation of circannual rhythms.

The work is concise and presents the data in a clear manner. The data is, for the most part, solid and supports the author's main claims. The use of CRISPR is a clear advancement in the field. This is, to my knowledge, the first study showing a clear (i.e., causal) role of Dio3 in the circannual rhythms in mammals. Having established a clear component of the circannual timing and a clean approach to address causality, this study could serve as a blueprint to decipher other components of the timing mechanism. It could also help to enlighten the elusive nature of the upstream regulators, in particular, on how the integration of day length takes place, maybe within the components in the Pars tuberalis, and the regulation of tanycytes.

Comments on revisions:

The authors have provided an improved version of the manuscript, particularly clarifying the methodology for their CRISPR manipulations. I am satisfied with their response and commend the authors for their work.

Reviewer #1 (Public review):

Summary:

The goal of the manuscript was to determine if strenuous exercise negatively impacted regeneration. Indeed, the major conclusion of the manuscript is that elevated exercise during the early stages of regeneration compromises the regenerative process. The authors further conclude that regeneration is disrupted due to defects in blastema formation, which is caused by impaired HA deposition and reduced active (nuclear) Yap.

Strengths:

(1) The paradigm of elevated exercise disrupting ECM and regeneration is significant, and provides an experimental model to better understand connections between the ECM and cell/tissue activities.

(2) The conclusion that exercise intensity correlates with defects in regeneration is supported.

(3) The demonstration for the requirement for HA is well supported via transcriptomics and multiple independent strategies to manipulate HA levels.

(4) The demonstration that nuclear Yap depends on the amount of HA is well-supported.

Weaknesses:

(1) The authors conclude throughout the manuscript that "blastema formation" is disrupted, but they do not provide any insights into how blastema formation is disrupted (reduced de-differentiation? reduced cell migration? both?). While they show that there are fewer dividing cells, the timing of exercise is prior to outgrowth. So, the effect of dividing cells is likely secondary, which is not considered (or not clearly explained).

(2) The authors conclude that patterning is affected, but their analyses of patterns (bifurcations) are very limited. It is also not clear if patterning is believed to be affected by a common exercise-induced mechanism or a different exercise-induced mechanism (or by a secondary mechanism).

(3) The significance of HA in regeneration has been shown before in zebrafish fins, as well as in a handful of other models of regeneration. Although largely cited, explaining some of this work in more detail would give the reader a better picture of how HA is believed to promote regeneration. It may also highlight some emerging questions about the role of HA in regeneration that would permit a richer story and specific future directions.

(4) In general, parts of the text lack specificity/clarity, and in other cases, there seems to be contradictory information.

(5) Overall, many of the conclusions were well supported by the data, and this study is likely to provide a foundation for future research on the role of the ECM in tissue repair and regeneration. The main limitations were in connecting the experimental details with the specific processes required for regeneration, and in clearly explaining the findings.

Reviewer #2 (Public review):

In this study, Lewis et al. established a forced swimming paradigm to investigate how mechanical loading influences caudal fin regeneration. They found that forced exercise impaired the normally robust regeneration process, particularly in the peripheral/lateral ray regions. Transcriptomic profiling of exercised fish further revealed that extracellular matrix (ECM) gene programs were affected, and the authors provided evidence that disruption of hyaluronic acid (HA) synthesis may underlie this impairment. While the question of how mechanical loading impacts tissue regeneration is rather intriguing and the study nicely demonstrates a role for HA in fin regeneration, I have some concerns regarding the specificity of forced exercise as a model for mechanical loading, and thus the causal link between mechanical loading and HA synthesis disruption.

Major concerns:

(1) Forced exercise as a model for mechanical loading.

Is it possible that the forced exercise paradigm imposes greater shear stress on the peripheral/lateral ray regions, thereby disrupting the fragile wound epidermis at this early stage and consequently affecting the regeneration program and phenotypes? The wound epidermis appears visibly torn or disrupted (Figure 1A, right panel, 2 dpa image). Given the critical role of the wound epidermis in blastema establishment and fin regeneration (PMID: 11002347; PMID: 34038742; PMID: 26305099), could this be a simpler explanation to consider, instead of the proposed role of mechanical loading and cryptic mechanical sensors?

(2) The general effect of HA on fin regeneration.

While the authors convincingly show that exogenous HA can ameliorate fin regeneration defects caused by forced exercise (Figure S7), it would be important to include a control examining the effect of HA supplementation in non-exercised animals. Does HA act as a general enhancer of fin regeneration even in the absence of forced exercise? Additionally, please consider merging Figure S7 (HA supplement) with Figure 5 (HA depletion) to improve clarity for readers.

(3) Proper annotation of the investigated ray regions.

As the authors clearly demonstrate that peripheral and central rays respond differently to forced exercise, it is important to explicitly define the regions corresponding to these rays. Do the peripheral rays refer to the dorsal-most and ventral-most rays among the 18-20 rays across the amputation plane? Which rays are considered central? Please clarify.

Reviewer #3 (Public review):

Summary:

In the submitted article by Lewis et al., the authors investigate how mechanical stimulation influences organ regeneration using the well-characterized zebrafish caudal fin regeneration model. Using a swim flume and a 30min/day exercise regime, the authors found that exercise during the establishment of the blastema reduced regeneration and led to skeletal deformations. Transcriptional profiling of regenerated caudal fin tissue revealed reduced expression of extracellular matrix-associated genes, which were found to be expressed by blastemal fibroblast and osteoblast lineage cells.

Downregulated genes included hyaluronic acid synthases 1 and 2; accordingly, hyaluronic acid levels were found to be reduced in regenerating fins exposed to exercise. The link between regeneration and HA was further confirmed through HA depletion and HA overexpression experiments, which showed a reduction in blastema size and partial rescue of blastema formation, respectively. The authors further show that HA levels, as well as the extent of mechanical loading correlate with nuclear localization of the mechanotransducer Yap and conclude that biomechanical forces play a significant role during regeneration through regulation of HA levels in the ECM and therewith regulation of YAP downstream signaling.

This work expands our understanding of the biochemical signaling connecting biomechanical forces with tissue regeneration. The conclusions are well supported by the data.

Strengths:

(1) Analysis is performed in multiple replicate experimental groups and shows the robust response to the experimental conditions.

(2) The link of HA levels to blastema formation was confirmed through HA overexpression and two different HA depletion experiments.

(3) The use of a previously established fin regeneration single cell dataset does elegantly show the correlation of changes in gene expression levels and specific tissue types, which was further confirmed by in vivo imaging of cell type-specific transgenic lines.

Weaknesses:

Tissue sections stained with hematoxylin and eosin would be helpful to show the changes in tissue architecture more clearly.

Reviewer #1 (Public review):

In this manuscript, Qin and colleagues aim to delineate a neural mechanism by which the internal satiety levels modulate the intake of sugar solution. They identified a three-step neuropeptidergic system that downregulates the sensitivity of sweet-sensing gustatory sensory neurons in sated flies. First, neurons that release a neuropeptide Hugin (which is an insect homolog of vertebrate Neuromedin U (NMU)) are in an active state when the concentration of glucose is high. This activation does not require synaptic inputs, suggesting that Hugin-releasing neurons sense hemolymph glucose levels directly. Next, the Hugin neuropeptides activate Allatostatin A (AstA)-releasing neurons via one of Hugin's receptors, PK2-R1. Finally, the released AstA neuropeptide suppresses sugar response in sugar-sensing Gr5a-expressing gustatory sensory neurons through AstA-R1 receptor. Suppression of sugar response in Gr5a-expressing neurons reduces the fly's sugar intake motivation (measured by proboscis extension reflex). They also found that NMU-expressing neurons in the ventromedial hypothalamus (VMH) of mice (which project to the rostral nucleus of the solitary tract (rNST)) are also activated by high concentrations of glucose, independent of synaptic transmission, and that injection of NMU reduces the glucose-induced activity in the downstream of NMU-expressing neurons in rNST. These data suggest that the function of Hugin neuropeptide in the fly is analogous to the function of NMU in the mouse.

Generally, their central conclusions are well-supported by multiple independent approaches. The parallel study in mice adds a unique comparative perspective that makes the paper interesting to a wide range of readers. It is easier said than done: the rigor of this study, which effectively combined pharmacological and genetic approaches to provide multiple lines of behavioral and physiological evidence, deserves recognition and praise.

A perceived weakness is that the behavioral effects of the manipulations of Hugin and AstA systems are modest compared to a dramatic shift of sugar solution-induced PER (the behavioral proxy of sugar sensitivity) induced by hunger, as presented in Figure 1B and E. It is true that the mutation of tyrosine hydroxylase (TH), which synthesizes dopamine, does not completely abolish the hunger-induced PER change, but the remaining effect is small. Moreover, the behavioral effect of the silencing of the Hugin/AstA system (Figure Supplement 13B, C) is difficult to interpret, leaving a possibility that this system may not be necessary for shifting PER in starved flies. These suggest that the Hugin-AstA system accounts for only a minor part of the behavioral adaptation induced by the decreased sugar levels. Their aim to "dissect out a complete neural pathway that directly senses internal energy state and modulates food-related behavioral output in the fly brain" is likely only partially achieved. While this outcome is not a shortcoming of a study per se, the depth of discussion on the mechanism of interactions between the Hugin/AstA system and the other previously characterized molecular circuit mechanisms mediating hunger-induced behavioral modulation is insufficient for readers to appreciate the novelty of this study and future challenges in the field. In this context, authors are encouraged to confront a limitation of the study due to the lack of subtype-level circuit characterization, despite their intriguing finding that only a subtype of Hugin- and AstA-releasing neurons are responsive to the elevated level of bath-applied glucose.

Reviewer #2 (Public review):

Summary:

The question of how caloric and taste information interact and consolidate remains both active and highly relevant to human health and cognition. The authors of this work sought to understand how nutrient sensing of glucose modulates sweet sensation. They found that glucose intake activates hugin signaling to AstA neurons to suppress feeding, which contributes to our mechanistic understanding of nutrient sensation. They did this by leveraging the genetic tools of Drosophila to carry out nuanced experimental manipulations and confirmed the conservation of their main mechanism in a mammalian model. This work builds on previous studies examining sugar taste and caloric sensing, enhancing the resolution of our understanding.

Strengths:

Fully discovering neural circuits that connect body state with perception remains central to understanding homeostasis and behavior. This study expands our understanding of sugar sensing, providing mechanistic evidence for a hugin/AstA circuit that is responsive to sugar intake and suppresses feeding. In addition to effectively leveraging the genetic tools of Drosophila, this study further extends their findings into a mammalian model with the discovery that NMU neural signaling is also responsive to sugar intake.

Weaknesses:

The effect of Glut1 knockdown on PER in hugin neurons is modest, and does not show a clear difference between fed and starved flies as might be expected if this mechanism acts as a sensor of internal energy state. This could suggest that glucose intake through Glut1 may only be part of the mechanism.

Reviewer #3 (Public review):

Summary:

This study identifies a novel energy-sensing circuit in Drosophila and mice that directly regulates sweet taste perception. In flies, hugin+ neurons function as a glucose sensor, activated through Glut1 transport and ATP-sensitive potassium channels. Once activated, hugin neurons release hugin peptide, which stimulates downstream Allatostatin A (AstA)+ neurons via PK2-R1 receptors. AstA+ neurons then inhibit sweet-sensing Gr5a+ gustatory neurons through AstA peptide and its receptor AstA-R1, reducing sweet sensitivity after feeding. Disrupting this pathway enhances sweet taste and increases food intake, while activating the pathway suppresses feeding.

The mammalian homolog of neuromedin U (NMU) was shown to play an analogous role in mice. NMU knockout mice displayed heightened sweet preference, while NMU administration suppressed it. In addition, VMH NMU+ neurons directly sense glucose and project to rNST Calb2+ neurons, dampening sweet taste responses. The authors suggested a conserved hugin/NMU-AstA pathway that couples energy state to taste perception.

Strengths:

Interesting findings that extend from insects to mammals. Very comprehensive.

Weaknesses:

Coupling energy status to taste sensitivity is not a new story. Many pathways appear to be involved, and therefore, it raises a question as to how this hugin-AstA pathway is unique.

Reviewer #1 (Public review):

This study extends the previous interesting work of this group to address the potentially differential control of movement and posture. Their earlier work explored a broad range of data to make the case for a downstream neural integrator hypothesized to convert descending velocity movement commands into postural holding commands. Included in that data were observations from people with hemiparesis due to stroke. The current study uses similar data, but pushes into a different, but closely related direction, suggesting that these data may address the independence of these two fundamental components of motor control. The study makes observations about the different expression movement deficits during postural fixation and movement, and the different effect of force perturbations during these periods, consistent with their hypothesis that movement and postural control are separate motor functions. They speculate that the appearance of the stereotypic flexor synergies characteristic of stroke, are the result of a breakdown of this normal separation between the two control modes.

Comments on revisions:

I had only two very trivial comments in the previous version. One was simply a figure that was mistakenly not updated, and the other was the use of the terms "proximal" and "distal" to describe the location of a target. Both have been corrected.

Reviewer #2 (Public review):

The reported findings by Hadjiosif and colleagues address an important question in sensorimotor neuroscience related to the idea that movement and postural control are regulated by unique circuits. To explain the reported compromised postural control for stroke patients, the authors propose a conceptual framework that differentially weights corticospinal tract and reticulospinal tract for neurologically intact and stroke patients. Based on the currently reported findings and experimental design, the interpretation of the authors provides support to this idea.

The authors have done well to include a limitations paragraph in their discussion. While it is difficult to truly compare across many of the experimental conditions to draw any strong conclusions, the authors have included additional analyses and a limitations paragraph highlighting some weaknesses in the paper.

Reviewer #1 (Public review):

The authors aim to predict ecological suitability for transmission of highly pathogenic avian influenza (HPAI) using ecological niche models. This class of models identify correlations between the locations of species or disease detections and the environment. These correlations are then used to predict habitat suitability (in this work, ecological suitability for disease transmission) in locations where surveillance of the species or disease has not been conducted. The authors fit separate models for HPAI detections in wild birds and farmed birds, for two strains of HPAI (H5N1 and H5Nx) and for two time periods, pre- and post-2020. The authors also validate models fitted to disease occurrence data from pre-2020 using post-2020 occurrence data.

Reviewer #2 (Public review):

Summary:

The geographic range of highly pathogenic avian influenza cases changed substantially around the period 2020, and there is much interest in understanding why. Since 2020 the pathogen irrupted in the Americas and the distribution in Asia changed dramatically. This study aimed to determine which spatial factors (environmental, agronomic and socio-economic) explain the change in numbers and locations of cases reported since 2020 (2020--2023). That's a causal question which they address by applying correlative environmental niche modelling (ENM) approach to the avian influenza case data before (2015--2020) and after 2020 (2020--2023) and separately for confirmed cases in wild and domestic birds. To address their questions they compare the outputs of the respective models, and those of the first global model of the HPAI niche published by Dhingra et al 2016.

ENM is a correlative approach useful for extrapolating understandings based on sparse geographically referenced observational data over un- or under-sampled areas with similar environmental characteristics in the form of a continuous map. In this case, because the selected covariates about land cover, use, population and environment are broadly available over the entire world, modelled associations between the response and those covariates can be projected (predicted) back to space in the form of a continuous map of the HPAI niche for the entire world.

Strengths:

The authors are clear about expected bias in the detection of cases, such geographic variation in surveillance effort (testing of symptomatic or dead wildlife, testing domestic flocks) and in general more detections near areas of higher human population density (because if a tree falls in a forest and there is no-one there, etc), and take steps to ameliorate those. The authors use boosted regression trees to implement the ENM, which typically feature among the best performing models for this application (also known as habitat suitability models). They ran replicate sets of the analysis for each of their model targets (wild/domestic x pathogen variant), which can help produce stable predictions. Their code and data is provided, though I did not verify that the work was reproducible.

The paper can be read as a partial update to the first global model of H5Nx transmission by Dhingra and others published in 2016 and explicitly follows many methodological elements. Because they use the same covariate sets as used by Dhingra et al 2016 (including the comparisons of the performance of the sets in spatial cross-validation) and for both time periods of interest in the current work, comparison of model outputs is possible. The authors further facilitate those comparisons with clear graphics and supplementary analyses and presentation. The models can also be explored interactively at a weblink provided in text, though it would be good to see the model training data there too.

The authors' comparison of ENM model outputs generated from the distinct HPAI case datasets is interesting and worthwhile, though for me, only as a response to differently framed research questions.

Weaknesses:

This well-presented and technically well-executed paper has one major weakness to my mind. I don't believe that ENM models were an appropriate tool to address their stated goal, which was to identify the factors that "explain" changing HPAI epidemiology.

Comments on the revised version from the editors:

We are extremely grateful to the authors for presenting a thoughtful and respectful point by point rebuttal to the prior reviewers' comments. After reading these comments carefully, we conclude that there is a straightforward strongly held disagreement between the authors and the reviewers as to the validity of the methods (Ecological Niche Modeling) for this particular dataset. Please note that the two reviewers have substantial expertise in the area of Ecologic Niche Modeling. We elected not to reach out to the reviewers for a third set of comments as we do not think their overall opinions will change, and wish to be respectful of their time.

To allow readers a balanced assessment of the paper, we intend to publish your rebuttal comments in full. It is our hope that interested readers can weigh both sides of this respectful and interesting debate in order to reach their own conclusions about the strength of evidence presented in your manuscript.

Reviewer #1 (Public review):

Summary:

In this submitted manuscript, Lu, Tang, and colleagues implement a novel serial perturbation paradigm during speech to isolate the effects of sensory and motor processes on compensation. They perform three main studies: in the first study, they validate their method by randomly perturbing pitch in a series of produced vowels. They demonstrate that the amount of perturbation is driven (in part) by the previous trial's amount of motor compensation applied as opposed to the sensory perturbation. In the second experiment, they found that this effect carries over to single vowel words, but the effect was much weaker when different words were produced. Thirdly, the authors reproduce these findings in a more linguistically relevant way (during sentences) and show that the previously shown compensation effect only occurs within syntactic structures and not across them, suggesting an interplay between sensorimotor systems and linguistic structure processing.

Strengths:

Overall, this is a very unique study and strikes me as being potentially quite impactful. The authors have performed a large number of experiments to validate their findings that provide novel insights into the processes underlying compensation during speech production. These findings are also likely to produce new avenues for studying the neural mechanisms that support these processes.

Weaknesses:

While the authors go to great lengths to disassociate the serial effects of sensory and motor compensation, which is commendable, one weakness is that they are intrinsically linked (motor actions produce sensory consequences). Therefore, there is no obvious way to decouple them for the purposes of investigation. It would be beneficial to discuss future research that could further disentangle these factors.

Reviewer #2 (Public review):

This study aims to disentangle the contribution of sensory and motor processes (mapped onto the inverse and forward components of speech motor control models like DIVA) to production changes as a result of altered auditory feedback. After five experiments, the authors conclude that it is the motor compensation on the previous trial, and not the sensory error, that drives compensatory responses in subsequent trials.

Assessment:

The goal of this paper is great, and the question is timely. Quite a bit of work has gone into the study, and the technical aspects are sound. That said, I just don't understand how the current design can accomplish what the authors have set as their goal. This may, of course, be a misunderstanding on my part, so I'll try to explain my confusion below. If it is indeed my mistake, then I encourage the authors to dedicate some space to unpacking the logic in the Introduction, which is currently barely over a page long. They should take some time to lay out the logic of the experimental design and the dependent and independent variables, and how this design disentangles sensory and motor influences. Then clearly discuss the opposing predictions supporting sensory-driven vs. motor-driven changes. Given that I currently don't understand the logic and, consequently, the claims, I will focus my review on major points for now.

Main issues

(1) Measuring sensory change. As acknowledged by the authors, making a motor correction as a function of altered auditory feedback is an interactive process between sensory and motor systems. However, one could still ask whether it is primarily a change to perception vs. a change to production that is driving the motor correction. But to do this, one has to have two sets of measurements: (a) perceptual change, and (b) motor change. As far as I understand, the study has the latter (i.e., C), but not the former. Instead, the magnitude of perceptual change is estimated through the proxy of the magnitude of perturbation (P), but the two are not the same; P is a physical manipulation; perceptual change is a psychological response to that physical manipulation. It is theoretically possible that a physical change does not cause a psychological change, or that the magnitude of the two does not match. So my first confusion centers on the absence of any measure of sensory change in this study.

To give an explicit example of what I mean, consider a study like Murphy, Nozari, and Holt (2024; Psychonomic Bulletin & Review). This work is about changes to production as a function of exposure to other talkers' acoustic properties - rather than your own altered feedback - but the idea is that the same sensory-motor loop is involved in both. When changing the acoustic properties of the input, the authors obtain two separate measures: (a) how listeners' perception changes as a function of this physical change in the acoustics of the auditory signal, and (b) how their production changes. This allows the authors to identify motor changes above and beyond perceptual changes. Perhaps making a direct comparison with this study would help the reader understand the parallels better.

(2) A more fundamental issue for me is a theoretical one: Isn't a compensatory motor change ALWAYS a consequence of a perceptual change? I think it makes sense to ask, "Does a motor compensation hinge on a previous motor action or is sensory change enough to drive motor compensation?" This question has been asked for changed acoustics for self-produced speech (e.g., Hantzsch, Parrell, & Niziolek, 2022) and other-produced speech (Murphy, Holt, & Nozari, 2025), and in both cases, the answer has been that sensory changes alone are, in fact, sufficient to drive motor changes. A similar finding has been reported for the role of cerebellum in limb movements (Tseng et al., 2007), with a similar answer (note that in that study, the authors explicitly talk about "the addition" of motor corrections to sensory error, not one vs. the other as two independent factors. So I don't understand a sentence like "We found that motor compensation, rather than sensory errors, predicted the compensatory responses in the subsequent trials", which views motor compensations and sensory errors as orthogonal variables affecting future motor adjustments.

In other words, there is a certain degree of seriality to the compensation process, with sensory changes preceding motor corrections. If the authors disagree with this, they should explain how an alternative is possible. If they mean something else, a comparison with the above studies and explaining the differences in positions would greatly help.

(3) Clash with previous findings. I used the examples in point 2 to bring up a theoretical issue, but those examples are also important in that all three of them reach a conclusion compatible with one another and different from the current study. The authors do discuss Tseng et al.'s findings, which oppose their own, but dismiss the opposition based on limb vs. articulator differences. I don't find the authors reasoning theoretically convincing here, but more importantly, the current claims also oppose findings from speech motor studies (see citations in point 2), to which the authors' arguments simply don't apply. Strangely, Hantzsch et al.'s study has been cited a few times, but never in its most important capacity, which is to show that speech motor adaptation can take place after a single exposure to auditory error. Murphy et al. report a similar finding in the context of exposure to other talkers' speech.

If the authors can convincingly justify their theoretical position in 2, the next step would be to present a thorough comparison with the results of the three studies above. If indeed there is no discrepancy, this comparison would help clarify it.

References

Hantzsch, L., Parrell, B., & Niziolek, C. A. (2022). A single exposure to altered auditory feedback causes observable sensorimotor adaptation in speech. eLife, 11, e73694.

Murphy, T. K., Nozari, N., & Holt, L. L. (2024). Transfer of statistical learning from passive speech perception to speech production. Psychonomic Bulletin & Review, 31(3), 1193-1205.

Murphy, T. K., Holt, L. L. & Nozari, N. (2025). Exposure to an Accent Transfers to Speech Production in a Single Shot. Preprint available at: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=5196109.

Tseng, Y. W., Diedrichsen, J., Krakauer, J. W., Shadmehr, R., & Bastian, A. J. (2007). Sensory prediction errors drive cerebellum-dependent adaptation of reaching. Journal of neurophysiology, 98(1), 54-62.

Reviewer #1 (Public review):

Summary:

Calle-Schuler et. al. reconstruct all the pre- and post-synaptic neurons to the bristle mechanosensory neurons on the adult fly head to understand how neural circuits determine the sequential motor patterns during fly grooming. They find that most presynaptic neurons, interneurons, and excitatory postsynaptic neurons are also somatotopically organized, such that each neuron is more connected to bristles mechanosensory neurons that are closer on the head and less connected to bristles mechanosensory neurons that are further away. These include the direct BMN-BMN circuits, excitatory interneurons, as well as the inhibitory networks. They also identify that the entire hemi-lineage 23b forms excitatory postsynaptic circuits with BMNs, highlighting how these circuits and hence their function could be developmentally determined.

Strengths:

This is a complete map of all the neurons that make 5 or more pre- and post-synaptic connections of the fly head BMNs. Using this, the authors have identified various trends, such as ascending neurons providing most of the GABAergic inhibitory input, which could provide the presynaptic inhibition essential for the parallel model for sequential grooming generation. Moreover, they identified that the entire cholinergic hemilineage 23b is postsynaptic to BMNs.

Weaknesses:

Although the somatotropic organization is an elegant mechanism to generate sequential motor sequences during grooming, none of the analyses in the paper directly demonstrate that this somatotropic connectivity is sufficient to generate hierarchical suppression and reconstruct the grooming sequence. If somatotropic organization is sufficient, then hierarchical clustering should recover the grooming sequence. Their detailed connectome enables the authors to test if some networks are more crucial for grooming sequence than others: to what extent can each network individually (ascending neurons-BMN alone) or a combination (BMN-BMN, ascending-BMN, BMN-descending, etc.) recover the sequence observed during grooming. If all the pre- and post-synaptic neurons put together cannot explain the sequence, then the sequence is probably determined by individual synaptic strengths or other key downstream neurons.

Reviewer #2 (Public review):

Summary:

Schuler et al. present an extensive analysis of the synaptic connectivity of mechanosensory head bristles in the brain of Drosophila melanogaster. Based on the previously described set of bristle afferent neurons, (BMNs), located on the head, the study aims to provide a complete, quantitative assessment of all synaptic partners in the ventral brain. Activation of head bristles induces grooming behavior, which is hierarchically organized, and hypothesized to be grounded in a parallel cellular architecture in the central brain. The authors found evidence that, at the synaptic level, neurons downstream of the BMN afferents, namely the postsynaptic LB23 interneurons and recurrent GABAergic neurons (involved in sensory gain control), are organized in parallel, following the somatotopic organization described for the BMN afferents. This study, therefore, represents an important step towards a better understanding of the cellular circuits that govern the hierarchical order of sequentially organized grooming behavior in Drosophila melanogaster.

The study is well done, the images are well designed and extensive in number, but the account is challenging to read and digest for the reader outside the Drosophila /connectome community. It is amazing what can be done with the connectome nowadays using the up-to-date FAFB dataset, the analytical and visual tools (as in FlyWire), in combination with known anatomy/physiology/behavior in DM. I suggest that the authors provide more detail on hemilineages, their relationship to the FAB connectome, the predicted neurotransmitter identity, and the use of statistical CatMAID tools used in some of the Figures.

A graphical summary at the end of the study would be very useful to highlight the important findings focusing on neuron populations identified in this study and their position in the hypothesized parallel central circuitry of BMNs.

Reviewer #3 (Public review):

Summary:

The authors set out to extend their previous mapping of Drosophila head mechanosensory neurons (Eichler et al., 2024) by reconstructing their full second-order connectome. Their aim is to reveal how bristle mechanosensory neurons (BMNs) interface with excitatory and inhibitory partners to generate location-specific grooming movements, and to identify the circuit motifs and developmental lineages that support this transformation.

Strengths:

The strengths of this work are clear. The authors present a comprehensive synaptic-resolution connectome for BMNs, identifying nearly all of their pre- and postsynaptic partners. This dataset reveals important circuit motifs:

(1) BMNs provide feedforward excitation to descending neurons, feedforward inhibition to interneurons, and are themselves strongly regulated by GABAergic presynaptic inhibition.

(2) These motifs together support the idea that BMN activity is locally gated and hierarchically suppressed, fitting well with known behavioural sequences of grooming.

(3) The study also shows that connectivity preserves somatotopy, such that BMNs from neighbouring bristle populations converge onto shared partners, while distant BMNs remain segregated.

(4) A developmental analysis reveals both primary and secondary partners, suggesting a layered scaffold plus adult-specific elaborations.

(5) Finally, the identification of hemilineage 23b (LB23) as a core postsynaptic pathway - incorporating previously described antennal grooming neurons (aBN2) - provides a striking link between developmental lineage, anatomical connectivity, and behavioral output.

(6) Together, the dataset represents a valuable resource for the neuroscience community and a foundation for future functional studies.

Weaknesses:

There are also some weaknesses that mostly only limit clarity.

(1) The writing is dense, with results often presented in a cryptic fashion and the functional implications deferred to the discussion. As a result, the significance of circuit motifs such as BMN→motor or reciprocal inhibitory loops is sometimes buried, rather than highlighted when first described.

(2) Some assumptions require more explanation for non-specialist readers - for example, how bristle identity is inferred in EM in the absence of cuticular structures, or what is meant by "ascending" and "descending" in a dataset that does not include the ventral nerve cord. While some of this comes from the earlier paper, it would help readers of this one to explain this.

(3) Visualization choices also sometimes obscure key conclusions: network graphs can be visually appealing but do not clearly convey somatotopy or BMN-type differences; heatmaps or region-level matrices would make the parallel, block-like organization of the circuit more evident.

(4) The data might also speak to roles beyond grooming (e.g., mechanosensory modulation of posture or feeding), and a brief acknowledgement of this would broaden the impact.

(5) The restriction to one hemisphere should be explicitly acknowledged as a limitation when framing this as a 'comprehensive' connectome.

Overall, the authors achieve their main goal: they convincingly show that BMNs connect into parallel, somatotopically organized pathways, with LB23 providing a key lineage-based link from sensory input to grooming output. The dataset is carefully analyzed, and while the presentation could be streamlined, the connectome will be a valuable resource for researchers studying sensory processing, motor control, and the logic of circuit organization.

Reviewer #1 (Public review):

The manuscript presents a compelling new in vitro system based on isogenic co-cultures of human iPSC-derived hepatocytes and macrophages, enabling the modelling of hepatic immune responses with unprecedented physiological relevance. The authors show that co-culture leads to enhanced maturation of hepatocytes and tissue-resident macrophage identity, which cannot be achieved through conditioned media alone. Using this system, they functionally validate immune-driven hepatotoxic responses to a panel of drugs and compare the system's predictive power to that of monocyte-derived macrophages. The results underscore the necessity of macrophage-hepatocyte crosstalk for accurate modelling of liver inflammation and drug toxicity in vitro.

The manuscript is clearly written and addresses a key limitation in liver organoid systems: the lack of immune complexity and tissue-specific macrophage imprinting. Nevertheless, several conclusions would benefit from a more careful interpretation of the data, and some important controls or explanations are missing, particularly in the flow cytometry gating strategies, stress marker validation, and cluster interpretations.

Strengths:

(1) Novelty and Relevance: The study presents a highly innovative co-culture system based on isogenic human iPSCs, addressing an unmet need in modelling immune-mediated hepatotoxicity.

(2) Mechanistic Insight: The reciprocal reprogramming between iHeps and iMacs, including induction of KC-specific pathways and hepatocyte maturation markers, is convincingly demonstrated.

(3) Functional Readouts: The application of the model to detect IL-6 responses to hepatotoxic compounds enhances its translational relevance.

Weaknesses:

(1) Several key claims, particularly those derived from PCA plots and DEG analyses, are overinterpreted and require more conservative language or further validation.

(2) The purity of sorted hepatocytes and macrophages is not convincingly demonstrated; contamination across gates may confound transcriptomic readouts.

(3) Stress response genes and ER stress/apoptosis signatures are not properly assessed, despite being potentially activated in the system.

(4) Some figure panels and legends lack statistical annotations, and microscopy validation of morphological changes is missing.

(5) The co-culture model with monocyte-derived macrophages is not fully characterised, making comparisons less informative.

Reviewer #2 (Public review):

Summary:

This study builds on work by Glass and Guilliams showing that mouse Kupffer cells depend on the surrounding cells, including endothelium, hepatocytes, and stellate cells, for their identity. Herein, the authors extend the work to human systems. It nicely highlights why taking monocyte-derived macrophages and pretending they are Kupffer cells is simply misleading.

Strengths:

Many, including human cells, difficult culture assays, and important new data.

Weaknesses:

This reviewer identified minor queries only, rather than 'weaknesses' as such.

Reviewer #3 (Public review):

Summary:

In this study, the authors establish a human in vitro liver model by co-culturing induced hepatocyte-like cells (iHEPs) with induced macrophages (iMACs). Through flow cytometry-based sorting of cell populations at days 3 and 7 of co-culture, followed by bulk RNA sequencing, they demonstrate that bidirectional interactions between these two cell types drive functional maturation. Specifically, the presence of iMACs accelerates the hepatic maturation program of iHEPs, while contact-dependent cues from iHEPs enhance the acquisition of Kupffer cell identity in iMACs, indicating that direct cell-cell interactions are critical for establishing tissue-resident macrophage characteristics.

Functionally, the authors show that iMAC-derived Kupffer-like cells respond to pathological stimuli by producing interleukin-6 (IL-6), a hallmark cytokine of hepatic immune activation. When exposed to a panel of clinically relevant hepatotoxic drugs, the co-culture system exhibited concentration-dependent modulation of IL-6 secretion consistent with reported drug-induced liver injury (DILI) phenotypes. Notably, this response was absent when hepatocytes were co-cultured with monocyte-derived macrophages from peripheral blood, underscoring the liver-specific phenotype and functional relevance of the iMAC-derived Kupffer-like cells. Collectively, the study proposes this co-culture platform as a more physiologically relevant model for interrogating macrophage-hepatocyte crosstalk and assessing immune-mediated hepatotoxicity in vitro.

Strengths:

A major strength of this study lies in its systematic dissection of cell-cell interactions within the co-culture system. By isolating each cell type following co-culture and performing comprehensive transcriptomic analyses, the authors provide direct evidence of bidirectional crosstalk between iMACs and iHEPs. The comparison with single-culture controls is particularly valuable, as it clearly demonstrates how co-culture enhances functional maturation and lineage-specific gene expression in both cell types. This approach allows for a more mechanistic understanding of how hepatocyte-macrophage interactions contribute to the acquisition of tissue-specific phenotypes.

Weaknesses:

(1) Overreliance on bulk RNA-seq data:

The primary evidence supporting cell maturation is derived from bulk RNA sequencing, which has inherent limitations in resolving heterogeneous cellular states and functional maturation. The conclusions regarding hepatocyte maturation are based largely on increased expression of a subset of CYP genes and decreased AFP levels - markers that, while suggestive, are insufficient on their own to substantiate functional maturation. Additional phenotypic or functional assays (e.g., metabolic activity, protein-level validation) would significantly strengthen these claims.

(2) Insufficient characterization of input cell populations:

The manuscript lacks adequate validation of the cellular identities prior to co-culture. Although the authors reference previously published protocols for generating iHEPs and iMACs, it remains unclear whether the cells used in this study faithfully retain expected lineage characteristics. For example, hepatocyte preparations should be characterized by flow cytometry for ALB and AFP expression, while iMACs should be assessed for canonical macrophage markers such as CD45, CD11b, and CD14 before co-culture. Without these baseline data, it is difficult to interpret the magnitude or significance of any co-culture-induced changes.

(3) Quantitative assessment of IL-6 production is insufficient:

The analysis of drug-induced IL-6 responses is based primarily on relative changes compared to control conditions. However, percentage changes alone are inadequate to capture the biological relevance of these responses. Absolute cytokine production levels - particularly in response to LPS stimulation - should be reported and directly compared to PBMC-derived macrophages to determine whether iMAC-derived Kupffer-like cells exhibit enhanced cytokine output. Moreover, the Methods section should clearly describe how ELISA results were normalized or corrected to account for potential differences in cell number, viability, or culture conditions.

(4) Unclear mechanistic interpretation of IL-6 modulation:

The observed changes in IL-6 production upon drug treatment cannot be interpreted solely as evidence of Kupffer cell-specific functionality. For instance, IL-6 suppression by NSAIDs such as diclofenac is well known to result from altered prostaglandin synthesis due to COX inhibition, while leflunomide's effects are linked to metabolite-induced modulation of immune cell proliferation and broader cytokine networks. These mechanisms are distinct from Kupffer cell identity and may not directly reflect liver-specific macrophage function. Consequently, changes in IL-6 secretion alone - particularly without additional mechanistic evidence or analysis of other cytokines - are insufficient to conclude that co-culture with hepatocytes drives the acquisition of bona fide Kupffer cell maturity.

Reviewer #1 (Public review):

Summary:

The presented study by Centore and colleagues investigates the inhibition of BAF chromatin remodeling complexes. The study is well written and includes comprehensive datasets, including compound screens, gene expression analysis, epigenetics, as well as animal studies. This is an important piece of work for the uveal melanoma research field, and sheds light on a new inhibitor class, as well as a mechanism that might be exploited to target this deadly cancer for which no good treatment options exist.

Strengths:

This is a comprehensive and well-written study.

Reviewer #2 (Public review):

Summary:

The authors generate an optimized small molecule inhibitor of SMARCA2/4 and test it in a panel of cell lines. All uveal melanoma (UM) cell lines in the panel are growth inhibited by the inhibitor making the focus of the paper. This inhibition is correlated with loss of promoter occupancy of key melanocyte transcription factors e.g. SOX10. SOX10 overexpression and a point mutation in SMARCA4 can rescue growth inhibition exerted by the SMARCA2/4 inhibitor. Treatment of a UM xenograft model results in growth inhibition and regression which correlates with reduced expression of SOX10 but not discernible toxicity in the mice. Collectively, the data suggest a novel treatment of uveal melanoma.

Strengths:

There are many strengths of the study, including the strong challenge of the on-target effect, the assays used and the mechanistic data. The results are compelling as are the effects of the inhibitor. The in vivo data is dose-dependent and doses are low enough to be meaningful and associated with evidence of target engagement.

Reviewer #3 (Public review):

Summary:

This manuscript reports the discovery of new compounds that selectively inhibit SMARCA4/SMARCA2 ATPase activity and have pronounced effects on uveal melanoma cell proliferation. They induce apoptosis and suppress tumor growth, with no toxicity in vivo. The report provides biological significance by demonstrating that the drugs alter chromatin accessibility at lineage specific gene enhancer regions and decrease expression of lineage specific genes, including SOX10 and SOX10 target genes.

Strengths:

The study provides compelling evidence for the therapeutic use of these compounds and does a thorough job at elucidating the mechanisms by which the drugs work. The study will likely have a high impact on the chromatin remodeling and cancer fields. The datasets will be highly useful to these communities.

[Editors' note: The authors have addressed all of the outstanding issues.]

Reviewer #1 (Public review):

Summary:

In this manuscript, the authors performed an integration of 48 scRNA-seq public datasets and created a single-cell transcriptomic atlas for AML (222 samples comprising 748,679 cells). This is important since most AML scRNA-seq studies suffer from small sample size coupled with high heterogeneity. They used this atlas to further dissect AML with t(8;21) (AML-ETO/RUNX1-RUNX1T1), which is one of the most frequent AML subtypes in young people. In particular, they were able to predict Gene Regulatory Networks in this AML subtype using pySCENIC, which identified the paediatric regulon defined by a distinct group of hematopoietic transcription factors (TFs) and the adult regulon for t(8;21). They further validated this in bulk RNA-seq with AUCell algorithm and inferred prenatal signature to 5 key TFs (KDM5A, REST, BCLAF1, YY1, and RAD21), and the postnatal signature to 9 TFs (ENO1, TFDP1, MYBL2, KLF1, TAGLN2, KLF2, IRF7, SPI1, and YXB1). They also used SCENIC+ to identify enhancer-driven regulons (eRegulons), forming an eGRN, and found that prenatal origin shows a specific HSC eRegulon profile, while a postnatal shows a GMP profile. They also did an in silico perturbation and found AP-1 complex (JUN, ATF4, FOSL2), P300 and BCLAF1 as important TFs to induce differentiation. Overall, I found this study very important in creating a comprehensive resource for AML research.

Strengths:

• The generation of an AML atlas integrating multiple datasets with almost 750K cells will further support the community working on AML

• Characterisation of t(8;21) AML proposes new interesting leads.

• The t(8;21) TFs/regulons identified from any of the single dataset are not complete and now the authors showed that the increase in the number of cells that allowed identification of novel ones.

Comments on revisions:

In the revised version of the manuscript, the authors addressed all my comments.

Reviewer #1 (Public review):

Summary:

Noell et al have presented a careful study of the dissociation kinetics of Kinesin (1,2,3) classes of motors moving in vitro on a microtubule. These motors move against the opposing force from a ~1 micron DNA strand (DNA tensiometer) that is tethered to the microtubule and also bound to the motor via specific linkages (Figure 1A). The authors compare the time for which motors remain attached to the microtubule when they are tethered to the DNA, versus when they are not. If the former is longer, the interpretation is that the force on the motor from the stretched DNA (presumed to be working solely along the length of the microtubule) causes the motor's detachment rate from the microtubule to be reduced. Thus, the specific motor exhibits "catch-bond" like behaviour.

Strengths:

The motivation is good - to understand how kinesin competes against dynein through the possible activation of a catch bond. Experiments are well done, and there is an effort to model the results theoretically.

Weaknesses:

The motivation of these studies is to understand how kinesin (1/2/3) motors would behave when they are pitted in a tug of war against dynein motors as they transport cargo in a bidirectional manner on microtubules. Earlier work on dynein and kinesin motors using optical tweezers has suggested that dynein shows a catch bond phenomenon, whereas such signatures were not seen for kinesin. Based on their data with the DNA tensiometer, the authors would like to claim that (i) Kinesin1 and Kinesin2 also show catch-bonding and (ii) the earlier results using optical traps suffer from vertical forces, which complicates the catch-bond interpretation.

While the motivation of this work is reasonable, and the experiments are careful, I find significant issues that the authors have not addressed:

(1) Figure 1B shows the PREDICTED force-extension curve for DNA based on a worm-like chain model. Where is the experimental evidence for this curve? This issue is crucial because the F-E curve will decide how and when a catch-bond is induced (if at all it is) as the motor moves against the tensiometer. Unless this is actually measured by some other means, I find it hard to accept all the results based on Figure 1B.

(2) The authors can correct me on this, but I believe that all the catch-bond studies using optical traps have exerted a load force that exceeds the actual force generated by the motor. For example, see Figure 2 in reference 42 (Kunwar et al). It is in this regime (load force > force from motor) that the dissociation rate is reduced (catch-bond is activated). Such a regime is never reached in the DNA tensiometer study because of the very construction of the experiment. I am very surprised that this point is overlooked in this manuscript. I am therefore not even sure that the present experiments even induce a catch-bond (in the sense reported for earlier papers).

(3) I appreciate the concerns about the Vertical force from the optical trap. But that leads to the following questions that have not at all been addressed in this paper:

(i) Why is the Vertical force only a problem for Kinesins, and not a problem for the dynein studies?

(ii) The authors state that "With this geometry, a kinesin motor pulls against the elastic force of a stretched DNA solely in a direction parallel to the microtubule". Is this really true? What matters is not just how the kinesin pulls the DNA, but also how the DNA pulls on the kinesin. In Figure 1A, what is the guarantee that the DNA is oriented only in the plane of the paper? In fact, the DNA could even be bending transiently in a manner that it pulls the kinesin motor UPWARDS (Vertical force). How are the authors sure that the reaction force between DNA and kinesin is oriented SOLELY along the microtubule?

(4) For this study to be really impactful and for some of the above concerns to be addressed, the data should also have included DNA tensiometer experiments with Dynein. I wonder why this was not done?

While I do like several aspects of the paper, I do not believe that the conclusions are supported by the data presented in this paper for the reasons stated above.

Reviewer #2 (Public review):

Summary:

To investigate the detachment and reattachment kinetics of kinesin-1, 2, and 3 motors against loads oriented parallel to the microtubule, the authors used a DNA tensiometer approach comprising a DNA entropic spring attached to the microtubule on one end and a motor on the other. They found that for kinesin-1 and kinesin-2, the dissociation rates at stall were smaller than the detachment rates during unloaded runs. With regard to the complex reattachment kinetics found in the experiments, the authors argue that these findings were consistent with a weakly-bound 'slip' state preceding motor dissociation from the microtubule. The behavior of kinesin-3 was different and (by the definition of the authors) only showed prolonged "detachment" rates when disregarding some of the slip events. The authors performed stochastic simulations that recapitulate the load-dependent detachment and reattachment kinetics for all three motors. They argue that the presented results provide insight into how kinesin-1, -2, and -3 families transport cargo in complex cellular geometries and compete against dynein during bidirectional transport.

Strengths:

The present study is timely, as significant concerns have been raised previously about studying motor kinetics in optical (single-bead) traps where significant vertical forces are present. Moreover, the obtained data are of high quality, and the experimental procedures are clearly described.

Weaknesses:

However, in the present version of the manuscript, the conclusions drawn from the experiments, the overall interpretation of the results, and the novelty over previous reports appear less clear.

Major comments:

(1) The use of the term "catch bond" is misleading, as the authors do not really mean consistently a catch bond in the classical sense (i.e., a protein-protein interaction having a dissociation rate that decreases with load). Instead, what they mean is that after motor detachment (i.e., after a motor protein dissociating from a tubulin protein), there is a slip state during which the reattachment rate is higher as compared to a motor diffusing in solution. While this may indeed influence the dynamics of bidirectional cargo transport (e.g., during tug-of-war events), the used terms (detachment (with or without slip?), dissociation, rescue, ...) need to be better defined and the results discussed in the context of these definitions. It is very unsatisfactory at the moment, for example, that kinesin-3 is at first not classified as a catch bond, but later on (after tweaking the definitions) it is. In essence, the typical slip/catch bond nomenclature used for protein-protein interaction is not readily applicable for motors with slippage.

(2) The authors define the stall duration as the time at full load, terminated by >60 nm slips/detachments. Isn't that a problem? Smaller slips are not detected/considered... but are also indicative of a motor dissociation event, i.e., the end of a stall. What is the distribution of the slip distances? If the slip distances follow an exponential decay, a large number of short slips are expected, and the presented data (neglecting those short slips) would be highly distorted.

(3) Along the same line: Why do the authors compare the stall duration (without including the time it took the motor to reach stall) to the unloaded single motor run durations? Shouldn't the times of the runs be included?

(4) At many places, it appears too simple that for the biologically relevant processes, mainly/only the load-dependent off-rates of the motors matter. The stall forces and the kind of motor-cargo linkage (e.g., rigid vs. diffusive) do likely also matter. For example: "In the context of pulling a large cargo through the viscous cytoplasm or competing against dynein in a tug-of-war, these slip events enable the motor to maintain force generation and, hence, are distinct from true detachment events." I disagree. The kinesin force at reattachment (after slippage) is much smaller than at stall. What helps, however, is that due to the geometry of being held close to the microtubule (either by the DNA in the present case or by the cargo in vivo) the attachment rate is much higher. Note also that upon DNA relaxation ,the motor is likely kept close to the microtubule surface, while, for example, when bound to a vesicle, the motor may diffuse away from the microtubule quickly (e.g., reference 20).

(5) Why were all motors linked to the neck-coil domain of kinesin-1? Couldn't it be that for normal function, the different coils matter? Autoinhibition can also be circumvented by consistently shortening the constructs.

(6) I am worried about the neutravidin on the microtubules, which may act as roadblocks (e.g. DOI: 10.1039/b803585g), slip termination sites (maybe without the neutravidin, the rescue rate would be much lower?), and potentially also DNA-interaction sites? At 8 nM neutravidin and the given level of biotinylation, what density of neutravidin do the authors expect on their microtubules? Can the authors rule out that the observed stall events are predominantly the result of a kinesin motor being stopped after a short slippage event at a neutravidin molecule?

(7) Also, the unloaded runs should be performed on the same microtubules as in the DNA experiments, i.e., with neutravidin. Otherwise, I do not see how the values can be compared.

(8) If, as stated, "a portion of kinesin-3 unloaded run durations were limited by the length of the microtubules, meaning the unloaded duration is a lower limit." corrections (such as Kaplan-Meier) should be applied, DOI: 10.1016/j.bpj.2017.09.024.

(9) Shouldn't Kaplan-Meier also be applied to the ramp durations ... as a ramp may also artificially end upon stall? Also, doesn't the comparison between ramp and stall duration have a problem, as each stall is preceded by a ramp ...and the (maximum) ramp times will depend on the speed of the motor? Kinesin-3 is the fastest motor and will reach stall much faster than kinesin-1. Isn't it obvious that the stall durations are longer than the ramp duration (as seen for all three motors in Figure 3)?

(10) It is not clear what is seen in Figure S6A: It looks like only single motors (green, w/o a DNA molecule) are walking ... Note: the influence of the attached DNA onto the stepping duration of a motor may depend on the DNA conformation (stretched and near to the microtubule (with neutravidin!) in the tethered case and spherically coiled in the untethered case).

(11) Along this line: While the run time of kinesin-1 with DNA (1.4 s) is significantly shorter than the stall time (3.0 s), it is still larger than the unloaded run time (1.0 s). What do the authors think is the origin of this increase?

(12) "The simplest prediction is that against the low loads experienced during ramps, the detachment rate should match the unloaded detachment rate." I disagree. I would already expect a slight increase.

(13) Isn't the model over-defined by fitting the values for the load-dependence of the strong-to-weak transition and fitting the load dependence into the transition to the slip state?

(14) "When kinesin-1 was tethered to a glass coverslip via a DNA linker and hydrodynamic forces were imposed on an associated microtubule, kinesin-1 dissociation rates were relatively insensitive to loads up to ~3 pN, inconsistent with slip-bond characteristics (37)." This statement appears not to be true. In reference 37, very similar to the geometry reported here, the microtubules were fixed on the surface, and the stepping of single kinesin motors attached to large beads (to which defined forces were applied by hydrodynamics) via long DNA linkers was studied. In fact, quite a number of statements made in the present manuscript have been made already in ref. 37 (see in particular sections 2.6 and 2.7), and the authors may consider putting their results better into this context in the Introduction and Discussion. It is also noteworthy to discuss that the (admittedly limited) data in ref. 37 does not indicate a "catch-bond" behavior but rather an insensitivity to force over a defined range of forces.

Reviewer #3 (Public review):

Summary:

Several recent findings indicate that forces perpendicular to the microtubule accelerate kinesin unbinding, where perpendicular and axial forces were analyzed using the geometry in a single-bead optical trapping assay (Khataee and Howard, 2019), comparison between single-bead and dumbbell assay measurements (Pyrpassopoulos et al., 2020), and comparison of single-bead optical trap measurements with and without a DNA tether (Hensley and Yildiz, 2025).

Here, the authors devise an assay to exert forces along the microtubule axis by tethering kinesin to the microtubule via a dsDNA tether. They compared the behavior of kinesin-1, -2, and -3 when pulling against the DNA tether. In line with previous optical trapping measurements, kinesin unbinding is less sensitive to forces when the forces are aligned with the microtubule axis. Surprisingly, the authors find that both kinesin-1 and -2 detach from the microtubule more slowly when stalled against the DNA tether than in unloaded conditions, indicating that these motors act as catch bonds in response to axial loads. Axial loads accelerate kinesin-3 detachment. However, kinesin-3 reattaches quickly to maintain forces. For all three kinesins, the authors observe weakly attached states where the motor briefly slips along the microtubule before continuing a processive run.

Strengths:

These observations suggest that the conventional view that kinesins act as slip bonds under load, as concluded from single-bead optical trapping measurements where perpendicular loads are present due to the force being exerted on the centroid of a large (relative to the kinesin) bead, needs to be reconsidered. Understanding the effect of force on the association kinetics of kinesin has important implications for intracellular transport, where the force-dependent detachment governs how kinesins interact with other kinesins and opposing dynein motors (Muller et al., 2008; Kunwar et al., 2011; Ohashi et al., 2018; Gicking et al., 2022) on vesicular cargoes.

Weaknesses:

The authors attribute the differences in the behaviour of kinesins when pulling against a DNA tether compared to an optical trap to the differences in the perpendicular forces. However, the compliance is also much different in these two experiments. The optical trap acts like a ~ linear spring with stiffness ~ 0.05 pN/nm. The dsDNA tether is an entropic spring, with negligible stiffness at low extensions and very high compliance once the tether is extended to its contour length (Fig. 1B). The effect of the compliance on the results should be addressed in the manuscript.

Compared to an optical trapping assay, the motors are also tethered closer to the microtubule in this geometry. In an optical trap assay, the bead could rotate when the kinesin is not bound. The authors should discuss how this tethering is expected to affect the kinesin reattachment and slipping. While likely outside the scope of this study, it would be interesting to compare the static tether used here with a dynamic tether like MAP7 or the CAP-GLY domain of p150glued.

In the single-molecule extension traces (Figure 1F-H; S3), the kinesin-2 traces often show jumps in position at the beginning of runs (e.g., the four runs from ~4-13 s in Fig. 1G). These jumps are not apparent in the kinesin-1 and -3 traces. What is the explanation? Is kinesin-2 binding accelerated by resisting loads more strongly than kinesin-1 and -3?

When comparing the durations of unloaded and stall events (Fig. 2), there is a potential for bias in the measurement, where very long unloaded runs cannot be observed due to the limited length of the microtubule (Thompson, Hoeprich, and Berger, 2013), while the duration of tethered runs is only limited by photobleaching. Was the possible censoring of the results addressed in the analysis?

The mathematical model is helpful in interpreting the data. To assess how the "slip" state contributes to the association kinetics, it would be helpful to compare the proposed model with a similar model with no slip state. Could the slips be explained by fast reattachments from the detached state?

Reviewer #1 (Public review):

The study addresses the organisation of synaptic connections from the medial to the lateral entorhinal cortex. Classic anatomical work has suggested these connections exist, but very little is known about their identity or functional impact. The manuscript argues that these projections are mediated by glutamatergic neurons, providing excitatory input from MEC to all layers of LEC, and by SST+ve interneurons sending inhibitory projections to L1 of LEC. This appears to be the most likely interpretation of the data, although in my opinion, more could be done to rule out the possible impact of the spread of the virus/tracer from the injection site.

While this concern might seem overly picky, the importance of this level of detail is nicely shown by the authors' previous work clarifying connectivity from postrhinal to entorhinal cortices through careful analysis of similar types of data (Doan et al. 2019). If additional analyses/data can address the concern here, then I think this will be an important set of fundamental results that will influence thinking about circuit mechanisms for spatial cognition and episodic memory. In particular, it will nicely add to an emerging view that MEC and LEC can interact directly, showing that the organisation of these interactions is asymmetric and identifying a potentially interesting long-range inhibitory pathway.

Reviewer #2 (Public review):

Summary:

The manuscript by Nilssen et al. presents a comprehensive study of the circuitry linking the medial and lateral entorhinal cortices (MEC and LEC). Using a combination of anatomical tracing, optogenetics, and in vitro electrophysiology, the authors convincingly demonstrate that the MEC sends both glutamatergic and long-range inhibitory SST+ GABAergic projections to the LEC, with distinct laminar and cell-type-specific targeting. Notably, they reveal that SST+ inhibitory projections selectively suppress the activity of layer IIa neurons, whereas excitatory inputs preferentially engage neurons in layers IIb and III, thereby differentially modulating hippocampal-projecting populations.

Strengths:

The experiments are carefully executed, the results are compelling, and the conclusions are well supported by the data. This work will be of broad interest to researchers studying memory circuits, cortical inhibition, and the organization of long-range connectivity.

Weaknesses:

Although the in vivo relevance of these connections remains to be determined, this is an important and timely contribution to our understanding of entorhinal-hippocampal interactions.

Reviewer #1 (Public review):

Fombellida-Lopez and colleagues describe the results of an ART intensification trial in people with HIV infection (PWH) on suppressive ART to determine the effect of increasing the dose of one ART drug, dolutegravir, on viral reservoirs, immune activation, exhaustion, and circulating inflammatory markers. The authors hypothesize that ART intensification will provide clues about the degree to which low-level viral replication is occurring in circulation and in tissues despite ongoing ART, which could be identified if reservoirs decrease and/or if immune biomarkers change. The trial design is straightforward and well-described, and the intervention appears to have been well tolerated. The investigators observed an increase in dolutegravir concentrations in circulation, and to a lesser degree in tissues, in the intervention group, indicating that the intervention has functioned as expected (ART has been intensified in vivo). Several outcome measures changed during the trial period in the intervention group, leading the investigators to conclude that their results provide strong evidence of ongoing replication on standard ART. The results of this small trial are intriguing, and a few observations in particular are hypothesis-generating and potentially justify further clinical trials to explore them in depth.

Reviewer #2 (Public review):

Summary:

An intensification study with a double dose of 2nd generation integrase inhibitor with a background of nucleoside analog inhibitors of the HIV retrotranscriptase in 2, and inflammation is associated with the development of co-morbidities in 20 individuals randomized with controls, with an impact on the levels of viral reservoirs and inflammation markers. Viral reservoirs in HIV are the main impediment to an HIV cure, and inflammation is associated with co-morbidities.

Strengths:

The intervention that leads to a decrease of viral reservoirs and inflammation is quite straightforward forward as a doubling of the INSTI is used in some individuals with INSTI resistance, with good tolerability.

This is a very well documented study, both in blood and tissues, which is a great achievement due to the difficulty of body sampling in well-controlled individuals on antiretroviral therapy. The laboratory assays are performed by specialists in the field with state-of-the art quantification assays. Both the introduction and the discussion are remarkably well presented and documented.

The findings also have a potential impact on the management of chronic HIV infection.

Reviewer #3 (Public review):

The introduction does a very good job of discussing the issue around whether there is ongoing replication in people with HIV on antiretroviral therapy. Sporadic, non-sustained replication likely occurs in many PWH on ART related to adherence, drug-drug interactions and possibly penetration of antivirals into sanctuary areas of replication and as the authors point out proving it does not occur is likely not possible and proving it does occur is likely very dependent on the population studied and the design of the intervention. Whether the consequences of this replication in the absence of evolution toward resistance have clinical significance challenging question to address.

It is important to note that INSTI-based therapy may have a different impact on HIV replication events that results in differences in virus release for specific cell type (those responsible for "second phase" decay) by blocking integration in cells that have completed reverse transcription prior to ART initiation but have yet to be fully activated. In a PI or NNRTI-based regimen, those cells will release virus, whereas with an INSTI-based regimen, they will not.

Given the very small sample size, there is a substantial risk of imbalance between the groups in important baseline measures.

Comments on the revised version from the editor:

I appreciate that the authors thoroughly address the reviewer's concerns in the response letter. Most importantly, they acknowledge that "The absence of a pre-specified statistical endpoint or sample size calculation reflects the exploratory nature of the trial." This is vital because the transient impact on total HIV DNA in the intensified versus standard dose arm raises questions about any sustained or meaningful anti-reservoir effect and was also not hypothesized a priori. The authors explanation that HIV DNA may have rebounded due to clonal expansion is interesting but not assessed directly in the trial.

The greater decrease in intact HIV DNA between days 0 and 84 in the intensified arm are notable but are somewhat limited by small sample size, small effect size and lack of data between these two timepoints.

Unfortunately, the hypothesis generating nature of the conclusions which is outlined nicely in the author's response letter is only acknowledged in the discussion of the revised paper. The abstract and results are only marginally different than the original version and still read as definitive when the evidence is only hypothesis generating. For these reasons, the level of evidence remains incomplete as before.

Reviewer #1 (Public review):

Summary:

Persistence is a phenomenon by which genetically susceptible cells are able to survive exposure to high concentrations of antibiotics. This is especially a major problem when treating infections caused by slow growing mycobacteria such as M. tuberculosis and M. abscessus. Studies on the mechanisms adopted by the persisting bacteria to survive and evade antibiotic killing can potentially lead to faster and more effective treatment strategies.

To address this, in this study, the authors have used a transposon mutagenesis based sequencing approach to identify the genetic determinants of antibiotic persistence in M. abscessus. To enrich for persisters they employed conditions, that have been reported previously to increase persister frequency - nutrient starvation, to facilitate genetic screening for this phenotype. M.abs transposon library was grown in nutrient rich or nutrient depleted conditions and exposed to TIG/LZD for 6 days, following which Tn-seq was carried out to identify genes involved in spontaneous (nutrient rich) or starvation-induced conditions. About 60% of the persistence hits were required in both the conditions. Pathway analysis revealed enrichment for genes involved in detoxification of nitrosative, oxidative, DNA damage and proteostasis stress. The authors then decided to validate the findings by constructing deletions of 5 different targets (pafA, katG, recR, blaR, Mab_1456c) and tested the persistence phenotype of these strains. Rather surprisingly only 2 of the 5 hits (katG and pafA) exhibited a significant persistence defect when compared to wild type upon exposure to TIG/LZD and this was complemented using an integrative construct. The authors then investigated the specificity of delta-katG susceptibility against different antibiotic classes and demonstrated increased killing by rifabutin. The katG phenotype was shown to be mediated through the production of oxidative stress which was reverted when the bacterial cells were cultured under hypoxic conditions. Interestingly, when testing the role of katG in other clinical strains of Mab, the phenotype was observed only in one of the clinical strains demonstrating that there might be alternative anti-oxidative stress defense mechanisms operating in some clinical strains.

Strengths:

While the role of ROS in antibiotic mediated killing of mycobacterial cells have been studied to some extent, this paper presents some new findings with regards to genetic analysis of M. abscessus susceptibility, especially against clinically used antibiotics, which makes it useful. Also, the attempts to validate their observations in clinical isolates is appreciated.

Weaknesses:

Amongst the 5 shortlisted candidates from the screen, only 2 showed marginal phenotypes which limits the impact of the screening approach.

While the role of KatG mediated detoxification of ROS and involvement of ROS in antibiotic killing was well demonstrated, the lack of replication of this phenotype in some of the clinical isolates limits the significance of these findings.